Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3028026	p-igm	g/l (g/l)	19629	37639	0.01%
3028026	s-igm	g/l (g/l)	7307	10838	0.04%
3028026	p-igm	— (—)	2541	3678	100.00%	Distribution not available
3028026	s-igm	— (—)	957	1437	100.00%	Distribution not available
3028026	p-igm	g/l_______ (g/l)	438	575	0.00%
3028026	s-igm	g/l_______ (g/l)	22	22	0.00%
3028026	s-immunoglobuliinim	g/l_______ (g/l)	21	21	0.00%
3028026	igm	g/l (g/l)	7	7	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic sinusitis

2639

12029

2.34

323.31

2.1

1.9

1.18

1.34

g/l

4.61

2442

11112

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

5425

19424

1.83

323.01

2.1

1.9

1.21

1.33

g/l

3.79

5019

17964

IBD (strict) with PSC

279

229

41.34

318.77

3.8

1.5

1.31

1.24

g/l

0.19

274

212

Neurological diseases, wide definition

1597

2579

3.28

318.28

1.9

1.24

1.36

g/l

1.17

1505

2417

Gastro-oesophageal reflux disease

3816

16715

2.02

317.89

1.9

2.0

1.32

1.29

g/l

0.33

3481

15423

Agranulocytosis

976

2699

4.28

317.60

3.0

1.9

1.18

1.35

g/l

1.46

918

2491

Diffuse large B-cell lymphoma, including Hilmo

533

907

7.69

316.95

3.4

1.4

1.13

1.16

g/l

0.12

507

837

Diffuse large B-cell lymphoma, helper endpoint

533

907

7.69

316.95

3.4

1.4

1.13

1.16

g/l

0.12

507

837

Diffuse large B-cell lymphoma

533

907

7.69

316.95

3.4

1.4

1.13

1.16

g/l

0.12

507

837

Ulcerative colitis, NAS

1141

3479

3.75

316.74

2.0

1.9

1.24

1.32

g/l

0.83

1077

3233

Codeine or tramadol medication

6044

19123

1.78

315.92

1.9

1.27

1.32

g/l

0.98

5576

17658

Other special examinations and investigations of persons without complaint or reported diagnosis

3384

8140

2.20

315.90

1.9

1.24

1.31

g/l

0.86

3141

7495

Abdominal and pelvic pain

5153

14286

1.88

314.71

1.9

1.23

1.30

g/l

1.56

4779

13166

Asthma, including avohilmo

6418

20981

1.74

314.32

1.9

2.0

1.27

1.31

g/l

0.73

5986

19322

Undetermined asthma, excluding more controls

898

2325

4.29

312.46

2.2

1.8

1.13

1.41

g/l

4.52

840

2130

Other diseases of pleura

2581

10175

2.35

312.29

2.1

2.0

1.24

1.34

g/l

1.13

2381

9268

Intestinal infectious diseases, including avohilmo, including avohilmo

6194

20404

1.75

308.15

2.0

1.9

1.25

1.31

g/l

1.18

5713

18834

Bacterial infection, other or unspecified, including avohilmo

4566

12329

3.35

307.65

2.3

1.9

1.21

1.36

g/l

3.52

4228

11296

Cough

2509

10072

2.48

307.65

2.0

1.9

1.12

1.36

g/l

12.25

2337

9261

Renal failure

3505

10183

3.23

307.65

2.2

1.9

1.23

1.36

g/l

2.11

3230

9257

Other acute lower respiratory infections

3251

15038

2.18

307.65

2.3

1.9

1.27

1.30

g/l

0.34

2990

13860

Asthma-related infections

4095

16989

2.52

307.65

2.0

1.9

1.25

1.30

g/l

0.81

3812

15623

5-aminosalicylic acid

1661

4499

4.16

307.65

2.0

1.8

1.26

1.29

g/l

0.27

1580

4133

Other disorders of fluid, electrolyte and acid-base balance

1959

7302

2.73

307.65

2.0

2.1

1.31

1.43

g/l

1.15

1785

6653

Other bacterial diseases, including avohilmo

7060

18122

2.60

307.65

2.1

1.9

1.23

1.31

g/l

2.40

6574

16706

Asthma, unspecified (mode), excluding more controls

3259

7850

3.18

307.65

1.9

1.8

1.28

1.39

g/l

1.49

3039

7240

Other pulmonary diagnosis

4253

9081

2.46

307.65

2.0

1.8

1.27

1.36

g/l

1.47

3960

8400

Condition for Implicit Sepsis (Organ dysfunction codes)

5134

16981

2.21

307.65

2.0

1.9

1.32

1.29

g/l

0.25

4731

15660

Bacterial Sepsis

3581

9777

3.34

307.65

2.2

1.9

1.31

1.34

g/l

0.29

3280

8942

Certain infectious and parasitic diseases

5627

12677

2.34

307.65

2.1

1.7

1.28

1.30

g/l

0.30

5213

11741

Other soft tissue disorders, not elsewhere classified

5242

16257

1.91

307.65

1.9

2.0

1.23

1.30

g/l

1.86

4833

15032

Anaemias

2172

2263

7.10

307.65

2.3

1.7

1.32

1.27

g/l

0.60

2041

2139

Septicaemia

3207

9299

3.48

307.65

2.3

1.9

1.25

1.36

g/l

1.37

2952

8502

All kidney diseases

6165

19740

2.21

307.65

2.1

1.9

1.24

1.31

g/l

1.72

5710

18228

Disorders of gallbladder, biliary tract and pancreas

5923

18464

2.10

307.65

2.0

1.9

1.32

1.31

g/l

0.09

5503

16984

Other respiratory diseases principally affecting the interstitium

1449

4114

4.05

307.65

2.2

1.9

1.11

1.35

g/l

4.97

1361

3709

Malaise and fatigue

3192

9810

2.73

307.65

2.0

1.8

1.32

1.33

g/l

0.04

2931

8962

Noninfective enteritis and colitis

3455

13430

2.81

307.65

2.0

1.9

1.24

1.29

g/l

0.70

3252

12373

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6215

13674

2.85

307.65

2.2

1.7

1.23

1.33

g/l

2.69

5727

12645

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2250

3367

9.64

307.65

1.6

2.0

1.54

1.29

g/l

4.66

2092

3095

6499

16983

2.03

307.65

2.2

1.8

1.28

1.32

g/l

0.78

5984

15659

Other systemic involvement of connective tissue (FG)

2253

5678

4.47

307.65

2.0

1.37

1.41

g/l

0.31

2112

5149

Other interstitial pulmonary diseases

1303

3472

4.39

307.65

2.3

1.9

1.13

1.39

g/l

4.45

1224

3134

Cholangitis (primary sclerosing, PSC), with reimbursement 202

468

410

29.47

307.65

3.3

1.7

1.34

1.28

g/l

0.23

455

377

Explicit Sepsis, including avohilmo

3387

10451

3.23

307.65

2.3

1.9

1.25

1.34

g/l

1.41

3119

9581

Liquid cancers, including Hilmo

4208

7499

6.08

307.65

3.8

1.6

1.78

1.20

g/l

12.31

3867

6878

Interstitial lung disease

1303

3481

4.38

307.65

2.3

1.9

1.13

1.38

g/l

4.37

1224

3145

Heart failure, not strict

4763

13335

2.58

307.65

2.1

2.0

1.23

1.35

g/l

2.71

4423

12232

Viral Sepsis

1603

4843

3.71

307.65

2.6

1.9

1.28

1.37

g/l

0.65

1496

4425

Implicit viral Sepsis, including avohilmo

2123

7372

3.15

307.65

2.5

1.9

1.30

1.36

g/l

0.48

1975

6742

Renal tubulo-interstitial diseases

5584

18843

2.31

307.65

2.1

1.9

1.24

1.32

g/l

2.19

5157

17377

Asthma, hospital admissions 3, pneumonia

2540

9639

2.86

307.65

2.2

1.9

1.23

1.31

g/l

0.89

2355

8780

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1003

830

23.69

307.65

5.1

1.3

3.23

1.14

g/l

20.29

902

761

Multiple myeloma and malignant plasma cell neoplasms

959

988

18.62

307.65

6.3

1.7

0.77

1.59

g/l

6.77

818

900

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

619

454

29.15

307.65

5.5

1.3

0.50

1.16

g/l

11.17

506

414

Excluding asthma or asthma-COPD overlap

4247

9081

2.46

307.65

2.0

1.8

1.28

1.36

g/l

1.19

3953

8400

Non-follicular lymphoma

1072

2112

6.58

307.65

3.4

1.9

1.59

1.26

g/l

1.97

1015

1926

Non-Hodgkin lymphoma, all, including Hilmo

1531

2571

7.68

307.65

3.5

1.5

1.94

1.19

g/l

7.47

1454

2346

Asthma, hospital admissions , main diagnosis only

4767

22245

1.95

307.65

1.9

1.27

1.30

g/l

0.40

4448

20494

Other septicaemia

2831

8378

3.53

307.65

2.3

1.9

1.27

1.37

g/l

1.11

2614

7648

Hernia of abdominal wall, postoperative

1000

2528

4.25

307.65

1.9

1.7

1.36

1.49

g/l

0.57

920

2319

General symptoms and signs

6807

13975

2.59

307.65

2.0

1.8

1.28

1.30

g/l

0.31

6359

12867

Autoimmune hepatitis, wide definition

714

782

13.70

307.65

2.1

1.8

1.40

1.49

g/l

0.31

678

704

Metabolic disorders

5314

17097

1.95

307.65

1.9

2.0

1.17

1.34

g/l

8.27

4912

15790

Asthma

4815

8991

2.94

307.65

1.9

1.8

1.22

1.36

g/l

4.32

4498

8317

Asthma, hospital admission 2, infections

4095

16989

2.52

307.65

2.0

1.9

1.25

1.30

g/l

0.81

3812

15623

Cholangitis (primary sclerosing, PSC)

822

1324

8.43

307.65

2.7

1.8

1.27

1.38

g/l

0.69

787

1213

Multiple myeloma, including Hilmo

937

766

24.01

307.65

6.4

1.4

0.76

1.15

g/l

3.08

798

702

Autoimmune diseases excluding thyroid diseases, strict definition

8291

13947

3.54

307.65

2.1

1.9

1.29

1.30

g/l

0.11

7807

12763

Abnormal findings on examination of blood, without diagnosis

4281

11273

3.93

307.65

2.3

1.9

1.51

1.27

g/l

5.32

4025

10321

Asthma, unspecified (mode)

3332

8491

3.03

307.65

1.9

1.8

1.28

1.37

g/l

1.41

3102

7839

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1819

6537

3.09

307.65

1.9

1.28

1.33

g/l

0.39

1706

5962

Lymphoid leukaemia

641

1220

6.97

307.65

2.4

1.9

0.99

1.44

g/l

3.16

582

1120

Any reimbursement code in KELA

3517

5353

3.51

307.65

2.0

1.4

1.23

1.36

g/l

2.95

3309

4940

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

237

126

104.95

307.65

14.8

1.3

14.46

1.13

g/l

37.81

228

119

Opioids

5406

14203

2.05

307.65

2.0

1.8

1.29

1.33

g/l

0.71

5033

13160

Asthma-related pneumonia

2534

9617

2.86

307.65

2.2

1.9

1.23

1.31

g/l

0.90

2350

8758

Other/unspecified seropositive rheumatoid arthritis

1831

6641

3.06

307.65

1.9

1.29

1.33

g/l

0.42

1718

6051

Oedema, not elsewhere classified

1960

7108

2.90

307.65

2.0

1.9

1.31

1.36

g/l

0.35

1791

6474

Other septicaemia, including avohilmo

2891

8567

3.50

307.65

2.3

1.9

1.26

1.37

g/l

1.31

2670

7823

Multiple myeloma

619

454

29.15

307.65

5.5

1.3

0.50

1.16

g/l

11.17

506

414

First line medication for Crohn's disease

9200

13972

3.90

307.65

2.2

1.6

1.23

1.35

g/l

4.78

8590

12822

Immunodeficiency with predominantly antibody defects

651

610

27.29

307.65

5.2

1.8

0.94

1.36

g/l

4.63

597

570

Abnormalities of breathing

5459

14399

2.28

307.65

1.9

1.21

1.33

g/l

4.27

5053

13310

Implicit Sepsis, including avohilmo

5131

16683

2.33

307.65

2.0

1.9

1.30

g/l

0.01

4725

15369

Pain in joint

3354

9314

2.33

307.65

1.9

1.25

1.34

g/l

1.90

3087

8606

Asthma-related pneumonia or sepsis

2540

9639

2.86

307.65

2.2

1.9

1.23

1.31

g/l

0.89

2355

8780

Methotrexate

1019

2675

4.31

307.65

2.0

1.9

1.21

1.35

g/l

1.68

941

2423

Acute upper respiratory infections of multiple and unspecified sites

4479

16863

2.03

307.65

2.3

1.8

1.23

1.33

g/l

2.39

4152

15564

Acute sinusitis

3167

13765

2.21

307.65

2.3

1.8

1.24

1.31

g/l

1.31

2931

12757

Gout

1693

5222

3.01

307.65

2.3

2.1

1.24

1.39

g/l

1.41

1571

4742

Iron deficiency anaemia

2773

11523

2.54

307.65

2.0

1.35

g/l

0.01

2547

10547

Other and unspecified anaemias

3518

9884

3.76

307.65

2.4

1.9

1.41

1.33

g/l

0.72

3211

9021

Second line medication for Crohn's disease

5948

15778

4.39

307.65

2.5

1.8

1.15

1.34

g/l

11.59

5561

14559

COPD/asthma related infections

5928

13674

2.28

307.65

2.1

1.7

1.25

1.33

g/l

1.68

5470

12645

Other heart diseases

2730

7720

2.43

307.65

2.0

1.9

1.24

1.33

g/l

1.57

2547

7189

Other arthritis (FG)

2043

7545

2.94

307.65

1.9

2.0

1.28

1.34

g/l

0.66

1929

6921

Nonhereditary hypogammaglobulinemia

305

258

42.67

307.65

5.9

1.6

0.93

1.44

g/l

2.07

268

240

Asthma (only as main-diagnosis)

4486

8991

2.98

307.65

1.9

1.8

1.28

1.36

g/l

1.33

4187

8317

Transplanted organ and tissue status

1214

2304

6.96

307.65

3.0

1.9

1.12

1.30

g/l

2.12

1147

2149

Purpura and other haemorrhagic conditions

1339

3346

4.83

307.65

2.3

2.0

1.22

1.34

g/l

1.23

1250

3080

Nonalcoholic fatty liver disease

1873

2568

11.76

307.65

1.5

2.0

1.21

1.31

g/l

1.37

1730

2393

Bronchitis

6401

20430

1.96

307.65

2.2

1.8

1.27

1.32

g/l

0.91

5893

18858

Codes for special purposes

3299

15622

2.23

307.65

2.4

1.9

1.30

1.31

g/l

0.06

3072

14408

Rheumatoid arthritis, including avohilmo

2600

10135

2.81

307.65

1.8

1.9

1.26

1.36

g/l

1.62

2432

9272

Provisional assignment of new diseases of uncertain etiology

3297

15608

2.23

307.65

2.4

1.9

1.30

1.31

g/l

0.06

3070

14396

COPD differential diagnosis

4205

9096

2.43

307.65

2.0

1.8

1.27

1.36

g/l

1.35

3916

8413

6215

13674

2.85

307.65

2.2

1.7

1.23

1.33

g/l

2.69

5727

12645

Symptoms and signs involving the digestive system and abdomen

5448

14286

1.99

307.65

1.9

1.25

1.30

g/l

0.92

5054

13166

Secondary and unspecified malignant neoplasm of lymph nodes

868

1678

6.45

307.65

3.0

1.5

1.11

1.16

g/l

0.36

818

1537

MS-disease / Multiple Sclerosis

881

1717

6.70

307.65

3.8

1.8

1.00

1.39

g/l

9.90

867

1603

Intestinal infectious diseases

5358

22337

1.86

307.65

2.1

1.9

1.25

1.31

g/l

1.03

4937

20631

Oral corticosteroids

9153

15332

3.88

307.65

2.0

1.9

1.24

1.33

g/l

2.82

8542

14026

3166

12847

2.64

307.65

2.1

1.9

1.22

1.30

g/l

1.41

2951

11847

Seropositive rheumatoid arthritis

1854

5464

3.78

307.65

1.9

2.0

1.28

1.39

g/l

1.18

1740

4939

ILD differential diagnosis

4202

9093

2.43

307.65

2.0

1.8

1.28

1.36

g/l

1.34

3913

8410

Secondary uncertain malignant neoplasm

1034

2627

4.51

307.65

2.8

1.5

1.16

1.17

g/l

0.04

967

2393

Cirrhosis of liver, NAS

1138

1157

19.35

307.65

1.6

1.9

1.52

1.37

g/l

0.83

1068

1063

Primary biliary cholangitis (PBC)

494

335

33.10

307.65

2.6

1.8

2.71

1.47

g/l

9.04

463

297

Persons encountering health services for specific procedures and health care

6027

19876

1.86

307.65

2.1

1.9

1.23

1.31

g/l

1.98

5581

18373

Biological medication for rheuma

1685

4951

3.97

307.65

1.7

1.9

1.23

1.26

g/l

0.34

1611

4615

Codeine

5079

13967

2.05

307.65

1.9

1.8

1.25

1.33

g/l

1.80

4705

12941

Seropositive rheumatoid arthritis, wide

1853

6714

3.06

307.65

1.9

1.28

1.34

g/l

0.50

1739

6121

Sulfasalazine

1836

6057

3.31

307.65

1.8

1.27

1.33

g/l

0.65

1732

5525

Abnormal findings on diagnostic imaging of lung

3115

11958

2.67

307.65

2.0

1.29

1.35

g/l

0.66

2880

10889

Polyarthropathies

5055

11906

2.96

307.65

2.0

1.25

1.32

g/l

1.41

4731

10977

All pneumoniae

6917

19600

2.44

307.65

2.2

1.8

1.21

1.31

g/l

3.17

6378

18157

Primary_lymphoid and hematopoietic malignant neoplasms

3544

5273

9.28

307.65

4.2

1.5

1.89

1.17

g/l

13.65

3258

4786

Other and unspecified immunodeficiencies with predominantly antibody defects

333

302

36.13

307.65

6.1

1.6

0.84

1.43

g/l

3.64

313

282

Tramadol

4838

12807

2.40

307.65

2.0

1.8

1.27

1.34

g/l

1.27

4468

11858

Kela reimbursement Agammaglobulinemia (D80-84)

271

201

72.83

307.65

6.4

1.5

0.92

1.47

g/l

1.78

236

191

Immunodeficiencies

867

1107

13.41

307.65

4.7

1.8

1.03

1.35

g/l

2.95

796

1030

Pain in throat and chest

4523

14084

1.98

307.65

1.8

1.9

1.23

1.33

g/l

2.84

4155

13013

Implicit bacterial Sepsis

3092

8665

3.37

307.65

2.1

1.9

1.30

1.35

g/l

0.52

2834

7893

Dialysis, with operation codes

1039

2847

4.26

307.65

2.5

1.9

1.18

1.34

g/l

1.38

973

2613

Asthma, excluding more controls

4679

8329

3.08

307.65

1.9

1.8

1.22

1.37

g/l

4.81

4380

7699

Aplastic and other anaemias

3791

10575

3.68

307.65

2.3

1.9

1.39

1.33

g/l

0.55

3460

9667

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4761

16271

2.77

307.65

2.1

2.0

1.27

1.33

g/l

1.05

4414

14899

Acute renal failure

1758

5025

3.98

307.65

2.2

1.9

1.25

1.35

g/l

0.88

1624

4551

Other specified/unspecified arthritis

1807

6759

2.91

307.65

2.0

1.25

1.35

g/l

1.06

1707

6206

Systemic connective tissue disorders

3214

9059

4.10

307.65

2.0

1.9

1.28

1.37

g/l

1.20

3012

8268

Tumor necrosis factor alpha inhibitors

1436

4446

3.73

307.65

1.6

2.0

1.24

1.25

g/l

0.13

1368

4141

Other anaemias

3533

9955

3.73

307.65

2.4

1.9

1.41

1.33

g/l

0.72

3226

9089

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1818

2799

3.42

307.65

1.9

1.7

1.26

1.28

g/l

0.16

1711

2573

Azathioprine

1635

3029

6.67

307.65

2.2

1.8

1.22

1.28

g/l

0.54

1551

2785

Chronic hepatitis, not elsewhere classified

635

658

17.02

307.65

2.1

1.8

1.49

1.43

g/l

0.17

598

607

Asthma (only as main-diagnosis), excluding more controls

4395

8329

3.12

307.65

1.9

1.8

1.24

1.37

g/l

3.34

4107

7699

Alcoholic liver disease

1215

1981

8.12

307.65

1.4

2.1

1.64

1.29

g/l

4.50

1107

1816

Other and unspecified iron deficiency

2255

9118

2.67

307.65

2.0

1.9

1.36

1.35

g/l

0.13

2067

8347

Other diseases of blood and blood-forming organs, wide

2092

5680

4.35

307.65

2.5

1.9

1.26

1.33

g/l

0.61

1945

5230

Coagulation defects, purpura and other haemorrhagic conditions

1692

5085

3.83

307.65

2.3

1.9

1.25

1.32

g/l

0.75

1583

4672

Certain disorders involving the immune mechanism

1846

4919

4.48

307.65

3.3

1.9

1.10

1.32

g/l

5.38

1713

4549

Inflammatory bowel disease

2449

8802

3.09

307.65

2.0

1.9

1.25

1.30

g/l

0.66

2318

8138

Any gastric operation

5223

7067

3.98

307.65

2.0

1.6

1.29

1.31

g/l

0.22

4858

6550

Certain infectious and parasitic diseases, including avohilmo

3626

8685

2.18

307.65

2.0

1.8

1.29

1.30

g/l

0.09

3361

8019

IBD patients in KELA-register

1869

6154

3.42

307.65

2.0

1.9

1.24

1.30

g/l

0.81

1773

5727

COPD/asthma/ILD related infections

5928

13674

2.28

307.65

2.1

1.7

1.25

1.33

g/l

1.68

5470

12645

Osteopathies and chondropathies

3402

15185

2.17

307.65

2.4

1.9

1.28

1.32

g/l

0.47

3097

13999

Headache

3682

13067

2.29

307.65

2.0

1.8

1.28

1.31

g/l

0.49

3434

12040

Budesonide

1246

2883

5.03

307.65

2.1

1.8

1.37

1.32

g/l

0.35

1165

2638

Other diseases of liver

2956

4079

10.44

307.65

1.7

2.0

1.28

1.27

g/l

0.16

2718

3782

Oesophageal varices

670

904

11.81

307.65

1.7

2.0

1.60

1.36

g/l

1.50

626

835

Cardiovascular diseases (excluding rheumatic etc)

3643

9814

2.23

307.65

1.8

1.9

1.25

1.32

g/l

1.08

3423

9163

Rheumatoid arthritis

2366

6940

3.33

307.65

1.8

2.0

1.26

1.38

g/l

1.78

2215

6332

Fever of other and unknown origin

5086

11904

4.15

307.65

2.4

1.8

1.26

1.31

g/l

0.71

4729

10916

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6692

19705

2.41

307.65

2.2

1.8

1.22

1.31

g/l

2.78

6167

18242

L04AX Other immunosuppressants

5679

15413

4.28

307.65

2.6

1.8

1.14

1.34

g/l

11.60

5305

14230

Liquid cancers

3966

6404

7.60

307.65

3.9

1.5

1.82

1.19

g/l

13.05

3648

5865

Dyspnoea

5422

19797

2.08

307.65

2.0

1.9

1.27

1.32

g/l

0.94

5024

18224

Used for control exclusion in common control thyroid runs

7028

13400

2.82

307.65

2.0

1.9

1.26

1.30

g/l

0.79

6586

12259

Other bacterial diseases

6824

17696

2.76

307.65

2.2

1.9

1.23

1.31

g/l

2.12

6320

16303

Erysipelas, including avohilmo

3852

14546

2.05

307.65

1.9

1.32

1.33

g/l

0.02

3547

13343

Heart failure,strict

2947

8870

2.47

307.65

2.1

2.0

1.20

1.38

g/l

3.30

2732

8076

Other diseases of intestines

6036

18177

1.93

307.65

2.0

1.9

1.26

1.30

g/l

0.68

5588

16830

Covid-19 confirmed case

2521

10095

2.71

307.65

2.5

1.9

1.27

1.33

g/l

0.57

2338

9241

Finngen Rheumatological endpoints

5727

15415

2.22

307.65

1.9

1.29

1.31

g/l

0.23

5341

14201

Chronic kidney disease

2321

6938

3.58

307.65

2.2

1.9

1.19

1.40

g/l

3.31

2139

6266

Symptoms and signs involving the circulatory and respiratory systems

5459

14438

1.97

307.65

1.9

1.25

1.33

g/l

1.80

5093

13346

L04AA Selective immunosuppressants

2713

5883

5.83

307.65

2.5

1.9

1.15

1.30

g/l

4.35

2595

5439

Influenza and pneumonia

7172

19244

2.45

307.65

2.3

1.8

1.21

1.31

g/l

3.33

6615

17830

Mucosal proctocolitis

1100

3178

4.00

307.65

2.1

1.9

1.26

1.31

g/l

0.42

1045

2959

Colitis, primary sclerosing

357

319

29.85

307.65

3.5

1.6

1.28

1.29

g/l

0.03

350

299

Demyelinating diseases of the central nervous system

975

2067

6.00

307.65

3.7

1.8

1.06

1.38

g/l

5.13

958

1927

Sicca syndrome [Sjögren]

832

1912

5.37

307.65

2.1

1.9

1.32

1.39

g/l

0.46

780

1749

Fibrosis and cirrhosis of liver

1676

1529

21.47

307.65

1.8

2.1

1.82

1.36

g/l

6.19

1573

1403

Medical observation and evaluation for suspected diseases and conditions

3575

8139

2.35

307.65

2.0

1.9

1.29

1.31

g/l

0.19

3273

7495

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5952

18174

1.80

307.65

1.9

1.24

1.30

g/l

1.24

5576

16688

Gastrointestinal diseases

3341

5802

3.05

307.65

1.9

1.28

1.30

g/l

0.13

3112

5377

Persons encountering health services in other circumstances, wide

6209

18203

1.82

307.65

1.9

1.26

1.31

g/l

0.86

5796

16709

GASTRO-related operations

5223

7067

3.98

307.65

2.0

1.6

1.29

1.31

g/l

0.22

4858

6550

Ulcerative colitis

1854

6539

3.15

307.65

2.0

1.9

1.24

1.30

g/l

0.79

1758

6063

Hepatic failure, not elsewhere classified

517

696

10.80

307.65

1.9

1.50

1.37

g/l

0.46

486

638

Diseases of oesophagus, stomach and duodenum

6473

18969

2.12

307.65

1.9

1.30

1.29

g/l

0.13

5962

17533

Primary Sclerosing Cholangitis, IBD and UDCA required

571

440

34.48

307.65

3.3

1.8

1.39

1.25

g/l

0.68

558

408

Acute upper respiratory infections

5787

19309

1.87

307.65

2.2

1.8

1.25

1.33

g/l

2.02

5339

17775

Implicit Sepsis

4907

15443

2.50

307.65

2.1

1.9

1.28

1.31

g/l

0.51

4518

14210

Hypertensive diseases (excluding secondary)

2922

7461

2.41

307.65

1.8

1.9

1.18

1.34

g/l

5.39

2733

6941

Inflammatory bowel disease, strict (require KELA)

1869

6392

3.28

307.65

2.0

1.9

1.24

1.29

g/l

0.67

1773

5943

Diseases of liver

5836

8114

10.20

307.65

1.7

2.0

1.43

1.26

g/l

5.78

5401

7476

Bacterial infection, other or unspecified

4257

11412

3.49

307.65

2.3

1.9

1.20

1.36

g/l

3.28

3934

10431

Oxycodone

2359

8276

2.60

307.65

2.6

1.9

1.18

1.38

g/l

2.76

2135

7594

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8731

17460

3.76

307.65

2.3

1.8

1.29

1.30

g/l

0.16

8087

16118

Thrombocytopenia, unspecified

850

1661

6.69

307.65

2.2

1.9

1.22

1.36

g/l

0.93

806

1523

Other inflammatory liver diseases

841

1296

8.89

307.65

2.1

2.0

1.37

1.34

g/l

0.13

800

1185

Autoimmune diseases

7636

14446

2.87

307.65

2.0

1.9

1.26

1.30

g/l

0.78

7158

13226

All chronic kidney diseases

3760

11648

2.78

307.65

2.3

1.9

1.23

1.34

g/l

1.90

3488

10667

Autoimmune diseases excluding thyroid diseases

8537

14361

3.53

307.65

2.1

1.9

1.29

1.31

g/l

0.29

8036

13150

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

5334

17697

2.14

307.65

2.0

1.9

1.31

1.28

g/l

0.42

4922

16347

ILD medications

10069

13918

4.34

307.65

2.2

1.6

1.21

1.37

g/l

7.73

9407

12746

Examination and observation for other reasons

3530

8100

2.60

307.65

1.9

1.28

1.31

g/l

0.25

3312

7462

Other systemic involvement of connective tissue

2316

6874

3.85

307.65

2.0

1.9

1.35

1.37

g/l

0.13

2167

6268

Caries of dentine

1744

5203

3.60

307.65

2.5

1.9

1.29

1.30

g/l

0.07

1601

4793

Explicit Sepsis

3324

10248

3.25

307.65

2.3

1.9

1.25

1.34

g/l

1.21

3061

9391

Nutritional anaemias

3121

13149

2.42

307.65

2.0

1.38

1.34

g/l

0.34

2858

12041

Bronchiectasis

769

1681

5.65

307.65

2.1

2.0

1.11

1.40

g/l

3.86

729

1517

ILD, hospital admissions 3, with pneumonia sepsis

793

1597

6.01

307.65

2.4

1.9

1.06

1.45

g/l

5.04

745

1443

Interstitial lung disease endpoints

1303

3481

4.38

307.65

2.3

1.9

1.13

1.38

g/l

4.37

1224

3145

Ascites

859

1531

7.21

307.65

1.6

2.0

1.45

1.46

g/l

0.06

801

1399

Abnormal serum enzyme levels

2373

7233

3.58

307.65

1.9

1.31

1.27

g/l

0.34

2249

6611

ILD, hospital admissions

1290

3445

4.39

307.65

2.3

1.9

1.12

1.38

g/l

4.58

1212

3114

Implicit bacterial Sepsis, including avohilmo

3337

9445

3.22

307.65

2.1

1.9

1.29

1.35

g/l

0.53

3059

8629

Enlarged lymph nodes

1467

3384

5.07

307.65

2.6

1.9

1.28

1.35

g/l

0.31

1372

3088

Asthma (diagnoses ohter than nonallergic)

5270

22056

2.03

307.65

1.9

1.25

1.31

g/l

1.16

4908

20319

Dental caries

1954

5821

3.52

307.65

2.5

1.9

1.28

1.30

g/l

0.13

1800

5362

Primary biliary cholangitis, wide definition

539

369

34.06

307.65

2.6

1.9

2.59

1.47

g/l

8.46

506

331

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

914

1569

7.61

307.65

3.4

1.9

2.30

1.43

g/l

5.15

848

1420

Asthma (mode)

4657

9093

2.86

307.65

1.9

1.8

1.23

1.36

g/l

3.99

4350

8410

Autoimmune diseases related-to ILD

7276

19318

3.48

307.65

2.1

1.9

1.22

1.34

g/l

4.77

6869

17665

Pneumonia, organism unspecified

6300

18143

2.55

307.65

2.2

1.8

1.22

1.31

g/l

2.83

5799

16786

ILD, hospital admissions 1, main diag only

1150

3125

4.32

307.65

2.2

1.9

1.09

1.39

g/l

5.48

1081

2822

Chronic lower respiratory diseases

6730

20074

1.83

307.65

1.9

2.0

1.25

1.31

g/l

1.36

6263

18504

Reimbursement for rheumatic diseases

5140

15373

3.77

307.65

2.0

1.9

1.34

1.29

g/l

0.91

4858

14067

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1150

977

10.09

307.65

2.3

2.2

1.13

1.52

g/l

2.42

1085

894

ILD medications: prednisolone, methylprednisolone, prednisone

9263

13630

4.18

307.65

2.1

1.6

1.24

1.37

g/l

5.24

8646

12470

ILD medications: immunosuppressive drugs

7580

12709

6.47

307.65

2.5

1.6

1.14

1.37

g/l

14.72

7132

11660

ILD, hospital admission 2, with pulmonary infections

951

1737

6.67

307.65

2.4

1.9

1.06

1.41

g/l

5.41

896

1560

Heart failure and antihypertensive medication

1543

3302

3.31

307.65

2.1

1.16

1.47

g/l

5.11

1445

3016

Infections, IBD-co-morbidities

1354

1575

6.91

307.65

2.2

2.0

1.27

1.44

g/l

1.00

1250

1457

ILD medications: azathioprine

1635

2698

7.52

307.65

2.2

1.6

1.22

1.35

g/l

1.67

1551

2483

Pneumonias (Asthma/COPD co-morbidities)

6903

19503

2.47

307.65

2.2

1.8

1.21

1.31

g/l

3.30

6367

18067

Cardiovascular diseases

3416

8473

2.24

307.65

1.9

1.24

1.31

g/l

1.68

3218

7930

Inflammatory bowel disease treatment related agents

9804

15874

3.78

307.65

2.1

1.9

1.25

1.32

g/l

2.00

9172

14538

Implicit viral Sepsis

1600

4835

3.71

307.65

2.6

1.9

1.28

1.37

g/l

0.65

1494

4417

L04AD Calcineurin inhibitors

1278

2798

5.89

307.65

2.7

2.0

1.25

1.26

g/l

0.08

1222

2612

Other specific joint derangements/joint disorders

4065

13308

1.99

306.31

1.9

2.0

1.26

1.31

g/l

1.06

3762

12316

Crohn disease

1088

3298

3.79

305.41

1.9

1.27

1.33

g/l

0.44

1031

3057

Gout, FINNGEN

1693

6463

2.81

303.96

2.3

2.0

1.24

1.36

g/l

1.08

1571

5857

Complications of surgical and medical care, not elsewhere classified

5418

20964

1.79

301.48

2.0

1.9

1.26

1.31

g/l

0.94

4991

19335

Colitis, primary sclerosing, strict definition

278

248

31.78

299.41

3.5

1.5

1.23

1.24

g/l

0.01

272

232

Viral hepatitis, IBD co-morbidity

468

720

7.61

299.00

1.4

1.9

1.63

1.30

g/l

3.61

440

668

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1068

3227

3.72

298.29

2.8

1.5

1.13

1.19

g/l

0.38

1002

2946

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1277

4314

3.34

298.13

2.1

1.9

1.26

1.29

g/l

0.31

1215

4015

Abnormal results of function studies

828

2133

4.63

298.07

1.9

2.0

1.23

1.35

g/l

1.05

759

1974

Non-Hodgkin lymphoma, all

468

739

8.11

297.62

4.1

1.4

2.84

1.14

g/l

6.68

441

672

Pain, not elsewhere classified

1674

6457

2.78

297.40

2.0

1.8

1.26

1.31

g/l

0.40

1570

5917

Diarrhoea and gastroenteritis of presumed infectious origin

3983

19222

1.93

296.17

2.1

1.9

1.25

1.31

g/l

0.88

3680

17763

Undetermined asthma

898

2423

4.11

294.85

2.2

1.8

1.13

1.40

g/l

4.34

840

2228

Heart failure, strict

3117

10619

2.15

294.59

2.0

1.21

1.37

g/l

3.28

2877

9663

Ulcerative colitis (strict definition, require KELA)

1298

4460

3.27

293.83

2.0

1.9

1.25

1.29

g/l

0.33

1233

4148

Bacterial pneumoniae

2286

8867

2.40

293.80

2.3

1.8

1.22

1.34

g/l

1.48

2103

8145

Erysipelas

2918

12236

2.16

292.46

1.9

1.33

1.35

g/l

0.19

2666

11195

Osteoporosis

1670

5941

2.81

292.15

2.5

1.9

1.31

1.37

g/l

0.40

1502

5383

Other necrotizing vasculopathies (FG)

567

1098

6.36

290.88

2.0

2.1

0.99

1.40

g/l

4.21

533

992

Autoimmune hepatitis

231

155

39.99

289.74

2.4

1.6

1.50

1.49

g/l

0.00

226

142

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

377

491

10.81

288.93

2.1

1.3

0.95

1.15

g/l

0.79

333

455

Chronic lymphocytic leukaemia, helper endpoint

377

491

10.81

288.93

2.1

1.3

0.95

1.15

g/l

0.79

333

455

Chronic lymphocytic leukaemia

377

491

10.81

288.93

2.1

1.3

0.95

1.15

g/l

0.79

333

455

Acute bronchitis

2469

11263

2.28

287.00

2.3

1.9

1.26

1.31

g/l

0.42

2261

10335

Obesity related asthma

2173

9661

2.42

285.40

1.8

1.9

1.17

1.33

g/l

3.54

2018

8891

Pain in limb

4499

15905

1.87

285.03

2.0

1.25

1.31

g/l

1.09

4138

14700

Bacterial pneumonia (organism specified)

2537

10759

2.26

284.93

2.4

1.9

1.20

1.34

g/l

2.27

2332

9840

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1349

4827

3.12

283.18

2.0

1.9

1.25

1.28

g/l

0.25

1282

4487

Endocrine, nutritional and metabolic diseases

4139

11123

1.95

283.14

1.9

2.0

1.20

1.36

g/l

5.77

3875

10351

Hypothyroidism (congenital or acquired)

1321

2330

3.36

283.01

1.9

1.7

1.19

1.27

g/l

1.41

1229

2199

Diseases of the skin and subcutaneous tissue

5084

14521

1.82

281.06

2.0

1.9

1.29

g/l

0.02

4695

13396

All-cause Heart Failure

3042

10463

2.13

280.84

2.0

1.21

1.37

g/l

3.11

2810

9519

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2394

6699

2.37

280.65

1.9

1.35

1.38

g/l

0.28

2244

6223

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

5437

20644

1.75

278.06

2.0

1.9

1.26

1.31

g/l

0.97

5033

19061

Nephropathy related operations

976

2941

3.85

277.76

2.5

1.9

1.15

1.30

g/l

1.26

913

2709

Cholelithiasis, broad definition with cholecystitis

4549

17097

1.84

277.25

2.0

1.32

1.33

g/l

0.03

4190

15712

Depression medications

1483

2498

3.14

276.96

1.8

1.7

1.23

1.26

g/l

0.27

1394

2358

Other disorders of white blood cells

583

1222

6.11

276.82

2.1

1.9

1.33

1.41

g/l

0.25

529

1133

Hypothyroidism, levothyroxine purchases

1302

2312

3.34

276.56

1.9

1.7

1.19

1.27

g/l

1.43

1213

2181

Hypothyroidism and >3 levothyroxin purchases

1302

2312

3.34

276.56

1.9

1.7

1.19

1.27

g/l

1.43

1213

2181

Nausea and vomiting

1648

6362

2.71

276.51

2.3

1.9

1.27

1.34

g/l

0.65

1531

5819

Seropositive rheumatoid arthritis, strict definition

1127

3709

3.45

275.91

1.8

2.0

1.27

1.36

g/l

0.68

1068

3385

Glomerular diseases

1279

4509

3.17

275.89

2.5

2.0

1.19

1.32

g/l

1.14

1187

4151

Other heart diseases, wide

4922

17134

1.80

275.87

1.9

1.25

1.29

g/l

0.69

4563

15861

Low back pain

4222

15771

1.88

275.71

1.9

1.25

1.33

g/l

1.45

3877

14597

Diseases of the digestive system

2635

12683

2.18

275.38

1.8

2.0

1.29

1.34

g/l

0.68

2432

11619

Dermatitis

3557

18682

1.95

275.27

2.1

1.9

1.36

1.31

g/l

0.61

3276

17223

Other and unspecified dermatitis

3067

15738

2.05

274.09

2.1

1.9

1.36

1.30

g/l

0.67

2825

14511

Other noninfective gastroenteritis and colitis

1636

6540

2.72

272.67

2.1

1.9

1.24

1.30

g/l

0.53

1526

6009

Other necrotizing vasculopathies

660

1538

5.23

272.48

2.0

1.02

1.42

g/l

4.74

621

1401

Hypertension, essential

4030

12340

1.92

270.65

1.8

2.0

1.19

1.37

g/l

6.67

3732

11435

Diseases of the respiratory system

3109

7596

2.13

270.26

2.0

1.8

1.32

1.36

g/l

0.35

2882

7007

Malignant immunoproliferative diseases

254

233

32.77

270.03

13.8

1.4

13.53

1.12

g/l

36.32

244

209

Neoplasms

3986

11215

1.93

269.53

2.2

1.6

1.31

1.18

g/l

2.78

3728

10442

All influenza

1586

6269

2.72

269.10

2.9

1.8

1.22

1.34

g/l

1.18

1449

5777

Bacterial pneumonia, not elsewhere classified

2118

8297

2.37

265.91

2.2

1.8

1.25

1.34

g/l

0.93

1949

7606

Cholelithiasis

4348

16808

1.84

263.74

2.0

1.9

1.34

1.32

g/l

0.10

4010

15441

General examination and investigation of persons without complaint and reported diagnosis

3131

8135

2.08

256.84

1.9

1.23

1.31

g/l

1.46

2924

7492

Parasetamol

3712

9964

1.95

255.51

1.9

1.26

1.33

g/l

1.15

3448

9227

Asthma/COPD (KELA code 203)

5039

20041

1.74

254.75

1.8

2.0

1.26

1.31

g/l

0.82

4679

18475

Persons encountering health services in other circumstances

2390

11376

2.20

254.59

1.9

1.30

1.31

g/l

0.05

2231

10465

Bleeding

4366

17631

1.81

251.99

1.9

2.0

1.35

1.28

g/l

1.12

4003

16234

Type 2 diabetes, wide definition

4070

14380

1.86

251.99

1.7

2.1

1.16

1.36

g/l

8.61

3732

13231

6-mercaptopurine

400

645

7.97

249.61

2.1

1.8

1.19

1.28

g/l

0.49

379

598

Malignant neoplasm, including Hilmo

4486

15030

1.80

249.35

2.5

1.6

1.37

1.21

g/l

2.94

4168

13912

Dermatitis and eczema

5880

21580

1.67

248.01

2.0

1.9

1.33

1.29

g/l

0.70

5434

19916

Malignant neoplasm, wide definition

4483

15075

1.80

245.54

2.5

1.6

1.38

1.22

g/l

2.99

4167

13951

Hypertensive diseases

4046

12780

1.86

244.24

1.8

2.0

1.18

1.36

g/l

6.75

3758

11847

Hypertension

4041

12771

1.85

243.38

1.8

2.0

1.18

1.36

g/l

6.73

3752

11840

Hypothyroidism, strict autoimmune

3300

11480

1.95

242.97

1.7

1.9

1.21

1.34

g/l

3.48

3014

10473

Adalimumab

859

2606

3.82

242.08

1.6

1.9

1.22

1.26

g/l

0.37

812

2441

Malignant neoplasm

4364

14721

1.80

241.92

2.5

1.6

1.40

1.22

g/l

3.40

4046

13619

Neurological diseases

4388

12559

1.81

241.73

2.0

1.9

1.28

1.32

g/l

0.57

4087

11646

Haemorrhage from respiratory passages

1881

7362

2.39

241.42

2.1

2.0

1.49

1.36

g/l

0.98

1734

6712

Malignant neoplasm

4368

14754

1.80

241.10

2.5

1.6

1.39

1.22

g/l

3.23

4050

13651

Non-allergic asthma (mode), excluding more controls

1026

3391

3.22

238.19

2.0

1.8

1.31

1.40

g/l

0.44

971

3110

Other disorders of skin and subcutaneous tissue

3898

18837

1.82

237.97

2.1

1.9

1.31

1.32

g/l

0.11

3587

17313

Antihypertensive medication - note that there are other indications

3216

8756

2.00

236.98

1.8

1.9

1.24

1.35

g/l

2.48

3019

8145

Other specified/unspecified systemic involvement of connective tissue

549

1246

5.43

235.00

2.0

1.9

1.44

1.40

g/l

0.18

521

1141

Other bacterial intestinal infections

1175

4312

2.98

232.93

2.0

1.9

1.20

1.38

g/l

1.86

1070

3937

Diseases of the musculoskeletal system and connective tissue

2723

6709

2.11

232.04

1.9

1.29

1.30

g/l

0.14

2542

6216

Pain (limb, back, neck, head abdominally)

3543

9590

1.91

231.04

2.0

1.9

1.25

1.34

g/l

1.37

3295

8853

Dorsalgia

5055

16166

1.71

230.33

1.9

1.26

1.32

g/l

1.04

4678

14960

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

156

124.19

229.20

16.8

1.4

15.22

1.14

g/l

25.85

151

Other medical care

2627

11275

2.05

229.20

2.4

1.9

1.27

1.36

g/l

1.02

2401

10295

Other demyelinating diseases of the central nervous system

442

863

6.76

228.86

3.5

1.7

1.17

1.37

g/l

1.07

436

805

Viral pneumonia

897

2875

3.47

227.24

3.1

1.8

1.35

1.34

g/l

0.03

823

2650

Other gastritis (incl. Duodenitis)

1328

5245

2.74

226.65

2.0

1.36

1.33

g/l

0.19

1231

4783

Implicit fungal Sepsis, including avohilmo

606

1521

4.69

225.14

2.1

1.9

1.16

1.45

g/l

2.83

551

1397

Other nutritional deficiencies

3693

19411

1.81

224.76

1.7

2.0

1.18

1.32

g/l

7.41

3413

17983

Other diseases of biliary tract

685

1876

4.22

224.16

2.3

2.0

1.23

1.36

g/l

0.95

643

1708

Explicit bacterial Sepsis, including avohilmo

781

2324

3.77

223.55

2.5

1.9

1.27

1.38

g/l

0.48

714

2123

Complications of medical and surgical care

3888

20474

1.77

220.71

2.0

1.9

1.26

1.33

g/l

1.23

3587

18850

Non-allergic asthma (mode)

1026

3548

3.07

219.88

2.0

1.8

1.31

1.39

g/l

0.36

971

3262

Explicit bacterial Sepsis

763

2263

3.79

219.54

2.6

1.9

1.27

1.38

g/l

0.45

696

2064

Cardiac arrhythmias

3082

10626

1.93

217.63

1.9

2.0

1.27

1.36

g/l

1.51

2854

9855

Streptococcal septicaemia, including avohilmo

672

1847

4.14

217.58

2.6

2.0

1.31

1.40

g/l

0.31

616

1684

Streptococcal septicaemia

655

1794

4.15

213.16

2.6

2.0

1.32

1.40

g/l

0.26

599

1637

Lower back pain or/and sciatica

5514

21754

1.62

213.08

1.9

1.25

1.32

g/l

1.39

5060

20106

SLE (Finngen)

345

563

7.74

212.22

2.1

1.8

1.29

1.48

g/l

0.77

321

506

Acute myeloid leukaemia and myelodysplastic syndromes

280

368

10.30

211.68

1.8

1.3

1.21

1.13

g/l

0.41

266

339

Constipation

4621

19172

1.69

210.86

2.0

1.9

1.30

1.31

g/l

0.05

4225

17705

Complications of procedures, not elsewhere classified

4178

20260

1.72

210.17

1.9

1.28

1.32

g/l

0.59

3855

18674

Symptoms and signs involving the skin and subcutaneous tissue

3832

21461

1.75

209.79

2.2

1.9

1.33

1.31

g/l

0.18

3586

19740

Glomerular disorders in diseases classified elsewhere

839

2728

3.48

209.56

2.6

2.0

1.15

1.35

g/l

1.55

777

2507

Disorders of mineral metabolism

673

1910

4.06

209.09

2.6

2.0

1.08

1.42

g/l

4.97

613

1745

Disorders of thyroid, IBD co-morbidities

857

1777

3.49

208.73

1.8

2.0

1.23

1.47

g/l

1.98

798

1646

Other bacterial intestinal infections, including avohilmo

1420

6015

2.54

208.37

2.0

1.9

1.22

1.34

g/l

1.15

1299

5517

Arthropathies

4507

13658

1.72

207.70

1.9

2.0

1.26

1.31

g/l

0.68

4211

12637

Bacterial intestinal infections, IBD co-morbidities

1166

4522

2.81

207.56

2.0

1.9

1.23

1.33

g/l

0.85

1062

4143

Other Crohn's disease

607

1633

4.38

205.34

1.9

1.24

1.33

g/l

0.62

579

1528

Asthma and opportunity respiratory infection

461

1022

5.69

204.45

2.2

1.8

1.06

1.48

g/l

3.98

438

925

Fungal Sepsis

427

890

6.00

202.92

2.3

1.8

1.13

1.55

g/l

2.86

387

823

Diabetes, varying definitions

5145

18799

1.64

201.93

1.7

2.0

1.20

1.33

g/l

6.12

4731

17399

Allergic asthma (mode), excluding more controls

1184

4523

2.70

201.56

1.8

1.21

1.34

g/l

2.22

1110

4208

Diabetes mellitus

5163

18816

1.63

201.30

1.7

2.0

1.20

1.33

g/l

5.89

4750

17413

Atrial fibrillation and flutter

1545

4245

2.48

200.35

1.8

2.0

1.18

1.41

g/l

3.86

1436

3908

Type 2 diabetes

4906

17737

1.65

199.79

1.7

2.0

1.19

1.35

g/l

6.85

4503

16397

Unspecified kidney failure

683

2002

3.81

199.62

2.4

1.9

1.14

1.46

g/l

2.51

626

1804

Ulcerative colitis (strict definition, all Crohn cases excluded)

1002

3684

3.01

199.53

2.0

1.9

1.25

1.30

g/l

0.35

952

3426

Viral infections characterized by skin and mucous membrane lesions

2382

12500

2.01

199.27

2.7

1.9

1.37

1.30

g/l

0.56

2213

11545

Diseases of arteries, arterioles and capillaries (FINNGEN)

1218

3228

2.77

199.19

1.9

2.0

1.25

1.46

g/l

2.52

1132

2971

Insulin medication

3108

14568

1.84

197.94

1.8

2.1

1.18

1.34

g/l

5.11

2850

13408

Persons encountering health services for examination and investigation

3013

8140

1.92

197.93

1.9

1.30

1.31

g/l

0.08

2803

7495

Implicit fungal Sepsis

404

822

6.21

197.82

2.3

1.8

1.14

1.56

g/l

2.63

367

759

Other and unspecified types of non-Hodgkin lymphoma, hilmo

416

873

6.06

197.03

3.6

1.9

1.81

1.49

g/l

0.61

401

793

Early onset COPD, excluding more controls

1000

3655

2.92

196.61

2.0

1.8

1.19

1.41

g/l

2.67

922

3351

Acute tubulo-interstitial nephritis

3121

14930

1.83

196.58

2.0

1.9

1.30

1.35

g/l

0.43

2857

13708

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

4702

23081

1.64

195.19

2.4

1.8

1.36

1.28

g/l

1.05

4355

21316

Noninfectious colitis NAS

936

3359

3.08

194.75

2.1

1.9

1.31

1.33

g/l

0.08

875

3086

Other antidepressants

5063

16254

1.64

194.52

1.9

2.0

1.23

1.31

g/l

1.88

4636

15056

Cerebrovascular diseases (FINNGEN)

1544

4719

2.42

193.86

1.8

1.9

1.20

1.41

g/l

4.59

1434

4367

Sleep apnoea

4794

19022

1.64

193.09

1.8

2.0

1.17

1.33

g/l

7.33

4364

17623

Rare circulating lymphoid malignancy, including Hilmo

319

534

7.82

192.96

3.3

1.5

0.92

1.15

g/l

1.35

291

501

Other functional intestinal disorders

2408

11570

1.98

192.37

2.1

1.9

1.29

1.32

g/l

0.26

2220

10628

Disorders of other endocrine glands

2439

12840

1.96

192.07

2.1

1.9

1.22

1.32

g/l

1.60

2268

11845

Idiopathic thrombocytopenic purpura

355

670

7.10

191.30

2.5

1.7

1.30

1.46

g/l

0.46

331

622

Allergic asthma (mode)

1184

4640

2.63

191.26

1.8

1.21

1.35

g/l

2.23

1110

4327

Other and unspecified disorders of white blood cells

413

889

5.91

190.08

2.3

1.9

1.43

1.44

g/l

0.02

371

828

Anxiety disorders, excluding more controls

4199

16422

1.69

189.44

2.0

1.27

1.28

g/l

0.16

3877

15231

Spondylopathies

3847

13547

1.74

189.34

1.9

1.18

1.34

g/l

5.14

3538

12491

Alcohol use disorder, Swedish definition

2835

14456

1.86

188.08

1.6

2.0

1.39

1.27

g/l

2.47

2601

13387

L04AC Interleukin inhibitors

592

1671

4.20

187.67

1.8

1.9

1.20

1.31

g/l

1.13

567

1567

Vocal cord dysfunction

696

1835

3.57

186.66

2.1

2.0

1.21

1.42

g/l

1.57

641

1693

2989

15234

1.82

186.32

1.6

2.0

1.39

1.27

g/l

2.38

2740

14113

Other (seronegative) rheumatoid arthritis, wide

1153

4692

2.68

186.19

1.8

1.9

1.26

1.35

g/l

1.02

1071

4283

Polyneuropathies and other disorders of the peripheral nervous system

1280

5460

2.54

185.88

2.6

1.9

1.52

1.31

g/l

1.73

1172

4992

Infections of the skin and subcutaneous tissue

3155

18123

1.78

184.56

2.0

1.9

1.26

1.28

g/l

0.16

2924

16781

Insulin, combination of fast acting with intermediate-acting or long-acting

3110

16349

1.79

183.93

1.8

2.0

1.18

1.32

g/l

4.20

2851

15042

Myeloid leukaemia

322

577

7.60

183.76

1.6

1.7

1.13

1.37

g/l

0.96

309

528

Other diseases of the digestive system

1694

8115

2.21

183.26

1.8

2.0

1.38

1.36

g/l

0.14

1570

7381

Episodal and paroxysmal disorders

5382

17658

1.59

183.08

1.8

2.0

1.25

1.33

g/l

1.84

4968

16344

Sleep apnoea, including avohilmo

5000

19420

1.60

183.02

1.8

2.0

1.16

1.34

g/l

9.91

4567

17980

Other joint disorders

4260

13598

1.68

182.92

1.9

2.0

1.29

1.31

g/l

0.18

3949

12578

GI-bleeding

1688

8085

2.21

182.51

1.8

2.0

1.38

1.35

g/l

0.24

1563

7353

Acquired haemolytic anaemia

307

534

8.05

181.50

2.7

1.6

1.71

1.45

g/l

0.68

286

492

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

388

814

5.61

179.97

1.8

1.4

1.45

1.15

g/l

2.61

353

748

Mood disorders, excluding more controls

4638

17282

1.62

178.00

1.9

2.0

1.26

1.29

g/l

0.56

4253

16015

Chronic rhinitis, nasopharyngitis and pharyngitis

1831

9141

2.12

177.49

1.8

1.9

1.14

1.34

g/l

7.53

1690

8452

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

463

1128

4.70

177.25

1.7

1.4

1.39

1.15

g/l

2.37

422

1023

3088

15677

1.78

176.96

1.6

2.0

1.37

1.27

g/l

2.20

2831

14524

Enterocolitis due to Clostridium difficile

723

2372

3.39

176.60

2.0

1.9

1.23

1.39

g/l

0.90

657

2159

Other dorsopathies, not elsewhere classified

4886

16226

1.61

175.66

1.9

1.26

1.32

g/l

1.05

4535

15016

Care involving dialysis

600

1773

3.89

175.65

2.4

2.0

1.08

1.36

g/l

2.51

559

1638

Marginal zone B-cell lymphoma, including Hilmo

226

296

11.56

174.62

3.3

1.4

2.65

1.19

g/l

3.70

217

273

Non-ischemic cardiomyopathy

1596

5936

2.26

174.62

2.2

2.0

1.31

1.42

g/l

0.88

1475

5372

Symptoms and signs concerning food and fluid intake

679

2147

3.48

174.58

1.9

1.14

1.38

g/l

3.08

627

1958

Obesity and other hyperalimentation

3351

18950

1.73

174.13

1.7

2.0

1.16

1.32

g/l

8.79

3097

17566

Heart failure and coronary heart disease

2065

7395

2.05

174.05

1.9

2.1

1.15

1.44

g/l

6.23

1916

6659

Diverticular disease of intestine

3399

12513

1.75

173.76

2.1

1.9

1.32

1.33

g/l

0.13

3116

11483

Soft tissue disorders

4978

16401

1.60

173.71

1.8

2.0

1.24

1.30

g/l

1.25

4610

15163

Obesity

3331

18881

1.72

172.55

1.7

2.0

1.16

1.32

g/l

8.67

3078

17505

Depression

4806

20825

1.59

172.28

1.9

2.0

1.26

1.29

g/l

0.66

4414

19288

Hypo-osmolality and hyponatraemia

998

3885

2.75

172.16

2.0

1.27

1.45

g/l

1.44

918

3509

Hard cardiovascular diseases

4082

14973

1.67

171.91

1.9

2.0

1.20

1.35

g/l

4.90

3805

13753

Any event in cancer register

4460

16499

1.63

171.73

2.4

1.7

1.36

1.25

g/l

1.74

4134

15303

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

4594

17441

1.61

169.83

1.7

2.0

1.20

1.33

g/l

5.13

4215

16126

Cytomegalovirus infection, IBD co-morbidity

299

546

7.76

168.87

2.8

1.6

1.28

1.34

g/l

0.17

273

508

Diseases of the eye and adnexa

3907

11940

1.69

168.70

2.0

1.8

1.24

1.28

g/l

0.41

3647

11122

Myelodysplastic syndrome, including Hilmo

282

475

7.40

167.82

2.2

1.3

1.44

1.15

g/l

0.90

260

434

Seronegative rheumatoid arthritis

710

2370

3.30

167.55

1.9

2.0

1.22

1.38

g/l

1.37

667

2147

Anxiety disorders

4536

20065

1.60

167.26

2.0

1.9

1.27

1.29

g/l

0.32

4195

18585

Obesity due to excess calories

2565

14557

1.84

167.07

1.7

2.0

1.16

1.32

g/l

7.66

2366

13529

Nonalcoholic steatohepatitis

192

227

17.30

166.91

1.5

1.6

1.25

1.53

g/l

0.69

178

210

Cytomegaloviral disease, including avohilmo

307

580

7.38

166.85

2.8

1.6

1.28

1.27

g/l

0.04

281

539

Type 2 diabetes, definitions combined

4564

17023

1.60

166.74

1.7

2.0

1.20

1.35

g/l

6.24

4184

15728

Hypothyroidism, drug reimbursement

681

1446

3.49

166.40

1.9

1.7

1.27

1.33

g/l

0.43

628

1368

Neurotic, stress-related and somatoform disorders

4494

19963

1.60

165.80

2.0

1.9

1.27

1.29

g/l

0.35

4158

18491

Atrial fibrillation and flutter with reimbursement

1201

3122

2.56

165.74

1.8

2.0

1.22

1.47

g/l

2.73

1119

2855

Hepatocellular carcinoma, including Hilmo

277

466

7.44

165.20

1.8

1.3

1.61

1.13

g/l

3.73

256

430

Exposure to unspecified factor

5093

22957

1.55

165.16

2.0

1.9

1.27

1.30

g/l

0.52

4657

21251

Candidiasis, including avohilmo

1726

8672

2.11

164.99

2.0

1.9

1.29

1.32

g/l

0.33

1578

8021

Crohn's disease NAS

521

1465

4.13

164.83

2.0

1.9

1.28

1.36

g/l

0.45

497

1366

Diagnoses used for exclusion with ILD

1392

6460

2.30

164.28

1.9

1.20

1.33

g/l

1.80

1281

5909

Type 2 diabetes, strict (exclude DM1)

4580

17158

1.60

164.21

1.7

2.0

1.19

1.35

g/l

6.38

4199

15853

Irritable bowel syndrome

1514

7256

2.21

163.80

1.8

1.9

1.19

1.35

g/l

3.41

1388

6694

Unspecified jaundice

399

930

5.01

162.78

1.9

2.1

1.42

1.59

g/l

0.43

371

845

Cytomegaloviral disease

301

572

7.32

162.54

2.8

1.6

1.28

1.27

g/l

0.00

275

531

Other disorders of lacrimal gland

2012

10708

1.98

162.12

2.3

1.9

1.28

1.34

g/l

0.75

1859

9829

Pneumonia due to other infectious organisms, not elsewhere classified

321

634

6.30

161.92

3.0

1.7

1.08

1.43

g/l

2.29

293

586

Mycoses

1598

7872

2.16

161.69

2.2

1.9

1.26

1.32

g/l

0.49

1460

7263

Mood disorders

5049

21404

1.55

161.55

1.9

1.26

1.30

g/l

0.70

4633

19798

Other and unspecified polyneuropathies, also in other diseases

1096

4650

2.55

161.16

2.6

1.9

1.48

1.31

g/l

1.36

997

4235

COPD (mode)

1301

4493

2.36

161.00

1.8

1.9

1.37

1.40

g/l

0.12

1182

4086

Mood [affective] disorders

5037

21399

1.55

160.92

1.9

1.26

1.30

g/l

0.70

4621

19794

Gout, idiopatic and unspecified

1319

6048

2.33

160.60

1.6

2.0

1.13

1.37

g/l

3.56

1231

5496

Haemolytic anaemias

359

792

5.75

160.55

2.7

1.7

1.64

1.34

g/l

1.14

334

732

Selective deficiency of immunoglobulin G [IgG] subclasses

162

163

25.02

160.50

4.5

1.6

1.09

1.38

g/l

0.78

154

153

Percutaneous Coronary Intervention

3787

14302

1.66

160.31

1.9

2.0

1.19

1.35

g/l

4.36

3529

13124

Disorders of calcium metabolism

494

1364

4.18

160.00

2.8

2.0

1.09

1.46

g/l

3.78

447

1253

Toxic liver disease

217

300

10.77

159.97

1.6

1.8

1.23

1.55

g/l

0.68

209

279

Benign neoplasm of colon, rectum, anus and anal canal

3085

15638

1.73

159.52

2.0

1.40

1.32

g/l

0.84

2860

14278

Syncope and collapse

1999

8767

1.97

159.35

2.0

1.9

1.41

1.34

g/l

0.46

1850

7992

Other autoimmune haemolytic anaemias

204

269

12.81

159.35

2.9

1.7

1.98

1.48

g/l

0.89

187

245

Insulin, intermediate and long-acting

2720

15324

1.78

158.58

1.7

2.0

1.19

1.33

g/l

3.20

2491

14104

Heart failure and bmi 25plus

1718

5658

2.14

158.28

2.0

2.1

1.13

1.34

g/l

3.55

1572

5095

Ischemic heart diseases

3975

14910

1.64

157.80

1.9

2.0

1.23

1.34

g/l

2.40

3702

13688

Type 2 diabetes, definitions combined, including avohilmo

4551

17082

1.58

157.09

1.7

2.0

1.20

1.35

g/l

6.22

4169

15795

Idiopathic pulmonary fibrosis

529

1545

3.90

156.97

2.3

2.0

1.07

1.46

g/l

3.79

496

1393

Other disorders of urethra and urinary system

3449

14720

1.68

156.90

2.0

1.9

1.29

1.36

g/l

0.85

3188

13535

Care involving use of rehabilitation procedures

3134

17066

1.71

156.89

1.9

1.23

1.32

g/l

1.70

2920

15736

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3042

18026

1.72

156.12

2.0

1.9

1.24

1.33

g/l

1.64

2804

16573

Dorsopathies

4912

16353

1.56

155.20

1.9

1.26

1.32

g/l

0.98

4556

15139

Follicular lymphoma, hilmo

391

949

5.12

154.64

2.7

1.9

0.89

1.48

g/l

6.00

369

868

Other viral diseases, including avohilmo

2101

11382

1.92

154.39

2.2

1.9

1.35

1.26

g/l

1.08

1971

10630

Valvular heart disease excluding rheumatic fever

2228

8688

1.91

154.23

2.2

2.0

1.29

1.32

g/l

0.24

2050

7939

Spondyloarthritis

970

3955

2.62

154.14

1.7

1.8

1.29

1.36

g/l

0.70

920

3630

Coronary revascularization (ANGIO or CABG)

3761

14311

1.65

153.60

1.9

2.0

1.20

1.35

g/l

3.76

3506

13132

Non-rheumatic valve diseases

2208

8603

1.91

152.84

2.2

2.0

1.29

1.32

g/l

0.24

2032

7861

Etanercept

537

1622

3.85

152.79

1.7

2.0

1.28

1.33

g/l

0.30

508

1505

Systemic lupus erythematosus

345

765

5.61

152.54

2.1

1.8

1.29

1.37

g/l

0.36

321

707

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2645

12041

1.79

152.21

1.7

2.1

1.19

1.39

g/l

4.23

2396

11027

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4625

19282

1.56

151.31

2.0

1.9

1.31

1.30

g/l

0.10

4283

17747

Disorders of lacrimal system

2316

12913

1.84

151.06

2.2

1.9

1.29

1.34

g/l

0.57

2136

11860

Diabetes, insulin treatment (Kela reimbursement)

4846

19179

1.54

150.72

1.7

2.0

1.20

1.33

g/l

5.02

4445

17716

Other ulcerative colitis

468

1305

4.18

150.13

2.2

1.9

1.23

1.33

g/l

0.67

446

1209

Cholecystectomy

3430

18245

1.65

148.92

1.9

2.0

1.34

1.33

g/l

0.12

3179

16744

Pneumocystosis

252

444

8.30

148.53

3.4

1.7

1.02

1.43

g/l

2.14

224

412

Pneumocystosis, including avohilmo

252

444

8.30

148.53

3.4

1.7

1.02

1.43

g/l

2.14

224

412

Other diseases of upper respiratory tract

5166

18093

1.52

148.02

2.0

1.9

1.23

1.33

g/l

2.96

4786

16669

Pleural effusion

867

3433

2.73

147.62

2.2

1.9

1.26

1.38

g/l

0.70

802

3094

Other/unspecified cytomegaloviral diseases

262

482

7.82

147.40

3.0

1.6

1.21

1.34

g/l

0.41

242

446

Gout, unspecified

1086

4770

2.44

146.90

1.6

2.0

1.12

1.35

g/l

3.01

1013

4309

Abnormalities of heart beat

1737

8773

2.00

146.75

1.9

1.35

1.37

g/l

0.08

1590

8041

Emergency coronary revascularization (for ACS)

3996

15494

1.60

146.42

1.9

2.0

1.20

1.35

g/l

4.30

3722

14173

Non-invasive ventilation

1174

4518

2.35

146.42

1.8

2.0

1.27

1.38

g/l

0.70

1065

4208

Continuous positive airway pressure

935

3137

2.64

145.98

2.0

2.1

1.16

1.37

g/l

2.10

837

2904

Sleep disorders (combined)

5250

18559

1.51

145.83

1.8

2.0

1.23

1.33

g/l

3.05

4808

17173

Chronic gastritis

1321

6282

2.22

145.64

1.9

2.0

1.26

1.35

g/l

0.95

1182

5704

Diabetes medication

5018

19758

1.52

145.54

1.7

2.0

1.20

1.33

g/l

5.55

4611

18270

Dysphagia

1251

5835

2.26

144.74

2.1

2.0

1.27

1.41

g/l

0.97

1156

5307

Major coronary heart disease event

3949

15171

1.60

144.62

1.9

2.0

1.22

1.35

g/l

3.32

3676

13897

Gastroduodenal ulcer

1242

5757

2.27

144.50

1.8

2.0

1.24

1.35

g/l

1.00

1148

5212

Disorders of lipoprotein metabolism and other lipidaemias

3787

14653

1.62

144.04

1.8

2.0

1.12

1.36

g/l

11.59

3484

13487

Osteoporosis with pathological fracture (FG)

448

1237

4.05

143.46

2.5

1.9

1.31

1.57

g/l

1.27

409

1083

Other diseases of urinary system

4698

17567

1.54

143.16

2.0

1.9

1.27

1.32

g/l

0.99

4346

16210

Presence of other functional implants

2758

11205

1.74

142.30

2.1

1.9

1.29

1.37

g/l

0.81

2481

10225

Collagenous colitis

635

2198

3.24

142.20

2.1

1.9

1.23

1.38

g/l

0.77

590

2017

Benzodiazepine use

4866

22233

1.51

142.09

1.9

1.33

1.30

g/l

0.42

4462

20549

Depression or dysthymia

3187

10609

1.69

141.22

1.9

2.0

1.31

1.29

g/l

0.15

2921

9862

Polymyalgia rheumatica

746

2808

2.89

140.90

1.7

2.0

1.39

1.38

g/l

0.03

694

2518

Acute myeloid leukaemia

175

217

11.77

140.48

1.5

1.3

1.14

1.19

g/l

0.21

169

207

Acute myeloid leukaemia, helper endpoint

175

217

11.77

140.48

1.5

1.3

1.14

1.19

g/l

0.21

169

207

Acute myeloid leukaemia, including Hilmo

175

217

11.77

140.48

1.5

1.3

1.14

1.19

g/l

0.21

169

207

Other respiratory disorders and diseases

1091

4895

2.38

140.03

2.2

1.9

1.24

1.32

g/l

0.40

996

4439

Other diseases of the respiratory system

1091

4895

2.38

140.03

2.2

1.9

1.24

1.32

g/l

0.40

996

4439

Acute pancreatitis

1044

4602

2.42

139.71

2.1

2.0

1.27

1.33

g/l

0.38

980

4226

SLE, strict definition

331

765

5.42

139.55

2.1

1.8

1.29

1.33

g/l

0.17

308

707

SLE, ICD10

331

765

5.42

139.55

2.1

1.8

1.29

1.33

g/l

0.17

308

707

Other viral diseases

1631

8486

2.02

139.28

2.3

1.9

1.38

1.26

g/l

1.21

1517

7938

Functional dyspepsia

1405

6966

2.13

138.83

2.0

1.9

1.36

1.32

g/l

0.25

1307

6415

Other viral hepatitis, including avohilmo

525

1658

3.64

138.78

1.5

1.9

1.62

1.27

g/l

4.66

498

1557

Symptoms and signs involving the urinary system

3659

17766

1.60

138.37

2.1

1.9

1.29

1.31

g/l

0.17

3328

16363

Abnormal findings on diagnostic imaging of other body structures

858

3500

2.66

137.87

2.0

1.19

1.33

g/l

1.75

806

3206

Viral hepatitis, including avohilmo

572

1906

3.41

137.69

1.5

1.9

1.63

1.27

g/l

5.09

540

1783

Other degenerative diseases of the nervous system

1434

5112

2.15

137.67

3.2

1.9

1.31

1.37

g/l

0.28

1359

4706

Disorders of eyelid, lacrimal system and orbit

4205

20455

1.55

137.32

2.1

1.9

1.29

1.31

g/l

0.28

3874

18851

Common variable immunodeficiency

138

137

23.54

137.10

5.8

1.8

0.82

1.46

g/l

1.53

112

131

Other immunodeficiencies

186

263

11.76

136.94

4.3

1.7

1.33

1.32

g/l

0.03

175

244

Substance abuse, excluding more controls

2699

13585

1.72

136.37

1.6

1.9

1.32

1.28

g/l

0.58

2479

12624

Crohn's disease of small intestine

516

1625

3.61

136.36

1.8

1.9

1.20

1.34

g/l

0.96

490

1518

Gout, strict definition

972

4212

2.48

135.94

1.6

2.0

1.11

1.38

g/l

3.95

902

3801

Factors influencing health status and contact with health services

1278

2883

2.30

135.20

2.0

1.8

1.30

1.33

g/l

0.13

1194

2672

Urticaria and erythema

1944

10828

1.88

135.17

2.0

1.9

1.23

1.30

g/l

1.44

1799

10060

Respiratory disorders in diseases classified elsewhere

201

311

9.91

135.09

2.6

1.7

1.11

1.51

g/l

0.83

191

285

Anxiety (asthma-related co-morbidities)

3037

14312

1.67

134.88

1.8

1.9

1.30

1.28

g/l

0.18

2803

13372

Benign neoplasm: Colon

2577

14549

1.73

134.07

1.9

2.0

1.36

1.33

g/l

0.23

2392

13265

Ulcer of lower limb, not elsewhere classified

820

3314

2.68

133.97

1.8

1.9

1.26

1.33

g/l

0.40

762

3006

Nerve, nerve root and plexus disorders

5037

20788

1.49

133.42

2.0

1.9

1.31

1.30

g/l

0.08

4653

19158

Other reaction to severe stress, and adjustment disorders

1907

10593

1.88

132.89

2.2

1.9

1.27

1.30

g/l

0.27

1796

9906

Insulin, fast-acting

1830

10051

1.91

132.84

1.7

2.0

1.18

1.30

g/l

3.34

1688

9271

Adrenocortical insufficiency

341

839

4.98

132.09

2.3

1.8

1.20

1.39

g/l

0.60

325

774

Use of hypnotics and sedatives

5035

19804

1.49

131.17

2.0

1.9

1.26

1.31

g/l

0.98

4627

18317

Other viral hepatitis

491

1546

3.65

130.47

1.4

1.9

1.62

1.27

g/l

4.34

465

1456

Chronic hepatitis NAS

191

291

10.18

130.42

2.1

1.7

1.38

1.36

g/l

0.07

177

268

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

346

853

4.62

130.34

1.7

1.4

1.36

1.15

g/l

1.47

312

782

Secondary hypertension

460

1348

3.69

130.20

2.1

2.0

1.11

1.52

g/l

3.66

423

1242

Crohn disease (strict definition, require KELA, min 2 HDR)

495

1569

3.62

130.01

1.8

1.9

1.19

1.29

g/l

1.01

471

1470

Symptoms and signs involving the nervous and musculoskeletal systems

2854

17805

1.66

129.52

2.1

1.9

1.28

1.32

g/l

0.49

2655

16373

Crohn disease (strict definition, require KELA)

499

1593

3.59

129.48

1.8

1.9

1.19

1.33

g/l

1.34

474

1493

Benign neoplasms

4629

17069

1.51

128.83

2.0

1.9

1.32

1.27

g/l

0.73

4281

15789

Zoster [herpes zoster]

1023

4641

2.36

128.28

3.0

1.9

1.58

1.35

g/l

1.11

930

4225

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2514

14660

1.71

128.23

2.0

1.9

1.21

1.31

g/l

2.25

2324

13537

Respiratory insufficiency

435

1259

3.75

127.84

2.0

1.9

1.13

1.47

g/l

1.73

402

1134

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

520

1714

3.46

127.71

1.8

1.9

1.19

1.32

g/l

1.30

493

1607

Zoster [herpes zoster], including avohilmo

2521

14765

1.71

127.32

2.5

1.9

1.46

1.31

g/l

1.48

2314

13519

Iron deficiency anaemia secondary to blood loss (chronic)

871

3701

2.52

127.09

1.9

1.28

1.35

g/l

0.41

804

3373

Hypokalaemia

697

2670

2.83

127.05

2.0

1.9

1.33

1.41

g/l

0.42

631

2441

Any mental disorder

5088

17589

1.48

126.74

1.9

2.0

1.27

1.29

g/l

0.32

4670

16298

Fibromyalgia

611

2197

3.06

126.73

1.9

1.25

1.44

g/l

1.38

559

2046

Migraine

2535

11904

1.71

125.88

1.9

1.25

1.33

g/l

1.51

2374

11077

Failure and rejection of transplanted organs and tissues

194

311

9.31

125.67

2.8

1.5

1.10

1.29

g/l

0.66

187

290

Psoriatic and enteropathic arthropathies

679

2583

2.86

125.63

1.6

2.0

1.25

1.33

g/l

0.53

630

2390

Chronic apical periodontitis

5264

20645

1.46

125.36

2.0

1.9

1.28

1.31

g/l

0.31

4851

19067

ILD-related respiratory insufficiency

297

683

5.35

125.36

2.3

1.9

1.09

1.47

g/l

2.01

273

616

Intracranial trauma

2652

10853

1.70

125.34

1.9

1.30

1.31

g/l

0.13

2443

10093

Extracorporeal dialysis

454

1401

3.76

124.99

2.5

1.9

1.03

1.34

g/l

2.99

422

1303

Viral hepatitis

533

1806

3.34

124.65

1.5

1.9

1.63

1.28

g/l

4.51

504

1692

Pulmonary heart disease, diseases of pulmonary circulation

1547

8223

1.97

124.62

2.4

1.9

1.23

1.35

g/l

1.12

1463

7469

Other disorders of adrenal gland

389

1094

4.22

124.23

2.3

1.8

1.21

1.41

g/l

0.74

370

1005

Myalgia

1287

6440

2.11

124.06

2.0

1.27

1.35

g/l

1.00

1177

5966

Any death

2939

12884

1.65

123.95

2.1

2.0

1.34

1.32

g/l

0.12

2647

11865

Other CVD (FINNGEN)

577

1483

3.19

123.78

2.3

2.1

1.17

1.63

g/l

3.73

523

1343

Other/unspecified dorsalgia

1824

10089

1.86

123.26

2.0

1.9

1.24

1.33

g/l

1.15

1687

9278

Systemic lupus erythematosus, unspecified

288

659

5.49

123.11

2.0

1.7

1.24

1.35

g/l

0.55

268

612

Recurrent or chronic depression

1964

7698

1.84

120.81

1.9

1.26

1.30

g/l

0.34

1801

7202

Other disorders involving the immune mechanism, not elsewhere classified

306

745

5.10

120.70

3.4

1.7

1.15

1.28

g/l

0.60

281

698

Asthma and allergy, excluding more controls

661

2480

2.79

120.43

1.8

1.7

1.19

1.36

g/l

2.10

621

2327

Glomerulonephritis

630

2372

2.94

120.41

2.3

2.0

1.27

1.36

g/l

0.42

588

2195

Spondylopathies (FG)

764

3136

2.62

120.38

1.7

1.9

1.29

1.31

g/l

0.13

731

2916

Drug-induced neutropenia

512

1735

3.37

120.22

2.9

1.9

1.13

1.36

g/l

1.71

489

1595

Other (not insulin) diabetes medications

4511

18177

1.49

119.55

1.7

2.0

1.19

1.34

g/l

5.74

4131

16791

Disorders of lens

3050

12003

1.62

118.59

2.0

1.28

1.33

g/l

0.44

2801

11094

All anxiety disorders

3086

15387

1.60

118.42

1.8

1.9

1.30

1.29

g/l

0.12

2850

14330

Insulin, fast-acting or short human

1834

10441

1.83

118.06

1.7

2.0

1.18

1.29

g/l

2.85

1692

9619

Sarcoidosis

780

3280

2.59

117.81

1.9

1.18

1.32

g/l

1.84

730

3034

Eosinophilic disease (BM)

173

257

8.99

117.62

1.7

1.6

1.08

1.38

g/l

1.28

161

239

Malignant neoplasm of liver and intrahepatic bile ducts

246

505

5.77

117.42

1.6

1.3

1.34

1.17

g/l

0.96

219

470

Wegener granulomatosis

191

321

8.41

117.16

2.5

1.8

0.81

1.28

g/l

3.29

184

298

Marginal zone B-cell lymphoma

146

184

12.48

117.08

2.8

1.4

1.95

1.20

g/l

2.61

140

173

Cystitis

3896

15524

1.53

117.00

1.9

1.26

1.34

g/l

1.82

3617

14298

Asthma and allergy

661

2516

2.75

116.94

1.8

1.7

1.19

1.34

g/l

1.82

621

2361

Use of glatiramer acetate

206

373

7.61

116.81

4.0

1.7

0.96

1.23

g/l

5.39

200

354

Other/unspecified rheumatoid arthritis

699

2801

2.72

116.81

1.9

1.24

1.37

g/l

1.28

637

2539

Genitourinary diseases

2624

7965

1.70

116.78

2.0

1.9

1.20

1.25

g/l

0.79

2461

7383

Diseases of arteries, arterioles and capillaries

2995

14036

1.61

116.63

1.8

2.0

1.25

1.35

g/l

1.64

2767

12809

Concussion

2309

10744

1.72

116.20

1.8

1.9

1.28

1.31

g/l

0.34

2133

9993

Venous thromboembolism

2482

14792

1.67

115.67

2.3

1.9

1.27

1.34

g/l

0.66

2309

13522

Crohn's disease of large intestine

392

1159

3.90

115.07

1.9

1.24

1.40

g/l

1.08

368

1078

Protozoal diseases

291

710

5.16

114.97

3.3

1.8

1.05

1.48

g/l

2.54

261

661

Other headache syndromes

2032

11949

1.76

114.59

1.9

2.0

1.25

1.35

g/l

1.38

1880

11054

Disturbances of skin sensation

1463

7870

1.95

114.16

2.2

1.9

1.38

1.30

g/l

0.43

1362

7314

Other diseases of intestine

831

3628

2.45

113.97

2.0

1.9

1.25

1.35

g/l

0.71

780

3307

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2716

17250

1.62

113.13

1.9

1.25

1.33

g/l

1.44

2495

15863

Protozoal diseases, including avohilmo

295

737

4.98

112.71

3.2

1.8

1.06

1.47

g/l

2.53

265

685

Symptoms and signs involving cognition, perception, emotional state and behaviour

4535

21180

1.46

112.09

1.9

1.31

1.30

g/l

0.11

4160

19582

Acute pancreatitis (for exclusion)

1044

5044

2.20

111.41

2.1

1.9

1.27

1.31

g/l

0.24

980

4639

Candidiasis

843

3755

2.42

111.19

2.1

1.9

1.25

1.34

g/l

0.73

767

3472

DVT of lower extremities and pulmonary embolism

1918

11217

1.77

110.19

2.4

1.9

1.27

1.35

g/l

0.61

1783

10239

Polyarthrosis

1011

4323

2.22

109.93

1.9

1.24

1.42

g/l

1.62

918

3922

Systemic sclerosis (FG)

215

420

6.35

109.82

1.8

1.9

1.43

1.50

g/l

0.19

200

383

Ulcerative ileocolitis

326

884

4.34

109.43

2.2

1.9

1.27

1.35

g/l

0.50

311

828

Hyperkalaemia

382

1139

3.75

109.30

2.2

2.0

1.38

1.54

g/l

0.44

349

1030

Urinary track infection

2769

8670

1.65

109.26

1.9

1.30

1.36

g/l

0.81

2575

8017

Pure hypercholesterolaemia

3284

13714

1.56

109.01

1.7

2.0

1.13

1.37

g/l

8.93

3014

12603

Follow-up examination after treatment for conditions other than malignant neoplasms

1848

7010

1.81

108.87

1.8

1.9

1.30

1.33

g/l

0.20

1707

6449

Visual disturbances and blindness

2519

15901

1.64

108.61

2.1

1.9

1.25

1.33

g/l

0.89

2311

14633

Cutaneous abscess, furuncle and carbuncle

1376

7386

1.96

108.11

2.0

1.9

1.28

1.31

g/l

0.21

1277

6860

Other intervertebral disc disorders

3672

14735

1.52

107.75

1.8

1.9

1.28

1.33

g/l

0.57

3391

13609

Mycoses, including avohilmo

4361

23318

1.46

107.42

1.9

1.30

g/l

0.03

4009

21563

Optic neuritis

341

969

4.13

106.99

3.6

1.7

1.08

1.36

g/l

4.17

333

911

Drug-induced adrenocortical insufficiency

220

460

6.48

106.66

2.5

1.8

1.08

1.30

g/l

1.46

211

426

Spondylosis

2452

11956

1.65

106.66

1.9

2.0

1.19

1.35

g/l

2.95

2254

11000

Hepatocellular carcinoma

190

339

6.81

106.26

1.6

1.3

1.56

1.16

g/l

1.90

174

313

Other diseases of pancreas

512

1848

3.06

105.83

1.9

2.0

1.24

1.38

g/l

0.81

475

1698

Disorders of optic nerve and visual pathways

601

2358

2.81

105.67

3.1

1.9

1.06

1.38

g/l

6.78

573

2187

Hyperlipidaemia, other/unspecified

1715

8834

1.81

105.60

2.0

1.18

1.41

g/l

3.52

1574

8060

Gastric ulcer

837

3781

2.34

105.14

1.8

1.9

1.24

1.31

g/l

0.38

772

3411

Solid cancers, including Hilmo

3735

14765

1.51

105.00

2.1

1.6

1.28

1.22

g/l

1.05

3477

13656

Chronic pancreatitis

675

2796

2.61

104.86

1.6

2.0

1.16

1.31

g/l

1.66

631

2568

Sciatica+with lumbago

2390

13268

1.64

103.97

1.8

1.9

1.21

1.33

g/l

2.23

2218

12253

Other diseases of anus and rectum

1405

7633

1.91

103.96

1.9

1.34

1.37

g/l

0.16

1272

6956

Other anxiety disorders

2309

12212

1.66

103.72

1.8

1.9

1.31

1.28

g/l

0.25

2124

11401

Diaphragmatic hernia

1696

9814

1.80

103.43

2.0

1.42

1.36

g/l

0.38

1544

8950

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

276

698

4.86

103.42

3.3

1.7

1.10

1.30

g/l

1.25

254

655

COPD

1925

9265

1.75

103.28

1.8

2.1

1.32

1.35

g/l

0.19

1764

8418

Any operation in hilmo

160

11.72

103.07

1.5

1.2

1.30

1.31

g/l

0.02

145

Other symptoms and signs involving the digestive system and abdomen

855

3931

2.30

103.04

2.2

1.9

1.31

1.39

g/l

0.47

778

3602

Convulsions, not elsewhere classified

1054

5172

2.10

102.37

1.8

1.9

1.32

1.30

g/l

0.08

973

4757

Mental and behavioural disorders due to psychoactive substance use

2790

16690

1.58

102.20

1.6

2.0

1.33

1.28

g/l

0.73

2563

15459

FESS (DNB20)

737

3228

2.47

101.49

2.1

1.9

1.14

1.34

g/l

3.11

683

3002

Visual disturbances

2341

14793

1.64

101.16

2.1

1.9

1.26

1.33

g/l

0.68

2161

13634

Unspecified acute lower respiratory infection

830

3813

2.32

100.84

2.3

1.9

1.27

1.31

g/l

0.18

768

3531

Other diseases of pericardium

318

892

4.07

100.61

2.3

2.0

1.21

1.46

g/l

1.26

292

819

Ethmoidectomy

754

3349

2.43

100.40

2.0

1.9

1.14

1.33

g/l

3.20

699

3110

Disorders of sclera, cornea, iris and ciliary body

2616

16993

1.59

99.96

2.0

1.9

1.27

1.30

g/l

0.33

2445

15672

Hypercalcemia

340

1011

3.94

99.71

2.9

1.9

0.99

1.49

g/l

4.96

308

921

Papulosquamous disorders

1907

11512

1.72

99.51

1.7

2.0

1.28

1.31

g/l

0.33

1766

10622

Other disorders of skin and subcutaneous tissue, not elsewhere classified

772

3468

2.38

99.37

2.2

1.9

1.32

1.34

g/l

0.05

695

3177

Diseases of the ear and mastoid process

5273

19195

1.40

98.76

2.0

1.9

1.32

1.28

g/l

0.54

4857

17798

Other abnormal findings of blood chemistry

342

1021

3.83

98.71

2.3

1.8

1.54

1.40

g/l

0.34

328

940

Fall on same level

5322

20689

1.40

98.62

1.8

2.0

1.27

1.29

g/l

0.47

4902

19211

Substance abuse

2699

16396

1.57

98.58

1.6

2.0

1.32

1.28

g/l

0.67

2479

15182

Amyloidosis

211

448

5.84

98.24

3.8

1.8

1.16

1.56

g/l

0.98

202

407

Ulcerative rectosigmoiditis

514

1936

2.92

97.93

1.9

1.28

1.36

g/l

0.42

486

1804

Disorders of parathyroid gland

996

4908

2.12

97.03

2.1

1.9

1.23

1.39

g/l

1.77

907

4449

Selective serotonin reuptake inhibitors

4444

16400

1.44

95.85

1.8

2.0

1.26

1.31

g/l

0.67

4063

15197

Urticaria

1527

8778

1.82

95.56

2.0

1.9

1.25

1.30

g/l

0.62

1410

8167

Other symptoms and signs involving the nervous and musculoskeletal systems

2007

12394

1.68

95.44

2.1

1.9

1.26

1.30

g/l

0.45

1880

11431

Exclusions for E4_PCOS_BROAD

971

4846

2.13

95.22

2.0

1.19

1.31

g/l

1.26

919

4523

Other arrhythmias

2829

13944

1.55

95.16

2.0

1.9

1.28

1.31

g/l

0.41

2622

12860

Psychiatric diseases

4390

15593

1.44

94.64

1.9

2.0

1.28

g/l

0.05

4043

14454

STROKE

2402

10267

1.62

94.59

1.9

2.1

1.25

1.39

g/l

2.18

2219

9407

Use of interferon beta-1a

221

506

5.48

94.47

3.6

1.7

0.93

1.35

g/l

4.79

216

478

Persons with potential health hazards related to communicable diseases

1871

11287

1.71

94.15

2.4

1.8

1.25

1.26

g/l

0.13

1774

10567

Volume depletion

505

1912

2.84

93.91

1.9

2.0

1.16

1.49

g/l

3.09

463

1725

Other chronic obstructive pulmonary disease

1814

8917

1.72

92.70

1.8

2.1

1.34

1.35

g/l

0.05

1655

8096

Solid cancers

3559

14385

1.48

92.34

2.2

1.6

1.27

1.22

g/l

0.74

3303

13306

Senile cataract

2676

10626

1.57

91.46

2.0

1.32

1.34

g/l

0.14

2441

9781

Pulmonary embolism

1350

7586

1.86

91.05

2.4

1.9

1.21

1.35

g/l

1.19

1275

6894

Psoriasis

1403

7991

1.84

90.86

1.7

2.0

1.31

g/l

0.02

1301

7387

Crohn disease (strict definition, all UC cases excluded)

367

1206

3.45

90.64

1.7

1.9

1.15

1.32

g/l

1.34

344

1125

Hypothyroidism, other/unspecified

3983

18577

1.44

90.53

1.8

2.0

1.21

1.34

g/l

4.66

3654

17158

Fibrosis of liver

124

178

11.77

90.46

1.6

1.7

1.27

1.30

g/l

0.06

116

162

Disorders of the thyroid gland

4247

19769

1.42

90.06

1.8

2.0

1.20

1.33

g/l

5.51

3910

18259

All influenza (not pneumonia)

745

3430

2.30

89.69

2.5

1.8

1.22

1.32

g/l

0.69

683

3181

Pulmonary heart disease

1350

7622

1.85

89.62

2.4

1.9

1.21

1.34

g/l

1.14

1275

6930

Childhood asthma (age<16), excluding more controls

611

1963

2.55

89.54

1.7

1.21

1.25

g/l

0.42

575

1861

Paroxysmal tachycardia

962

3989

2.09

89.45

1.9

2.0

1.24

1.42

g/l

1.46

895

3694

Hypothyreosis and Thyroxine purchase for inclusion criteria

4118

19309

1.43

88.82

1.8

2.0

1.21

1.34

g/l

4.91

3776

17832

Systemic sclerosis

215

505

5.23

88.56

1.8

1.43

1.31

g/l

0.46

200

462

Amyloidosis, other/unspecified

182

374

6.16

88.50

4.1

1.8

1.21

1.64

g/l

0.85

173

341

Drug-induced osteoporosis with pathological fracture

182

379

6.40

88.38

2.7

1.9

1.13

1.27

g/l

0.52

172

342

Mixed connective tissue disease

180

368

6.27

88.32

2.3

1.8

1.31

1.37

g/l

0.15

174

341

Biguanides

4249

18433

1.42

88.28

1.6

2.0

1.20

1.34

g/l

4.95

3886

17022

Hereditary hypogammaglobulinemia

27.67

88.09

5.0

1.5

0.84

1.15

g/l

1.88

Mantle cell lymphoma, including Hilmo

143

236

7.91

87.92

3.2

1.3

1.06

1.24

g/l

0.40

132

223

Childhood asthma (age<16)

612

1986

2.52

87.84

1.8

1.7

1.21

1.25

g/l

0.42

576

1884

Hodgkin lymphoma, hilmo

249

657

4.58

87.77

2.3

1.7

0.99

1.42

g/l

2.60

234

607

Herpesviral [herpes simplex] infections

673

3016

2.40

87.64

2.5

1.9

1.16

1.37

g/l

2.50

632

2793

Other general symptoms and signs

330

1025

3.52

86.70

1.9

1.8

1.48

1.37

g/l

0.23

306

951

Other pleural conditions

530

2143

2.66

86.57

2.2

2.0

1.28

1.39

g/l

0.42

492

1938

Hepatomegaly and splenomegaly, not elsewhere classified

129

201

9.21

85.28

2.2

2.0

1.25

1.29

g/l

0.07

121

187

Vasomotor and allergic rhinitis

1768

10615

1.68

85.17

1.9

1.24

1.31

g/l

1.11

1640

9876

Other diseases of blood and blood-forming organs

423

1556

3.01

84.69

2.1

1.9

1.45

1.34

g/l

0.33

392

1433

Later onset COPD, excluding more controls

760

2680

2.25

84.54

1.6

1.9

1.47

1.44

g/l

0.08

690

2386

736

3470

2.25

83.69

2.2

1.9

1.29

1.32

g/l

0.14

678

3202

Abnormal weight loss

547

2294

2.60

83.39

1.8

1.9

1.14

1.35

g/l

2.43

510

2096

Infection due to other mycobacteria

149

269

6.95

83.08

1.8

1.7

1.35

1.64

g/l

0.46

138

242

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1478

8756

1.76

83.08

1.6

2.1

1.10

1.36

g/l

10.16

1365

8135

Glucagon-like peptide-1 (GLP-1) analogues

1478

8756

1.76

83.08

1.6

2.1

1.10

1.36

g/l

10.16

1365

8135

Myelodysplastic syndrome

124

186

8.51

82.94

2.0

1.3

1.30

1.17

g/l

0.31

114

171

Viral pneumonia (unknown virus, not influenza)

428

1603

2.95

82.67

3.3

2.0

1.32

1.38

g/l

0.20

398

1488

Chronic ulcer of skin, not elsewhere classified

406

1477

3.02

82.64

2.0

1.9

1.31

1.38

g/l

0.18

375

1350

COPD, hospital admission 2, with asthma infections

1382

6871

1.80

82.58

1.9

2.0

1.36

1.34

g/l

0.07

1255

6233

Weight loss

583

2526

2.50

82.45

1.9

2.0

1.14

1.35

g/l

2.78

544

2307

Sequelae of external causes of morbidity and mortality

1240

7016

1.85

82.20

2.2

2.0

1.27

1.33

g/l

0.49

1144

6442

Missing teeth due to accident, extraction or parodontitis

2770

16893

1.50

81.88

2.0

1.39

1.32

g/l

0.73

2485

15561

Other external causes of accidental injury

3593

12639

1.45

81.85

1.9

1.30

1.31

g/l

0.14

3324

11746

Other complications of surgical and medical care, not elsewhere classified

559

2389

2.53

81.34

2.2

1.9

1.27

1.32

g/l

0.19

528

2204

Diseases of pulp and periapical tissues, including avohilmo

4649

17687

1.38

81.19

1.9

1.27

1.31

g/l

0.59

4311

16319

Disorders of conjunctiva

3858

21632

1.41

80.35

2.0

1.9

1.30

1.29

g/l

0.07

3587

19988

Giant cell arteritis

281

845

3.81

80.35

1.6

1.9

1.15

1.47

g/l

1.52

260

757

Paralytic ileus and intestinal obstruction

1121

6172

1.89

80.33

2.1

1.9

1.27

1.37

g/l

0.64

1039

5610

Coronary atherosclerosis

2657

11259

1.53

80.09

1.9

2.0

1.20

1.38

g/l

3.43

2463

10258

Vasculitis limited to skin, not elsewhere classified

222

576

4.63

79.92

2.2

1.7

1.20

1.44

g/l

0.84

205

531

Eosinophilia

174

380

5.99

79.72

1.8

1.7

1.08

1.39

g/l

1.48

162

355

Cardiomyopathy

765

3721

2.16

79.50

2.0

1.27

1.36

g/l

0.40

716

3397

Falls/tendency to fall

4825

17927

1.37

79.40

1.8

2.0

1.25

1.30

g/l

1.03

4469

16650

Sequelae with surgical and medical care as external cause

997

5339

1.97

79.37

2.1

2.0

1.25

1.34

g/l

0.72

924

4890

Cellulitis

1100

6072

1.90

79.22

2.1

1.9

1.28

1.31

g/l

0.17

1012

5610

Other abnormalities of plasma proteins

158

318

6.36

78.90

3.5

1.7

1.50

1.23

g/l

0.48

150

292

Diseases of salivary glands

1563

9524

1.71

78.85

1.9

1.23

1.33

g/l

1.66

1439

8801

Systemic sclerosis, icd10

214

549

4.77

78.73

1.8

1.43

1.30

g/l

0.54

199

501

Ischaemic heart disease, wide definition

3264

14088

1.46

78.62

1.9

2.0

1.25

1.35

g/l

1.64

3028

12910

Other viral diseases, not elsewhere classified, including avohilmo

1347

7847

1.78

78.57

2.2

1.9

1.29

1.27

g/l

0.12

1274

7331

Dizziness and giddiness

3357

18526

1.44

78.53

1.9

2.0

1.31

g/l

0.05

3082

17094

Hypertensive heart and/or renal disease

1065

4185

1.93

77.66

1.7

2.3

1.20

1.52

g/l

4.45

965

3784

Anaemia in chronic diseases classified elsewhere

196

475

4.93

77.05

1.8

1.7

1.00

1.47

g/l

2.04

176

440

Ulcerative enterocolitis

239

667

4.18

76.96

2.3

1.8

1.20

1.32

g/l

0.71

222

619

Rheumatism, unspecified

682

3233

2.24

76.80

1.9

2.0

1.23

1.41

g/l

1.49

622

2977

Golimumab

278

858

3.75

76.77

1.7

1.9

1.29

1.28

g/l

0.08

267

809

Gonarthrosis [arthrosis of knee](FG)

2891

11410

1.49

76.53

1.9

2.0

1.30

1.34

g/l

0.40

2633

10433

Accidents

3555

12639

1.44

76.38

1.9

1.29

1.31

g/l

0.21

3292

11746

Obesity, other/unspecified

1594

9832

1.68

76.35

1.6

1.9

1.14

1.33

g/l

6.47

1490

9152

External causes of morbidity and mortality

2885

9868

1.50

76.26

1.9

1.28

1.30

g/l

0.18

2677

9151

Conjunctivitis (acute, non atopic), including avohilmo

4539

20396

1.37

75.94

2.0

1.9

1.27

1.30

g/l

0.27

4216

18814

Other and unspecified vasculitis limited to skin

204

520

4.74

75.39

2.2

1.6

1.21

1.29

g/l

0.26

189

481

Arthrosis

2881

10835

1.49

75.37

1.8

2.0

1.27

1.34

g/l

0.82

2659

9962

Diseases of oral cavity, salivary glands and jaws

2337

7902

1.56

74.90

2.0

1.9

1.31

1.36

g/l

0.37

2157

7230

Other and unspecified diseases of blood and blood-forming organs

218

585

4.46

74.89

2.5

1.7

1.61

1.45

g/l

0.28

204

540

Infection due to other mycobacteria, including avohilmo

151

303

6.12

74.87

1.8

1.7

1.33

1.57

g/l

0.38

140

275

Chronic laryngitis and laryngotracheitis

706

3426

2.19

74.69

1.8

1.9

1.30

1.39

g/l

0.54

629

3135

Other diseases of lip and oral mucosa

1970

12848

1.58

74.41

1.9

1.24

1.31

g/l

1.14

1807

11855

Benign neoplasm of other and ill-defined parts of digestive system

869

4552

2.02

74.21

2.0

1.37

1.36

g/l

0.06

810

4165

Lumbar disc prolapse

2748

14047

1.48

74.19

1.8

1.9

1.31

1.33

g/l

0.19

2556

12989

Psoriatic arthropathies

529

2303

2.46

73.45

1.6

2.0

1.22

1.36

g/l

0.83

492

2120

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1233

7077

1.78

73.43

1.9

1.32

1.30

g/l

0.21

1136

6639

Adjustment and management of implanted device

770

3867

2.09

73.39

1.9

1.34

1.43

g/l

0.32

712

3479

Other or unspecified immunodeficiency

104

18.33

72.83

4.9

1.8

1.08

1.45

g/l

0.59

Other infectious diseases, including avohilmo

495

2108

2.54

72.63

2.1

1.9

1.16

1.36

g/l

1.92

452

1933

Spinal stenosis

2087

10088

1.56

72.48

2.0

1.29

1.38

g/l

0.81

1903

9229

Injuries to the head

5013

22616

1.34

72.00

1.9

1.27

1.30

g/l

0.40

4610

20921

Other metabolic disorders

674

3261

2.19

71.81

2.0

1.9

1.29

1.40

g/l

0.46

634

3031

Shoulder lesions

3178

13494

1.44

71.55

1.8

2.0

1.27

1.33

g/l

0.71

2944

12425

Diseases of spleen

173

409

5.29

71.20

2.3

1.6

1.13

1.44

g/l

0.98

160

384

Mental and behavioural disorders due to alcohol

2245

14428

1.52

70.99

1.6

2.0

1.33

1.28

g/l

0.59

2054

13360

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

503

2182

2.49

70.84

2.5

1.9

1.33

1.36

g/l

0.08

473

2015

Other arthrosis

2153

9538

1.55

70.68

1.8

2.0

1.23

1.34

g/l

1.52

1977

8759

Inflammatory diseases of the central nervous system

477

2029

2.55

70.50

2.3

1.9

1.40

1.34

g/l

0.16

446

1878

Conjunctivitis

3469

20329

1.40

70.25

2.0

1.9

1.32

1.30

g/l

0.27

3221

18800

Chronic viral hepatitis

345

1262

3.05

70.17

1.4

2.0

1.66

1.24

g/l

5.03

321

1189

Migraine with aura

1161

6736

1.79

69.91

1.8

1.9

1.26

1.35

g/l

1.72

1101

6279

Total colectomy operation

290

972

3.39

69.57

2.1

1.9

1.19

1.33

g/l

0.82

276

909

Total colectomy

290

972

3.39

69.57

2.1

1.9

1.19

1.33

g/l

0.82

276

909

Disorders of skin appendages

2300

15607

1.51

69.49

2.0

1.9

1.30

1.29

g/l

0.09

2127

14481

Migraine without aura

974

5383

1.89

69.49

2.0

1.9

1.25

1.33

g/l

1.37

905

5057

Viral pneumonia (known virus, not influenza)

224

644

4.08

69.34

3.9

1.8

1.48

1.47

g/l

0.01

204

596

Other cataract

1863

8955

1.59

69.25

2.2

1.9

1.29

1.34

g/l

0.36

1719

8226

Other symptoms and signs involving the circulatory and respiratory systems

364

1368

2.88

69.13

1.9

2.1

1.09

1.34

g/l

2.50

335

1259

Injuries to the abdomen, lower back, lumbar spine and pelvis

1814

11626

1.58

68.89

2.0

1.9

1.34

1.31

g/l

0.21

1653

10659

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1942

12722

1.56

68.50

1.5

2.0

1.34

1.28

g/l

0.79

1780

11773

COPD, hospital admissions 3, with asthma pneumonia sepsis

1133

5594

1.80

68.31

2.0

1.33

1.36

g/l

0.13

1021

5048

Diseases of middle ear and mastoid

2604

14826

1.47

67.97

2.1

1.9

1.28

g/l

0.03

2421

13771

Disorders of choroid and retina

3453

17637

1.40

67.43

2.0

1.31

g/l

0.00

3155

16207

Suggestive for eosinophilic asthma

488

2137

2.46

67.24

2.0

1.9

1.18

1.37

g/l

1.28

459

1955

Use of teriflunomide

125

239

7.13

67.03

3.8

1.7

0.90

1.34

g/l

2.99

125

228

Early onset COPD

1000

5647

1.85

66.92

2.0

1.19

1.31

g/l

1.30

922

5182

Pneumonia derived septicemia

247

770

3.67

66.90

3.1

1.9

1.30

1.46

g/l

0.39

227

706

Dental operations

2478

8675

1.50

66.84

2.0

1.9

1.29

1.33

g/l

0.36

2273

7953

Psoriasis vulgaris

897

4922

1.91

66.17

1.8

2.0

1.34

1.31

g/l

0.13

831

4571

Substance use, excluding alcohol

965

5417

1.86

65.84

1.7

2.0

1.35

1.29

g/l

0.50

898

5040

Pacemaker

1455

8431

1.66

65.73

1.9

2.0

1.29

1.36

g/l

0.38

1336

7616

Nephrotic syndrome

236

730

3.77

65.26

2.4

1.8

1.33

1.32

g/l

0.02

223

684

Vascular disorders of the intestines

344

1293

2.87

65.17

1.9

1.33

1.42

g/l

0.29

316

1156

Other diseases of hard tissues of teeth

2262

7873

1.52

65.16

2.0

1.9

1.30

1.35

g/l

0.42

2071

7206

Symptoms and signs involving speech and voice

1495

9445

1.64

65.08

2.0

1.9

1.22

1.34

g/l

1.72

1385

8665

Polyarthritis, unspecified

233

709

3.70

65.06

1.8

2.0

1.31

1.44

g/l

0.31

224

653

Dermatitis due to substances taken internally

332

1235

2.96

65.03

2.5

1.9

1.14

1.34

g/l

0.97

305

1143

Hypothyroidism, strict autoimmune, 3 medication purchases required

3611

17915

1.38

64.93

1.8

1.9

1.24

1.34

g/l

2.83

3293

16537

Diseases of the myoneural junction and muscle

612

2972

2.19

64.90

1.9

2.0

1.14

1.36

g/l

2.34

564

2714

Mantle cell lymphoma

155

8.54

64.35

2.5

1.3

0.87

1.14

g/l

1.78

147

Personality disorders, excluding more controls

1122

6585

1.76

64.25

1.7

1.9

1.27

1.29

g/l

0.20

1019

6195

Other viral diseases, not elsewhere classified

918

5102

1.88

64.18

2.4

1.9

1.30

1.28

g/l

0.14

861

4757

Disorders of synovium and tendon

2302

13463

1.48

63.95

1.8

2.0

1.26

1.33

g/l

0.89

2123

12433

Other infectious diseases

410

1701

2.61

63.88

2.2

1.9

1.19

1.40

g/l

1.50

371

1563

Elevated blood glucose level

446

1921

2.50

63.80

2.1

1.9

1.19

1.36

g/l

1.44

416

1758

Coxarthrosis [arthrosis of hip](FG)

2051

9445

1.53

63.68

1.9

2.0

1.18

1.37

g/l

3.41

1867

8586

Cholecystitis

617

3020

2.15

63.34

1.8

2.0

1.27

1.37

g/l

0.79

555

2741

Other chronic obstructive pulmonary disease, including avohilmo

2215

12475

1.50

63.26

1.8

2.0

1.30

1.34

g/l

0.23

2028

11393

Herpesviral [herpes simplex] infections, including avohilmo

1214

7345

1.72

63.06

2.2

1.8

1.26

1.32

g/l

0.40

1129

6816

Myeloproliferative diseases

435

1867

2.52

62.96

1.9

2.0

1.42

g/l

0.02

405

1700

Benign neoplasm: Colon, unspecified

1099

6486

1.76

62.81

1.8

2.0

1.31

1.32

g/l

0.01

1002

5906

Portal vein thrombosis

148

341

5.37

62.71

1.6

1.8

1.32

1.30

g/l

0.04

143

316

Other abnormal immunological findings in serum

168

425

4.70

62.47

2.0

1.8

1.29

1.38

g/l

0.25

159

396

Hyperparathyroidism

796

4229

1.95

62.34

1.9

1.24

1.39

g/l

1.29

725

3814

Other diseases of stomach and duodenum

345

1333

2.81

62.32

1.8

2.0

1.22

1.39

g/l

1.05

327

1219

Other retinal disorders

2690

14536

1.44

62.09

1.9

2.0

1.31

1.33

g/l

0.11

2446

13312

Injury, poisoning and certain other consequences of external causes

2329

7959

1.50

62.06

1.9

2.0

1.35

1.32

g/l

0.23

2158

7367

Calcific aortic valvular stenosis, including rheumatic fever

1150

6602

1.73

61.91

1.9

2.0

1.38

g/l

0.00

1033

5929

Calcific aortic valvular stenosis

1149

6604

1.73

61.87

1.8

2.0

1.35

1.38

g/l

0.16

1032

5933

Calcific aortic valvular stenosis, operated

1149

6604

1.73

61.87

1.8

2.0

1.35

1.38

g/l

0.16

1032

5933

Kidney transplant status

338

1309

2.88

61.86

2.3

2.0

1.12

1.28

g/l

1.04

321

1226

Coeliac disease

617

3061

2.14

61.81

2.0

1.14

1.34

g/l

3.34

565

2836

Disorders of oesophagus in diseases classified elsewhere

172

447

4.58

61.74

2.6

1.7

1.21

1.40

g/l

0.62

156

410

Operations 2 for CAVS

1146

6586

1.73

61.72

1.8

2.0

1.35

1.38

g/l

0.16

1029

5915

Calcific aortic valvular stenosis, diagnosis (helper)

1146

6586

1.73

61.72

1.8

2.0

1.35

1.38

g/l

0.16

1029

5915

Temporal arteritis

233

736

3.59

61.63

1.6

1.9

1.15

1.42

g/l

0.98

214

659

Fracture of lumbar spine and pelvis

968

5523

1.82

61.57

2.2

1.9

1.38

1.35

g/l

0.11

877

4984

Hyperkinetic disorders, excluding more controls

615

2821

2.13

61.44

1.6

1.9

1.23

1.22

g/l

0.04

576

2674

Thyroiditis, ILD-related definition

536

2522

2.25

61.39

1.9

1.8

1.25

1.41

g/l

1.34

495

2325

Intestinal malabsorption

298

1084

3.06

61.33

2.0

1.9

1.09

1.40

g/l

2.46

271

1001

Pericarditis

225

698

3.61

60.87

2.6

1.9

1.20

1.49

g/l

1.13

217

644

Drug-induced cataract

195

564

4.14

60.36

3.0

1.8

1.21

1.30

g/l

0.32

184

518

Unspecified haematuria

1755

9436

1.56

60.35

2.0

1.29

1.32

g/l

0.22

1590

8662

Nonorganic sleeping disorders, excluding more controls

935

5328

1.82

60.22

1.8

1.9

1.29

1.32

g/l

0.18

869

4985

Alcohol use disorder, ICD-based

1786

11930

1.54

60.16

1.6

2.0

1.35

1.27

g/l

0.82

1635

11049

Hernia

4023

20289

1.34

59.94

2.0

1.9

1.35

1.29

g/l

0.78

3707

18707

Non-selective monoamine reuptake inhibitors

1551

9635

1.59

59.87

1.8

2.0

1.24

1.33

g/l

1.33

1416

8875

Raynaud syndrome

488

2247

2.34

59.82

1.9

1.36

1.38

g/l

0.13

460

2078

Selective deficiency of immunoglobulin A [IgA]y

116

12.55

59.80

2.9

1.8

1.22

1.44

g/l

0.35

111

Other peripheral vascular diseases

436

1915

2.45

59.72

1.8

1.9

1.34

1.42

g/l

0.45

402

1759

Other or unspecified ileus, impaction or obstruction

777

4196

1.93

59.61

2.0

1.9

1.33

1.34

g/l

0.04

719

3797

COPD, early/later onset

1820

10204

1.54

59.58

1.8

2.0

1.34

1.33

g/l

0.06

1660

9292

Haemorrhoids and perianal venous thrombosis

1393

8754

1.63

59.52

1.9

1.34

1.36

g/l

0.05

1274

7992

Other and unspecified aplastic anaemias

119

242

6.38

59.08

2.5

1.5

1.43

1.19

g/l

0.48

105

224

Other specified/unspecified inflammatory spondylopathies

290

1057

3.02

59.06

1.8

2.0

1.32

1.50

g/l

0.82

277

989

Viral and other specified intestinal infections, including avohilmo

1280

7651

1.66

59.06

2.0

1.9

1.16

1.28

g/l

2.44

1201

7133

Other specified/unspecified necrotizing vasculopathies

129

280

5.80

59.01

2.2

1.7

0.88

1.41

g/l

2.69

123

259

Biological medicines for asthma

187

534

4.17

58.85

1.7

1.8

1.06

1.31

g/l

2.03

173

504

Iridocyclitis

1034

6114

1.76

58.76

2.0

1.32

g/l

0.00

980

5646

COPD, hospital admissions

1798

10130

1.54

58.57

1.8

2.0

1.34

1.33

g/l

0.08

1641

9222

Nonsuppurative otitis media, including avohilmo

1473

8182

1.60

58.15

2.1

1.8

1.17

1.27

g/l

2.34

1379

7633

Nonsuppurative otitis media

1102

5728

1.73

57.99

2.1

1.8

1.16

1.30

g/l

2.40

1033

5340

Fissure and fistula of anal and rectal regions

1033

6118

1.75

57.93

1.9

1.19

1.33

g/l

1.71

951

5643

Acute suppurative otitis media

1237

7135

1.67

57.92

2.2

1.8

1.31

1.27

g/l

0.18

1144

6700

Subjective visual disturbances

1169

7164

1.69

57.87

2.0

1.9

1.21

1.34

g/l

1.63

1072

6600

Other and unspecified drugs and medicaments

458

2084

2.37

57.79

2.6

1.9

1.32

1.37

g/l

0.12

432

1917

Enteropathic arthropathies

172

467

4.27

57.61

1.8

1.7

1.34

1.44

g/l

0.25

160

433

Other skin changes

907

5207

1.82

57.38

2.3

1.9

1.34

1.33

g/l

0.03

845

4745

Conduction disorders

1166

5670

1.70

57.16

2.0

1.30

1.36

g/l

0.36

1068

5156

Gingivitis and periodontal diseases

4246

16782

1.33

56.94

2.0

1.9

1.31

1.30

g/l

0.18

3921

15481

Other and unspecified effects of external causes

1279

8043

1.65

56.87

1.9

1.40

1.28

g/l

1.17

1187

7485

Somatoform disorder

777

4277

1.90

56.73

1.8

1.9

1.22

1.35

g/l

1.22

711

3975

Secondary right heart disease

249

856

3.24

56.72

2.4

1.8

1.22

1.60

g/l

1.42

238

775

Other and unspecified tonsillitis

1431

7616

1.60

56.60

2.0

1.8

1.23

1.25

g/l

0.15

1339

7137

Intestinal stricture

1312

8307

1.63

56.53

2.1

2.0

1.32

1.33

g/l

0.06

1216

7578

Disease of hard tissues of teeth, NOS

2153

7729

1.49

56.38

2.0

1.9

1.29

1.36

g/l

0.68

1991

7084

Osteonecrosis

352

1448

2.65

56.27

3.1

1.8

1.13

1.38

g/l

0.92

326

1324

Gonarthrosis

2456

9789

1.44

56.04

1.8

2.0

1.31

1.35

g/l

0.30

2243

8985

Endocarditis

215

682

3.51

56.03

1.9

2.0

1.11

1.54

g/l

2.30

205

624

Other and unspecified urticaria

936

5461

1.79

56.02

1.9

1.26

1.31

g/l

0.51

865

5088

Other pulmonary heart/vessel disease

268

966

3.07

55.92

2.4

1.8

1.23

1.57

g/l

1.26

257

873

Pneumonia due to Streptococcus pneumoniae

237

797

3.27

55.70

2.4

1.7

1.01

1.33

g/l

2.53

215

739

COPD related to multimorbidity

1563

8672

1.57

55.70

1.8

2.0

1.27

1.35

g/l

0.57

1427

7861

AV-block

699

3156

1.96

55.60

1.9

2.0

1.30

1.42

g/l

0.50

636

2834

COPD-related respiratory insufficiency

527

2563

2.17

55.47

2.1

2.0

1.14

1.37

g/l

2.59

477

2311

Pneumococcal septicemia

230

771

3.39

55.28

3.2

1.8

1.33

1.38

g/l

0.09

213

715

Pruritus

566

2834

2.11

55.09

2.0

1.9

1.46

1.36

g/l

0.30

518

2613

Voice disturbances

1201

7503

1.66

55.07

2.0

1.19

1.36

g/l

2.75

1122

6887

Presence of cardiac and vascular implants and grafts

1650

8035

1.55

54.93

1.7

2.0

1.22

1.38

g/l

1.96

1511

7317

Other CVD

841

4781

1.83

54.73

2.2

1.9

1.26

1.37

g/l

0.59

762

4321

Periodontitis

4266

21049

1.31

54.65

2.0

1.9

1.31

1.30

g/l

0.10

3911

19431

Paracetamol or NSAID medication

706

1819

2.01

54.64

1.8

1.9

1.41

1.23

g/l

0.73

654

1691

L01XX Other antineoplastic agents

319

1271

2.75

54.63

2.2

1.9

1.14

1.48

g/l

1.90

282

1153

Injuries to the knee and lower leg

5184

22152

1.28

54.52

1.9

1.25

1.31

g/l

1.33

4797

20448

Giant cell arteritis with polymyalgia rheumatica

233

793

3.32

54.44

1.6

1.9

1.15

1.51

g/l

1.28

214

713

Injuries to the thorax

1946

13468

1.48

54.41

2.0

1.37

1.33

g/l

0.35

1796

12356

Special screening examination for infectious and parasitic diseases

972

4127

1.76

54.35

2.0

1.8

1.26

1.30

g/l

0.26

884

3863

Idiopathic gout

445

2051

2.32

54.12

1.7

1.9

1.15

1.40

g/l

1.35

423

1860

Conjunctivitis (acute, non atopic)

1306

8312

1.62

54.11

2.2

1.9

1.29

g/l

0.01

1225

7727

Reactive arthropathies, FINNGEN

353

1473

2.57

54.11

1.9

2.0

1.24

1.34

g/l

0.59

335

1358

Inflammatory diseases of female pelvic organs

2673

13278

1.41

54.02

1.9

1.33

1.34

g/l

0.07

2460

12263

Generalized skin eruption due to drugs and medicaments

255

917

3.12

53.85

2.7

1.9

1.16

1.45

g/l

1.14

235

850

Acute generalized exanthematous pustulosis

279

1051

2.95

53.77

2.7

1.9

1.15

1.43

g/l

1.22

259

973

Acute pharyngitis

702

3765

1.92

53.51

1.8

1.15

1.28

g/l

2.88

657

3546

Hypertensive Heart Disease

901

3929

1.79

53.38

1.6

2.3

1.19

1.53

g/l

4.62

810

3551

Chronic periodontitis, including avohilmo

4250

21050

1.31

53.37

2.0

1.9

1.31

1.30

g/l

0.12

3896

19432

Ankylosing spondylitis

441

2036

2.31

53.37

1.6

2.0

1.26

1.38

g/l

0.82

421

1891

Arthropathic psoriasis

562

2846

2.10

53.34

1.6

2.0

1.17

1.35

g/l

1.99

521

2646

Myocarditis

236

810

3.14

52.96

2.5

2.1

1.45

1.50

g/l

0.09

219

749

167

472

4.10

52.84

2.2

2.0

1.07

1.48

g/l

2.00

157

427

Other disorders of bone

895

5243

1.78

52.70

2.2

1.9

1.17

1.32

g/l

1.81

814

4879

Other disorders of kidney and ureter

613

3209

2.02

52.68

2.0

1.9

1.31

1.33

g/l

0.08

570

2937

Dental caries, including avohilmo

2978

11197

1.39

52.68

2.0

1.9

1.31

1.29

g/l

0.15

2747

10272

Peripheral artery disease

1655

8765

1.53

52.65

1.7

2.0

1.25

1.38

g/l

1.54

1517

7915

Preparatory care for dialysis

265

985

3.01

52.59

1.8

1.9

1.14

1.40

g/l

1.02

251

909

Malignant neoplasm of digestive organs, including Hilmo

1582

7710

1.54

52.36

1.8

1.5

1.33

1.20

g/l

1.30

1459

7055

Hypersplenism

12.74

52.23

3.0

1.9

1.24

1.64

g/l

0.43

Invasive ventilation

390

1734

2.43

52.16

2.1

1.9

1.18

1.36

g/l

1.20

357

1601

Pyogenic arthritis

328

1346

2.61

52.07

1.9

2.0

1.15

1.43

g/l

2.13

302

1232

Keratitis

1572

10545

1.53

52.05

2.0

1.9

1.23

1.30

g/l

0.85

1455

9746

Disorders resulting from impaired renal tubular function

241

859

3.17

51.99

1.9

1.8

1.11

1.41

g/l

1.69

224

806

Suppurative and unspecified otitis media

1610

9574

1.53

51.94

2.2

1.9

1.32

1.27

g/l

0.34

1499

8949

Other and unspecified acquired haemolytic anaemias

106

220

6.41

51.82

2.6

1.7

1.83

1.46

g/l

0.44

201

Recurrent aphthous stomatitis , including avohilmo

700

3850

1.91

51.50

2.2

2.0

1.15

1.34

g/l

3.15

663

3557

Allergic rhinitis

1423

9251

1.57

51.45

1.9

1.21

1.27

g/l

0.74

1315

8675

Deforming dorsopathies

1191

7531

1.63

51.44

2.0

1.9

1.26

1.34

g/l

0.69

1096

6930

Retention of urine

1364

7139

1.59

51.40

2.1

2.0

1.41

1.35

g/l

0.32

1246

6526

Caries of dentine, including avohilmo

3228

12325

1.36

51.20

2.0

1.9

1.36

1.30

g/l

0.69

2989

11328

Coxarthrosis

1895

8409

1.48

51.00

1.8

2.0

1.19

1.36

g/l

2.61

1721

7683

Other juvenile arthritis

243

874

3.06

50.83

2.1

1.9

1.24

1.29

g/l

0.32

225

819

Diseases of pulp and periapical tissues and dental caries

2644

9825

1.40

50.80

2.0

1.9

1.32

1.30

g/l

0.20

2440

8997

Other coagulation defects

392

1764

2.39

50.79

2.2

1.9

1.34

1.42

g/l

0.27

373

1631

Soft tissue disorders related to use, overuse and pressure

1172

7415

1.63

50.64

1.9

2.0

1.40

1.35

g/l

0.29

1075

6809

Neuromuscular dysfunction of bladder

446

2114

2.25

50.56

2.2

2.0

1.17

1.42

g/l

2.07

416

1943

Fracture of rib(s), sternum and thoracic spine

1291

8357

1.59

50.52

2.0

1.31

g/l

0.05

1192

7645

Polyuria

938

5629

1.73

50.33

2.2

2.0

1.23

1.37

g/l

1.09

847

5152

Type 1 diabetes

1076

6673

1.66

50.22

1.7

2.0

1.20

1.32

g/l

1.94

999

6175

Adverse effects, not elsewhere classified

929

5577

1.74

50.09

2.0

1.9

1.40

1.30

g/l

0.64

859

5196

Juvenile arthritis (FINNGEN)

265

1004

2.88

50.06

2.1

1.9

1.23

1.28

g/l

0.31

246

943

Stomatitis and related lesions

930

5589

1.73

49.92

2.1

1.9

1.20

1.30

g/l

1.11

873

5172

Atopic dermatitis, strict definition with reimbursement

1340

8409

1.58

49.90

1.9

1.8

1.19

1.25

g/l

1.07

1266

7868

Hypotension

721

4027

1.86

49.89

2.3

1.9

1.27

1.36

g/l

0.39

650

3625

Diplopia

617

3303

1.97

49.48

2.2

1.9

1.19

1.34

g/l

0.91

579

3037

Reactive arthropathies

413

1913

2.29

49.45

1.9

2.0

1.26

1.36

g/l

0.60

392

1765

Pain in thoracic spine

694

3855

1.88

49.05

2.0

1.9

1.34

1.36

g/l

0.09

659

3568

Coxibs

1124

3606

1.68

48.98

1.9

1.21

1.36

g/l

1.42

1037

3319

Internal derangement of knee

1469

9731

1.53

48.73

2.0

1.32

1.33

g/l

0.09

1341

8955

Cardiomyopathy in other diseases

106

9.45

48.72

3.6

1.5

1.72

1.66

g/l

0.03

Need for other prophylactic measures

329

1404

2.56

48.68

2.3

1.9

1.13

1.32

g/l

1.15

311

1307

Irregular menses

2073

11058

1.44

48.51

1.9

1.8

1.33

g/l

0.02

1931

10265

Complications of internal orthopaedic prosthetic devices, implants and grafts

915

5510

1.72

48.43

1.8

1.9

1.13

1.38

g/l

4.45

824

4993

Emphysema

346

1505

2.45

48.25

1.9

2.1

1.16

1.41

g/l

2.00

322

1349

Transport accidents

1976

11614

1.44

48.18

1.8

1.9

1.25

1.30

g/l

0.63

1832

10802

Abnormal findings on examination of urine, without diagnosis

261

1006

2.87

48.06

2.7

1.8

1.12

1.42

g/l

1.93

246

928

Polycystic ovarian syndrome, consortium definition

2989

12841

1.36

47.94

1.9

1.34

1.35

g/l

0.11

2751

11850

Persons encountering health services for specific procedures, not carried out

440

2117

2.21

47.94

1.9

1.41

1.37

g/l

0.12

412

1973

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

484

2418

2.13

47.82

2.2

2.0

1.22

1.36

g/l

0.66

457

2213

Hypermobility syndrome

294

1199

2.66

47.77

2.3

1.8

1.30

1.37

g/l

0.48

277

1128

Hypoparathyroidism

224

803

3.12

47.63

2.9

1.8

1.20

1.36

g/l

0.80

204

728

Major coronary heart disease event excluding revascularizations

2271

10807

1.41

47.36

1.9

2.1

1.23

1.40

g/l

2.98

2083

9809

Drug-induced osteoporosis

123

310

4.94

46.81

3.1

1.7

1.21

1.39

g/l

0.49

113

282

Other diseases of oesophagus

414

1961

2.23

46.68

2.1

2.0

1.57

1.37

g/l

0.48

381

1785

Pain and other conditions associated with female genital organs and menstrual cycle

916

4620

1.71

46.64

1.8

1.24

1.33

g/l

1.49

837

4280

Amputation

436

2110

2.18

46.45

1.8

2.0

1.18

1.42

g/l

1.44

390

1900

Myositis

168

517

3.68

46.43

1.8

1.01

1.55

g/l

2.68

160

473

Rash and other nonspecific skin eruption

473

2372

2.12

46.19

2.1

1.9

1.18

1.33

g/l

1.26

457

2192

Isolated proteinuria

194

656

3.37

46.13

2.8

1.7

1.03

1.40

g/l

2.66

184

613

Problems related to lifestyle

491

2490

2.07

46.05

1.8

1.9

1.40

1.30

g/l

0.46

442

2300

Exposure to other specified factors

3501

23335

1.31

46.03

1.9

1.24

1.30

g/l

0.95

3237

21602

CR(E)ST syndrome

133

358

4.51

45.98

1.8

1.7

1.62

1.31

g/l

1.16

122

329

Rotator cuff syndrome

2461

12457

1.39

45.92

1.8

2.0

1.25

1.33

g/l

0.86

2289

11452

Ulcerative proctitis

325

1411

2.48

45.89

1.9

1.21

1.36

g/l

0.95

306

1320

Psoriatic arthropathies, ICD10

519

2698

2.04

45.84

1.6

2.0

1.22

1.32

g/l

0.53

482

2510

Atherosclerosis, excluding cerebral and coronary sclerosis

1513

8055

1.51

45.67

1.7

2.0

1.25

1.39

g/l

1.59

1387

7259

Migraine with aura and triptan purchases

751

4363

1.79

45.65

1.8

1.9

1.28

1.33

g/l

0.55

716

4079

Other disorders of ear

3876

19627

1.30

45.38

2.1

1.9

1.28

1.29

g/l

0.07

3547

18122

Anterior Iridocyclitis

890

5423

1.71

45.31

2.0

1.9

1.31

g/l

0.02

848

5011

Acute and subacute iridocyclitis

838

5028

1.73

45.27

2.0

1.9

1.31

g/l

0.04

799

4653

Other psoriatic arthropathies

506

2621

2.05

45.18

1.6

2.0

1.23

1.31

g/l

0.42

470

2435

Osteomyelitis

328

1443

2.45

44.94

2.3

1.9

1.37

1.38

g/l

0.04

300

1330

Excessive, frequent and irregular menstruation

1552

5587

1.52

44.80

1.9

1.33

1.35

g/l

0.14

1427

5139

Dialysis

235

892

2.92

44.72

2.3

1.8

1.08

1.35

g/l

1.35

221

834

Cervical disc disorders

1426

9675

1.51

44.52

2.0

1.27

1.34

g/l

0.61

1299

8916

Congenital malformations, deformations and chromosomal abnormalities

2515

17806

1.36

44.47

2.0

1.9

1.28

g/l

0.01

2370

16524

Abnormality of white blood cells, not elsewhere classified

201

6.09

44.25

2.2

1.7

1.58

1.49

g/l

0.09

187

Statin medication

2870

12186

1.35

43.67

1.7

2.1

1.14

1.40

g/l

13.78

2670

11293

Unknown and unspecified causes of morbidity

302

1292

2.47

43.50

2.2

1.8

1.17

1.38

g/l

1.44

288

1176

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1724

8121

1.46

43.37

2.3

1.5

1.47

1.21

g/l

2.82

1557

7419

Diabetic nephropathy, excluding more controls

705

3309

1.82

43.15

1.7

1.8

1.12

1.24

g/l

0.94

657

3004

Small fibre neuropathy

197

698

3.20

43.10

3.0

1.8

1.66

1.38

g/l

0.70

182

644

Phlebitis and thrombophlebitis (not including DVT)

930

5799

1.66

42.95

2.2

2.0

1.28

1.34

g/l

0.36

864

5333

Hernia of abdominal wall

1857

13324

1.43

42.89

1.9

2.0

1.33

1.31

g/l

0.15

1721

12270

Duodenal ulcer

429

2123

2.11

42.87

1.5

2.0

1.18

1.35

g/l

1.25

397

1913

Injuries to the ankle and foot

3141

20733

1.32

42.84

1.9

1.29

1.28

g/l

0.12

2909

19231

Vitamin deficiency

260

1054

2.67

42.83

2.2

1.9

1.32

1.41

g/l

0.28

240

971

Vitamin deficiency, wide

260

1054

2.67

42.83

2.2

1.9

1.32

1.41

g/l

0.28

240

971

Peripheral artery operations in Hilmo

506

2662

1.98

42.34

1.8

2.0

1.28

1.39

g/l

0.51

456

2382

Other neurological diseases

2906

17232

1.33

42.33

2.1

2.0

1.28

1.33

g/l

0.56

2674

15795

Special screening examination for other diseases and disorders

493

2568

1.99

42.30

1.6

1.9

1.24

1.34

g/l

0.47

463

2356

Suppurative and necrotic conditions of lower respiratory tract

293

1263

2.51

42.26

2.3

1.9

1.41

1.39

g/l

0.04

269

1163

Other and unspecified coagulation defects

287

1228

2.54

42.26

2.2

1.9

1.45

1.46

g/l

0.02

276

1144

Ovarian cyst

1394

5353

1.53

41.79

1.9

1.33

1.35

g/l

0.18

1303

4919

Cerebrovascular diseases

2909

15423

1.33

41.76

1.8

2.0

1.20

1.35

g/l

3.91

2660

14142

Lung diseases due to external agents

568

3124

1.89

41.51

1.9

2.0

1.25

1.38

g/l

0.69

509

2820

Viral and other specified intestinal infections

909

5536

1.65

41.46

2.2

1.8

1.20

1.28

g/l

0.87

851

5155

Postprocedural endocrine and metabolic disorders, not elsewhere classified

549

2994

1.92

41.41

1.9

1.25

1.39

g/l

0.78

518

2782

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2747

19108

1.33

41.41

2.0

1.9

1.28

1.29

g/l

0.13

2588

17722

Secondary thrombocytopenia

111

284

4.81

41.30

3.0

1.5

1.26

1.37

g/l

0.25

105

262

Disorders of muscles

470

2440

2.02

41.29

1.6

2.0

1.09

1.35

g/l

3.35

444

2239

Other encephalitis

184

645

3.22

40.97

2.5

1.7

1.18

1.40

g/l

0.87

169

602

Chronic diseases of tonsils and adenoids

3198

15623

1.31

40.89

1.9

1.26

1.31

g/l

0.74

2989

14484

Open wound of lower leg

684

4000

1.78

40.70

1.9

1.31

1.30

g/l

0.02

624

3683

Intracranial injury

2449

17202

1.35

40.55

1.8

2.0

1.31

g/l

0.02

2234

15862

Diabetic maculopathy, excluding more controls

465

2421

2.01

40.47

1.6

2.0

1.13

1.42

g/l

2.43

423

2221

Fentanyl

399

1959

2.12

40.39

2.3

1.8

1.08

1.39

g/l

3.01

361

1768

Atopic dermatitis

2507

15064

1.35

40.35

1.8

1.9

1.24

1.28

g/l

0.51

2355

14018

Other disorders of eye and adnexa

666

3886

1.79

40.14

2.1

1.9

1.16

1.32

g/l

2.34

618

3609

Encephalitis

191

692

3.09

39.98

2.5

1.7

1.18

1.39

g/l

0.82

176

643

Cardiodefibrillation

1330

9084

1.50

39.77

2.1

2.0

1.24

1.37

g/l

1.15

1234

8248

Myeloproliferative diseases (CML excluded)

354

1691

2.23

39.61

2.0

1.9

1.50

1.42

g/l

0.22

329

1544

Myocardial infarction

1779

8888

1.43

39.58

1.8

2.1

1.16

1.41

g/l

4.47

1633

8081

Other embolism and thrombosis

544

3001

1.89

39.57

2.2

2.0

1.18

1.38

g/l

1.95

509

2749

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1627

7764

1.45

39.47

2.3

1.5

1.44

1.21

g/l

2.21

1466

7082

Ankylosing spondylitis, ICD10

429

2201

2.07

39.47

1.6

1.9

1.27

1.34

g/l

0.40

410

2059

Malignant neoplasm of skin, including Hilmo

1904

9218

1.41

39.28

2.3

1.5

1.49

1.21

g/l

3.44

1726

8455

Acetic acid derivatives and related substances

1063

3499

1.61

39.28

1.8

1.9

1.23

1.36

g/l

1.39

975

3215

Dermatographic urticaria

347

1652

2.24

39.20

2.1

1.8

1.31

1.40

g/l

0.41

323

1540

Migraine without aura and triptan purchases

758

4601

1.71

39.18

1.9

1.27

1.33

g/l

0.77

706

4305

Post-traumatic stress disorder

409

2061

2.09

39.15

1.7

1.9

1.43

1.33

g/l

0.41

377

1950

Localized swelling, mass and lump of skin and subcutaneous tissue

1326

9112

1.49

39.05

2.1

1.9

1.27

1.29

g/l

0.08

1245

8373

Temporomandibular joint disorders, including avohilmo

1927

13672

1.39

39.01

1.9

1.24

1.31

g/l

1.49

1782

12710

COPD, hospital admissions 1, only main diagnosis

1268

7387

1.51

38.97

1.9

2.0

1.39

1.35

g/l

0.18

1147

6698

Atypical mycobacterium lung infection

102

256

4.86

38.83

1.9

1.8

1.24

1.36

g/l

0.24

226

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

980

5498

1.60

38.75

1.6

1.8

1.23

g/l

0.06

921

5181

Generalized anxiety disorder

726

4359

1.72

38.74

1.7

1.9

1.33

1.30

g/l

0.17

672

4096

Unspecified fall

2131

15598

1.37

38.39

2.0

1.34

1.30

g/l

0.35

1942

14376

Angina pectoris

2073

10122

1.38

38.34

1.8

2.0

1.25

1.39

g/l

1.84

1922

9202

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1432

10027

1.47

38.26

1.9

2.0

1.27

1.31

g/l

0.33

1347

9257

Chronic myeloid leukaemia, including Hilmo

171

5.87

38.24

1.3

1.4

1.11

1.12

g/l

0.01

161

Pollen allergy

885

5534

1.63

38.23

1.9

1.23

1.25

g/l

0.18

815

5196

Behavioural syndromes associated with physiological disturbances and physical factors

3972

21581

1.26

38.16

1.8

2.0

1.31

1.29

g/l

0.14

3669

19947

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1331

9207

1.48

37.91

1.9

1.33

1.30

g/l

0.18

1222

8503

Poisoning by drugs, medicaments and biological substances

1027

6748

1.57

37.85

1.7

1.9

1.34

1.31

g/l

0.17

942

6298

Disorders of ocular muscles, binocular movement, accommodation and refraction

2054

15142

1.37

37.84

2.1

1.9

1.31

1.28

g/l

0.22

1908

14046

Meniscus derangement

2029

9906

1.38

37.47

2.0

1.29

1.34

g/l

0.34

1878

9100

Other dialysis

194

736

2.97

37.39

2.0

1.9

1.05

1.44

g/l

2.14

181

688

Phobic anxiety disorders

606

3498

1.80

37.36

1.9

1.28

1.29

g/l

0.11

566

3290

Postviral fatigue syndrome

196

5.50

37.26

2.3

1.8

1.23

1.38

g/l

0.38

187

Acute peritonitis

304

1402

2.32

37.20

2.0

1.15

1.37

g/l

1.40

281

1294

Simple and mucopurulent chronic bronchitis

204

787

2.79

37.07

1.9

1.19

1.44

g/l

1.15

194

716

Cardiomyopathies, Primary/intrinsic

469

2518

1.94

37.06

1.7

2.0

1.20

1.37

g/l

0.92

440

2284

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1233

8444

1.50

37.00

1.9

1.32

1.30

g/l

0.16

1136

7892

Arthropathies in other diseases classified elsewhere

188

701

2.92

36.77

1.8

2.0

1.34

1.46

g/l

0.21

169

643

Liver disorders in diseases classified elsewhere

12.41

36.65

1.7

1.8

2.06

1.02

g/l

3.67

Microscopic polyangiitis

138

7.03

36.64

2.0

1.8

0.94

1.45

g/l

1.18

123

Malignant neoplasm of skin

1784

8742

1.41

36.57

2.2

1.5

1.43

1.21

g/l

2.47

1606

7998

Aspergillosis, including avohilmo

200

5.43

36.45

2.8

1.6

1.19

1.34

g/l

0.21

181

Cardiomyopathy (excluding other)

481

2619

1.91

36.36

1.7

2.0

1.20

1.39

g/l

1.11

452

2374

Certolizumab pegol

134

420

3.66

36.30

1.7

1.8

1.37

1.39

g/l

0.05

127

388

Chronic nephritic syndrome

214

860

2.73

36.29

2.5

1.9

1.28

1.39

g/l

0.25

201

803

Postmenopausal osteoporosis with pathological fracture

292

1338

2.33

36.28

2.4

1.8

1.38

1.37

g/l

0.02

263

1186

Faecal incontinence

380

1921

2.07

36.05

2.1

1.9

1.40

1.47

g/l

0.16

339

1745

Open wound of head

2240

15937

1.34

35.98

1.9

2.0

1.28

1.29

g/l

0.14

2029

14683

Postprocedural disorders of nervous system

356

1768

2.14

35.91

2.3

1.8

1.18

1.37

g/l

1.92

340

1655

Renal tubulo-interstitial disorders in diseases classified elsewhere

206

5.24

35.88

4.3

1.6

0.84

1.72

g/l

1.76

190

Cerebral cysts

291

1339

2.33

35.87

1.9

1.24

1.40

g/l

1.06

272

1243

Aspergillosis

199

5.42

35.79

2.8

1.6

1.20

1.34

g/l

0.20

180

Diseases of peritoneum

444

2377

1.96

35.78

1.9

2.0

1.15

1.40

g/l

2.54

412

2181

Misadventures to patients during surgical and medical care

615

3624

1.77

35.71

2.1

1.9

1.37

1.34

g/l

0.13

565

3332

Disorder of lipoprotein metabolism, unspecified

500

2772

1.88

35.67

1.8

1.9

1.19

1.44

g/l

1.78

459

2501

Chronic periodontitis, complicated

2287

16983

1.34

35.60

1.9

2.0

1.30

1.31

g/l

0.04

2086

15650

Exclusions for E4_PCOS_CONSORTIUM

2997

14643

1.30

35.47

1.8

1.9

1.29

1.31

g/l

0.17

2781

13568

Cervicalgia

832

5295

1.62

35.26

1.7

1.9

1.26

1.36

g/l

0.62

763

4870

Sacroiliitis, not elsewhere classified

245

1056

2.49

35.20

1.6

1.9

1.26

1.41

g/l

1.19

239

994

Carpal tunnel syndrome

2455

16348

1.32

35.18

1.9

1.24

1.32

g/l

1.02

2265

15044

Type 1 diabetes, wide definition, subgroup 1

854

5470

1.61

35.08

1.7

2.0

1.23

1.33

g/l

1.28

789

5076

Triptan medication for migraine, min. 3 purchases

2377

13567

1.33

35.02

1.8

1.31

1.29

g/l

0.24

2247

12628

Panic disorder

646

3873

1.73

34.99

1.7

1.9

1.27

1.31

g/l

0.38

598

3642

Spondylopathies in diseases classified elsewhere

243

4.63

34.97

4.7

1.8

0.61

1.86

g/l

3.62

221

DVT of lower extremities

728

4500

1.67

34.92

2.3

2.0

1.40

1.35

g/l

0.18

661

4106

Ocular pain

411

2170

2.00

34.71

2.1

1.9

1.18

1.38

g/l

1.79

383

2000

Heartburn

460

2515

1.90

34.35

1.8

1.9

1.40

1.37

g/l

0.05

420

2308

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1178

8017

1.49

34.34

2.0

1.9

1.19

1.31

g/l

2.98

1101

7498

Other enthesopathies

1195

8247

1.48

34.31

2.0

1.39

1.34

g/l

0.29

1096

7604

Haemorrhage, not elsewhere classified

177

661

2.87

34.23

1.8

1.15

1.43

g/l

1.06

165

604

Hypertensive Renal Disease

169

617

2.94

34.10

2.1

2.2

1.24

1.72

g/l

1.19

157

557

Contact with and exposure to communicable diseases

1306

9137

1.46

34.10

2.4

1.8

1.28

1.27

g/l

0.08

1241

8570

Other specified/unspecified bacterial intestinal infections

315

1527

2.20

33.99

2.0

1.8

1.17

1.38

g/l

1.13

284

1405

Basal cell carcinoma, including Hilmo

1608

7849

1.41

33.89

2.4

1.5

1.51

1.21

g/l

2.85

1452

7159

Other and unspecified rosacea

429

2316

1.95

33.85

1.9

1.31

1.36

g/l

0.14

394

2145

Other inflammation of eyelid, including avohilmo

1879

14031

1.37

33.80

2.0

1.9

1.28

1.31

g/l

0.19

1731

13023

Colectomy operation

675

4135

1.69

33.80

2.2

1.9

1.41

1.34

g/l

0.23

629

3770

Amputation of toe

317

1545

2.18

33.60

1.8

2.0

1.20

1.39

g/l

0.86

286

1407

Diseases of external ear

1459

10491

1.42

33.50

1.9

2.0

1.30

1.32

g/l

0.09

1304

9666

Sleep disorders

3778

21096

1.25

33.42

1.8

2.0

1.31

1.30

g/l

0.15

3490

19500

Poisoning by medicine

924

6112

1.56

33.12

1.7

1.9

1.32

1.29

g/l

0.21

849

5710

Dentofacial anomalies [including malocclusion]

2976

18447

1.28

33.09

1.9

1.25

1.30

g/l

0.75

2761

17123

Use of anticholinesterases

524

6869

0.58

33.09

1.7

2.0

1.59

1.40

g/l

0.44

440

6143

N06DA Anticholinesterases

524

6869

0.58

33.09

1.7

2.0

1.59

1.40

g/l

0.44

440

6143

Benign neoplasm: Caecum

472

2648

1.87

32.89

1.8

2.0

1.44

1.36

g/l

0.23

444

2419

Enthesopathies of lower limb, excluding foot

918

6066

1.56

32.88

1.9

1.28

1.33

g/l

0.28

842

5607

Disturbance of activity and attention

612

3592

1.73

32.76

1.6

1.9

1.24

1.22

g/l

0.15

573

3390

Rosacea

576

3420

1.76

32.70

2.1

1.9

1.38

1.36

g/l

0.06

532

3173

Deviated nasal septum

1260

8854

1.45

32.68

1.9

2.0

1.20

1.32

g/l

1.29

1161

8169

Diabetic retinopathy, excluding more controls

1132

4305

1.52

32.52

1.6

1.8

1.13

1.26

g/l

2.05

1036

3913

Malignant neoplasm of digestive organs

1324

7135

1.45

32.48

1.9

1.5

1.37

1.19

g/l

1.46

1217

6528

KRA_PSY_EATING, excluding more controls

342

1711

2.06

32.35

1.7

1.9

1.19

1.37

g/l

2.58

321

1623

Colonic or urogenital fistula

1092

7506

1.50

32.34

1.9

2.0

1.19

1.33

g/l

1.99

1001

6935

Personality disorders

1122

7756

1.48

32.19

1.7

1.9

1.27

1.30

g/l

0.33

1019

7261

Dermatophytosis

589

3532

1.74

32.17

2.1

2.0

1.28

1.33

g/l

0.15

541

3248

Viral infections of the central nervous system, including avohilmo

359

1860

2.04

32.11

2.3

1.9

1.18

1.36

g/l

1.35

330

1731

Myocardial infarction, without ST-elevation

1424

9240

1.42

31.98

1.8

2.0

1.19

1.37

g/l

2.02

1294

8370

Cardiomyopathy, other and unspecified

318

1581

2.12

31.76

2.1

1.9

1.36

1.41

g/l

0.08

297

1446

Viral infections of the central nervous system

335

1703

2.08

31.69

2.3

1.9

1.21

1.35

g/l

0.90

308

1584

Abnormalities of gait and mobility

510

2954

1.80

31.68

1.8

2.0

1.22

1.35

g/l

1.02

464

2692

Other follicular disorders

361

1886

2.02

31.53

2.1

2.0

1.19

1.37

g/l

1.12

336

1775

Viral warts

451

2529

1.87

31.39

2.5

1.9

1.41

1.35

g/l

0.19

429

2353

Carrier of infectious disease

157

584

3.00

31.36

2.1

1.7

1.31

1.46

g/l

0.42

146

541

Disorders of continuity of bone

453

2545

1.86

31.32

2.3

1.8

1.26

1.33

g/l

0.31

416

2354

Unspecified chronic bronchitis

170

652

2.80

31.28

1.7

1.8

1.10

1.46

g/l

1.68

156

587

Other symptoms and signs involving the urinary system

441

2458

1.88

31.22

2.1

1.9

1.13

1.35

g/l

1.06

421

2245

UC patients in KELA-register (code 208), prior to 1994

220

959

2.49

31.21

2.2

1.8

1.25

1.35

g/l

0.40

208

891

Cerebral palsy and other paralytic syndromes

483

2766

1.82

31.20

2.2

2.0

1.37

1.36

g/l

0.01

449

2553

Nonorganic sleeping disorders

935

6285

1.53

31.07

1.8

1.9

1.29

1.31

g/l

0.11

869

5861

Disorders of vestibular function (Vertigo)

1836

13481

1.35

30.91

2.0

1.25

1.36

g/l

1.63

1685

12342

Injuries to the hip and thigh

1885

12763

1.35

30.86

1.8

2.0

1.28

1.33

g/l

0.34

1717

11700

Folate deficiency anaemia

216

4.65

30.86

2.1

1.8

1.88

1.75

g/l

0.09

197

Malignant neoplasm of bone and articular cartilage

190

4.93

30.79

5.3

1.4

0.74

1.14

g/l

4.96

182

1490

9776

1.40

30.78

2.3

2.0

1.44

1.37

g/l

0.41

1352

8845

Oxicams

847

3096

1.59

30.74

2.0

1.18

1.38

g/l

1.61

768

2838

Insomnia

3697

21001

1.24

30.71

1.7

2.0

1.30

g/l

0.02

3426

19407

Hypopituitarism

365

1938

2.00

30.51

2.0

1.9

1.16

1.24

g/l

0.54

348

1817

Superficial injury of lower leg

1096

7621

1.47

30.48

1.8

1.9

1.25

1.32

g/l

0.49

1013

7030

Lung cancer and mesothelioma

565

2848

1.72

30.42

2.0

1.9

1.72

1.46

g/l

0.78

516

2565

375

2005

1.96

30.41

1.3

2.0

1.76

1.33

g/l

3.14

338

1846

Other obstetric conditions, not elsewhere classified

1267

5634

1.45

30.33

1.9

1.8

1.33

1.35

g/l

0.15

1196

5317

Injuries to the shoulder and upper arm

3511

22065

1.24

30.27

1.9

2.0

1.27

1.30

g/l

0.40

3206

20370

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2259

16818

1.31

30.18

2.0

1.9

1.35

1.29

g/l

0.49

2083

15569

Nonischemic cardiomyopathy

400

2184

1.91

30.14

1.9

2.0

1.36

1.38

g/l

0.05

373

1980

Menorrhagia

1282

5038

1.45

29.97

1.8

1.9

1.34

1.36

g/l

0.11

1175

4623

Other inflammation of eyelid

605

3721

1.69

29.92

2.2

1.9

1.30

1.37

g/l

0.33

553

3434

Basal cell carcinoma

1514

7530

1.39

29.82

2.3

1.5

1.47

1.22

g/l

2.27

1364

6864

Alzheimer disease, including avohilmo

597

6644

0.61

29.78

2.0

1.98

1.37

g/l

2.05

503

5953

Diabetic nephropathy

710

4497

1.62

29.76

1.7

1.8

1.12

1.21

g/l

0.70

662

4108

Type of accident

1199

8515

1.44

29.70

1.9

1.34

1.30

g/l

0.23

1096

7871

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1233

5468

1.45

29.67

1.9

1.8

1.33

1.35

g/l

0.32

1166

5162

Radiculopathy

602

3700

1.68

29.60

2.0

1.9

1.33

1.36

g/l

0.09

558

3384

Valvular operations

501

2933

1.76

29.58

1.7

2.0

1.13

1.38

g/l

1.95

463

2663

Type 1 diabetes, wide definition

875

5850

1.53

29.55

1.7

2.0

1.23

1.33

g/l

1.39

810

5431

Mature T/NK-cell lymphomas, hilmo

289

3.97

29.50

1.7

1.22

1.37

g/l

0.27

262

Alcohol abuse, main dg, excluding more controls

595

3658

1.68

29.31

1.6

2.0

1.29

1.28

g/l

0.04

557

3417

Alcohol dependence

1019

7041

1.48

29.30

1.5

2.1

1.32

1.30

g/l

0.19

925

6512

Hyperkinetic disorders

633

3853

1.66

29.29

1.6

1.9

1.22

g/l

0.00

594

3639

Unspecific neurodegenerative disorder

746

7789

0.64

29.24

1.9

2.0

1.82

1.40

g/l

1.59

633

7003

Other problems related to primary support group, including family circumstances

521

3019

1.75

29.15

2.3

1.9

1.11

1.28

g/l

3.19

485

2840

Peripheral arterial reconstruction

603

3725

1.67

29.07

1.7

1.9

1.21

1.36

g/l

0.98

544

3338

Covid-19 suspected case

891

6015

1.52

28.97

2.2

1.9

1.43

1.29

g/l

0.73

840

5604

Hypocalcemia

150

572

2.94

28.75

2.4

1.8

1.19

1.44

g/l

0.90

133

527

Bipolar affective disorders

756

4942

1.57

28.62

1.7

1.9

1.24

1.32

g/l

0.50

694

4621

Diseases of inner ear

2104

15620

1.31

28.58

1.9

2.0

1.23

1.34

g/l

2.12

1927

14329

Other and unspecified disorders of skin and subcutaneous tissue

282

1402

2.13

28.44

2.3

1.9

1.26

1.40

g/l

0.55

239

1285

Disorders of adult personality and behaviour

1165

8300

1.44

28.35

1.7

1.9

1.26

1.29

g/l

0.30

1060

7781

Iron deficiency

179

743

2.61

28.31

1.8

1.9

1.29

1.38

g/l

0.52

163

699

Osteonecrosis due to drugs

109

354

3.60

28.26

3.9

1.7

0.68

1.45

g/l

3.32

321

Other disorders of veins

1593

11737

1.36

28.22

1.8

1.9

1.38

1.31

g/l

0.44

1450

10766

Intestinal adhesions without obstruction

342

1817

1.97

28.18

2.0

1.9

1.18

1.43

g/l

1.60

319

1646

Mental and behavioural disorders due to opioids

204

900

2.44

28.09

1.6

1.8

1.66

1.21

g/l

3.96

192

839

Conductive and sensorineural hearing loss

3079

16518

1.25

28.09

2.1

1.9

1.31

1.30

g/l

0.04

2802

15198

Umbilical hernia

1067

7499

1.46

28.07

1.9

2.0

1.31

1.32

g/l

0.07

985

6951

Fracture of shoulder and upper arm

1429

10526

1.38

28.03

1.9

1.34

1.32

g/l

0.11

1299

9671

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

396

2176

1.86

27.91

2.4

1.4

1.56

1.15

g/l

1.61

353

1942

Alzheimer’s disease, strict definition

333

4928

0.53

27.90

2.0

1.9

2.01

1.40

g/l

1.23

274

4408

Other/unspecified reactive arthropathies

309

1601

2.05

27.84

2.0

1.8

1.27

1.32

g/l

0.25

293

1489

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

765

5047

1.56

27.83

1.9

1.8

1.29

1.34

g/l

0.54

723

4680

Donors of organs and tissues

104

329

3.60

27.82

3.6

1.6

1.11

1.19

g/l

0.11

306

Infections with a predominantly sexual mode of transmission

1240

8938

1.42

27.75

1.9

1.8

1.35

1.30

g/l

0.40

1132

8362

Pyothorax

213

962

2.38

27.74

2.3

1.8

1.50

1.35

g/l

0.25

196

888

Primary hyperparathyroidism

459

2685

1.79

27.69

1.9

1.28

1.37

g/l

0.39

412

2443

Malignant neoplasm of bone and articular cartilage, including Hilmo

107

345

3.46

27.48

4.5

1.4

0.95

1.13

g/l

0.43

101

327

Injuries to the wrist and hand

4201

23263

1.21

27.47

1.9

1.24

1.30

g/l

1.33

3872

21515

Sensorineural hearing loss

2900

15563

1.26

27.43

2.1

1.9

1.33

1.31

g/l

0.18

2636

14308

Oter anti-inflammatory and antirheumatic agents, non-steroids

781

2781

1.58

27.40

1.9

1.25

1.40

g/l

0.93

711

2541

Asthma mixed form (mode), excluding more controls

187

797

2.46

27.21

1.7

1.8

1.31

1.39

g/l

0.25

179

723

Actinic keratosis

1339

8917

1.39

27.16

2.3

2.0

1.47

1.38

g/l

0.43

1210

8032

Nasal polyp

731

4801

1.57

27.15

1.9

2.0

1.21

1.37

g/l

1.48

681

4409

Skin changes due to chronic exposure to nonionizing radiation

1378

9174

1.39

27.15

2.4

2.0

1.46

1.38

g/l

0.37

1247

8275

Hydronephrosis

432

2494

1.80

27.01

1.9

1.16

1.44

g/l

2.01

407

2264

Disorders of porphyrin and bilirubin metabolism

262

3.98

26.93

1.8

1.7

1.08

1.52

g/l

0.94

238

Alzheimer disease

498

5826

0.60

26.90

2.0

1.9

1.79

1.39

g/l

1.12

412

5207

Abnormal findings on diagnostic imaging of central nervous system

237

1129

2.24

26.89

2.6

2.0

1.25

1.31

g/l

0.15

230

1050

Decubitus ulcer and pressure area

261

1286

2.14

26.85

1.8

1.9

1.11

1.39

g/l

1.95

237

1160

Allergic conjunctivitis

2354

17965

1.28

26.78

2.0

1.9

1.34

1.29

g/l

0.49

2172

16653

Disorders of tooth development and eruption

648

3355

1.61

26.70

2.2

1.8

1.24

1.29

g/l

0.39

612

3097

Benign neoplasm: Stomach

405

2314

1.83

26.61

1.9

2.0

1.48

1.38

g/l

0.27

372

2118

Acute gastritis

296

1529

2.03

26.59

1.9

2.0

1.38

1.39

g/l

0.03

271

1397

Ventral hernia

915

6316

1.49

26.56

1.8

2.0

1.33

1.32

g/l

0.02

848

5783

Acute posthaemorrhagic anaemia

160

647

2.65

26.55

2.6

1.8

1.57

1.54

g/l

0.03

144

593

Allergic purpura

165

682

2.64

26.47

1.8

1.08

1.43

g/l

1.67

148

634

Epilepsy

1157

8301

1.42

26.36

1.8

2.0

1.34

1.32

g/l

0.07

1056

7682

Migraine, single triptan purchase ok & required. ICD-code if available is included

3113

17189

1.24

26.34

1.9

1.26

1.29

g/l

0.38

2926

15926

Triptan medication for migraine, single purchase ok

3113

17189

1.24

26.34

1.9

1.26

1.29

g/l

0.38

2926

15926

Ankylosing spondylitis, strict definition

224

1057

2.28

26.25

1.6

1.9

1.17

1.27

g/l

0.78

216

997

Speech and linguistic disorders, excluding more controls

355

1826

1.90

26.21

2.1

1.9

1.09

1.23

g/l

1.55

332

1716

Myocardial infarction, strict

1569

8332

1.36

26.08

1.7

2.1

1.15

1.42

g/l

4.76

1440

7567

Other sleep disorders

457

2710

1.75

26.01

1.9

2.1

1.12

1.38

g/l

2.99

418

2511

Spondylolisthesis/Spondylolysis

700

4598

1.57

26.00

2.0

1.9

1.29

1.37

g/l

0.41

641

4227

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

212

4.40

25.98

3.8

1.6

2.57

1.44

g/l

0.49

191

Mental and behavioural disorders due to tobacco

390

2221

1.84

25.96

1.7

1.9

1.23

1.33

g/l

0.46

361

2058

Atopic dermatitis, strict definition

1235

8815

1.40

25.93

1.9

1.19

1.28

g/l

1.64

1174

8263

Abscess of anal and rectal regions

354

1954

1.89

25.92

1.8

2.0

1.25

1.35

g/l

0.60

330

1816

Familial hypercholesterolemia

519

3180

1.68

25.90

1.9

2.0

1.14

1.43

g/l

1.90

475

2875

Other disorders of bladder

463

2760

1.74

25.88

2.4

2.0

1.16

1.40

g/l

1.79

403

2507

Other and unspecified local infections of skin and subcutaneous tissue

426

2487

1.79

25.88

2.2

2.0

1.25

1.36

g/l

0.41

397

2294

Emotional disorders starting during childhood or adolecense, excluding more controls

207

914

2.32

25.86

2.0

1.9

1.25

1.18

g/l

0.60

192

867

Lichen simplex chronicus and prurigo

281

1444

2.05

25.85

2.0

1.9

1.23

1.31

g/l

0.29

254

1331

Arthropathy in ulcerative colitis

299

3.68

25.85

1.7

1.29

1.42

g/l

0.36

279

Vitamin B12 deficiency anaemia

381

2151

1.84

25.74

2.0

1.9

1.40

1.41

g/l

0.02

343

1952

Viral warts, including avohilmo

908

6300

1.48

25.73

2.3

1.9

1.31

1.29

g/l

0.12

852

5853

Other local infections of skin and subcutaneous tissue

447

2648

1.76

25.73

2.1

2.0

1.24

1.36

g/l

0.46

416

2439

Propionic acid derivatives

1094

3858

1.45

25.65

1.9

2.0

1.35

1.33

g/l

0.09

1006

3559

Degeneration of macula and posterior pole

1713

10089

1.33

25.62

2.0

1.35

g/l

0.01

1544

9134

Smoking dependency

390

2230

1.83

25.62

1.7

1.9

1.23

1.33

g/l

0.48

361

2069

Psoriasis (vulgaris), strict definition

184

812

2.45

25.47

1.5

1.8

1.26

1.29

g/l

0.08

174

762

Stroke, excluding SAH

2202

12524

1.29

25.47

1.8

2.0

1.16

1.36

g/l

5.72

1996

11427

Bullous disorders

257

1289

2.11

25.41

1.8

1.9

1.25

1.42

g/l

0.69

243

1177

Acute lymphadenitis

271

1387

2.07

25.27

2.4

1.9

1.12

1.30

g/l

0.84

249

1299

Stroke, including SAH

2335

13314

1.28

25.19

1.8

2.1

1.17

1.35

g/l

5.14

2116

12170

Cutaneous lupus erythematosus

137

532

2.85

25.18

1.8

1.32

1.48

g/l

0.43

126

490

Malignant neoplasm, without specification of site, including Hilmo

180

783

2.42

25.13

2.1

1.3

1.55

1.22

g/l

0.85

166

719

Other diseases of arteries and capillaries

367

2069

1.85

25.12

1.8

2.0

1.30

1.40

g/l

0.37

346

1885

Acute laryngitis and tracheitis

489

2928

1.70

25.10

2.1

1.8

1.21

1.29

g/l

0.81

456

2746

Other and unspecified myopathies

360

2021

1.86

25.05

1.8

2.0

1.22

1.40

g/l

0.88

328

1837

Dental pulpitis, including avohilmo

3794

20278

1.21

25.03

1.8

1.9

1.24

1.29

g/l

0.93

3543

18802

Seborrhoeic dermatitis

413

2413

1.78

24.97

2.0

1.37

1.32

g/l

0.14

374

2228

Tubulo-interstitial nephritis, not specified as acute or chronic

267

1361

2.05

24.90

2.2

1.8

1.23

1.50

g/l

1.51

250

1240

Other disorders of optic [2nd] nerve and visual pathways

292

1543

2.00

24.85

2.5

1.9

1.09

1.35

g/l

2.49

269

1422

Anti-inflammatory and antirheumatic products, non-steroids

1089

3860

1.44

24.84

1.9

2.0

1.35

1.33

g/l

0.08

1006

3561

Crystal arthropathies, rheuma endpoint

102

339

3.32

24.82

1.6

1.9

1.29

1.44

g/l

0.21

308

Caries of enamel

3967

21771

1.20

24.80

2.0

1.9

1.35

1.28

g/l

0.93

3658

20164

Benign neoplasm: Rectum, anus and anal canal

762

5150

1.52

24.80

2.1

1.9

1.54

1.33

g/l

0.99

711

4689

Sub-endpoint used in defining T1D endpoints

1111

7899

1.41

24.74

1.7

2.0

1.21

1.29

g/l

0.93

1029

7286

Allergic urticaria

361

2039

1.85

24.66

2.1

1.9

1.28

1.35

g/l

0.36

334

1899

Diseases of tongue

258

1306

2.07

24.63

2.1

1.8

1.34

1.39

g/l

0.11

238

1176

Oesophagitis

230

1119

2.17

24.60

1.6

1.9

1.19

1.39

g/l

0.62

213

1025

Specific personality disorders

946

6669

1.45

24.58

1.6

1.9

1.30

1.31

g/l

0.05

862

6251

Fluid overload

9.07

24.49

2.8

1.7

2.58

1.19

g/l

0.67

Trochanteric bursitis

573

3651

1.62

24.47

1.8

2.0

1.36

1.41

g/l

0.23

525

3348

Chronic iridocyclitis

232

1139

2.17

24.41

2.0

1.8

1.37

1.43

g/l

0.18

220

1053

Superficial injury of head

955

6740

1.45

24.40

1.7

1.9

1.23

1.30

g/l

0.63

889

6189

Neuralgia and neuritis, unspecified

233

1147

2.15

24.20

2.2

1.9

1.45

1.49

g/l

0.06

218

1053

Other enthesopathy of foot (+metatarsalgia)

428

2550

1.74

24.03

2.0

1.45

1.40

g/l

0.16

388

2353

Pyoderma gangrenosum

186

4.50

24.01

2.3

1.6

1.13

1.33

g/l

0.51

174

Disorders of iron metabolism

110

393

3.17

23.98

1.5

1.7

0.95

1.31

g/l

2.53

100

363

Benign neoplasm: Rectum

688

4590

1.55

23.94

2.0

1.9

1.43

1.31

g/l

0.59

641

4187

Benign neoplasm: Ascending colon

551

3504

1.63

23.91

2.1

2.0

1.44

1.35

g/l

0.33

517

3182

Abnormal involuntary movements

549

3487

1.63

23.91

1.9

2.0

1.32

1.34

g/l

0.05

509

3211

Amputation of ankle bones

120

447

2.95

23.85

1.7

1.6

1.20

1.47

g/l

0.56

113

413

Unspecified urinary incontinence

365

2093

1.82

23.66

1.9

1.38

1.35

g/l

0.07

310

1907

Disorders of myoneural junction and muscle in diseases classified elsewhere

179

4.55

23.62

2.5

1.6

1.18

1.35

g/l

0.32

164

Asthma mixed form (mode)

187

849

2.30

23.56

1.7

1.8

1.31

1.37

g/l

0.16

179

776

Malnutrition

129

504

2.84

23.51

2.4

1.7

1.61

1.44

g/l

0.17

117

462

Postprocedural disorders of digestive system, not elsewhere classified

164

713

2.48

23.45

1.8

1.10

1.37

g/l

1.41

153

661

Fracture of foot, except ankle

1011

7273

1.42

23.40

2.1

1.9

1.30

g/l

0.02

934

6761

Other crystal arthropathies

102

351

3.20

23.40

1.6

1.8

1.29

1.66

g/l

0.53

317

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

684

4584

1.54

23.30

1.8

1.9

1.38

1.29

g/l

0.59

626

4290

Isolated proteinuria with specified morphological lesion

278

3.67

23.29

2.0

1.5

1.54

1.47

g/l

0.06

257

Endometriosis

1228

5228

1.39

23.24

1.8

1.9

1.37

1.35

g/l

0.08

1123

4809

Metatarsalgia

399

2358

1.76

23.14

2.0

1.46

1.41

g/l

0.15

359

2174

Artrosis, including avohilmo

3242

14669

1.22

23.11

1.8

2.0

1.30

1.31

g/l

0.09

2988

13549

Acute bronchiolitis

296

1446

1.95

22.99

2.1

1.9

1.20

1.18

g/l

0.12

281

1356

Benign neoplasm: Sigmoid colon

712

4825

1.52

22.93

2.0

1.9

1.32

1.34

g/l

0.11

669

4397

Amenorrhoea

293

1586

1.93

22.91

2.2

1.9

1.37

1.38

g/l

0.01

273

1485

Vitamin D deficiency

118

447

2.93

22.87

2.3

1.7

1.19

1.35

g/l

0.65

108

409

Other symptoms and signs involving cognitive functions and awareness

1760

12171

1.30

22.81

1.9

2.0

1.41

1.34

g/l

0.60

1586

11142

Squamous cell neoplasms and carcinomas of the skin

313

1724

1.87

22.81

2.5

1.4

1.49

1.15

g/l

1.11

284

1539

Essential (haemorrhagic) thrombocythaemia

161

702

2.45

22.72

2.0

1.4

1.27

1.23

g/l

0.11

147

647

Infections with a predominantly sexual mode of transmission, including avohilmo

1594

11247

1.32

22.72

1.9

1.8

1.33

1.28

g/l

0.62

1453

10537

Polycythaemia vera

139

568

2.62

22.61

1.8

1.4

1.58

1.20

g/l

1.24

130

519

Benign neoplasm: Transverse colon

435

2653

1.71

22.53

2.0

1.20

1.36

g/l

1.25

405

2424

Other bursopathies

500

3149

1.64

22.50

2.2

2.1

1.22

1.41

g/l

0.77

459

2881

Other and unspecified psoriasis

291

1586

1.93

22.48

1.8

1.9

1.32

1.38

g/l

0.18

276

1469

Benign paroxysmal vertigo

1106

8128

1.39

22.47

2.0

1.29

1.36

g/l

0.70

1022

7452

Social phobias

363

2107

1.79

22.40

1.9

1.8

1.27

1.29

g/l

0.11

340

1982

Cervicobrachial syndrome

821

5748

1.46

22.12

1.8

1.9

1.34

1.35

g/l

0.04

768

5306

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

177

817

2.32

21.97

2.5

1.7

1.30

1.45

g/l

0.54

165

756

L01XE Protein kinase inhibitors

237

1221

2.07

21.95

3.5

1.9

1.82

1.45

g/l

0.70

211

1126

In situ neoplasms

1483

11406

1.32

21.94

2.2

1.9

1.29

1.37

g/l

0.72

1366

10414

Chronic myeloproliferative disease

292

3.44

21.92

1.9

1.7

1.51

1.31

g/l

0.28

260

Ischaemic Stroke, excluding all haemorrhages

2015

11784

1.28

21.91

1.8

2.0

1.14

1.36

g/l

7.28

1828

10753

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

356

2074

1.79

21.90

1.8

1.9

1.45

1.35

g/l

0.34

328

1932

Cardiac arrest

212

872

2.14

21.89

1.5

2.1

1.17

1.72

g/l

2.56

193

789

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

100

353

3.08

21.83

1.6

1.3

1.35

1.12

g/l

0.51

328

Alzheimer’s disease (Late onset)

314

4488

0.56

21.80

2.1

1.9

2.07

1.41

g/l

1.23

256

3994

Maternal care for other conditions predominantly related to pregnancy

821

5619

1.46

21.79

1.8

1.40

1.33

g/l

0.54

773

5280

Hyperhidrosis

138

571

2.56

21.77

2.0

1.7

1.38

1.29

g/l

0.16

129

526

Other localized connective tissue disorders

112

424

2.92

21.72

2.3

1.8

1.37

1.40

g/l

0.04

101

392

Otitis media, unspecified

478

2763

1.65

21.62

2.3

1.8

1.16

1.29

g/l

1.37

454

2593

Other disorders starting during childhood or adolecense, excluding more controls

216

1024

2.11

21.62

2.0

1.9

1.17

g/l

0.01

209

968

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

299

1663

1.88

21.59

1.7

1.9

1.36

g/l

0.04

279

1574

Hidradenitis suppurativa

187

888

2.25

21.58

1.6

1.9

1.10

1.35

g/l

2.64

170

835

Fitting and adjustment of other devices

1240

8182

1.36

21.56

1.9

2.0

1.33

1.38

g/l

0.23

1131

7418

Otitis externa

911

6535

1.43

21.54

1.9

1.26

1.32

g/l

0.33

828

6063

Otalgia

361

2128

1.77

21.30

2.0

1.9

1.28

1.34

g/l

0.22

339

1977

Artificial opening status

230

1184

2.05

21.16

2.3

1.9

1.10

1.41

g/l

2.26

211

1091

Autoimmune hyperthyroidism

220

1112

2.06

21.05

1.9

1.8

1.23

1.41

g/l

1.18

207

1011

Vascular diseases of the intestine

166

758

2.32

20.96

1.9

1.8

1.40

1.45

g/l

0.08

152

681

Bronchitis, not specified as acute or chronic

329

1896

1.80

20.89

2.0

1.9

1.23

1.35

g/l

0.58

303

1745

Cardiac murmurs and other cardiac sounds

370

2175

1.74

20.86

1.9

2.0

1.13

1.30

g/l

2.27

342

2007

Postzoster neuralgia

315

3.21

20.82

3.1

1.6

1.36

g/l

0.00

279

Arthropathy in Crohn disease

234

3.71

20.78

1.7

1.5

1.42

1.29

g/l

0.33

216

Use of memantine

410

5298

0.61

20.77

2.0

1.9

2.19

1.39

g/l

1.91

327

4723

Use of other anti-dementia drugs

410

5298

0.61

20.77

2.0

1.9

2.19

1.39

g/l

1.91

327

4723

Seborrhoeic keratosis

912

6581

1.42

20.77

2.5

1.9

1.37

1.33

g/l

0.18

835

5996

IgA nephropathy (IgA glomerulonephritis)

134

566

2.60

20.76

1.7

1.6

1.14

1.31

g/l

0.75

126

525

Infectious mononucleosis, including avohilmo

361

2141

1.75

20.76

1.8

1.47

1.25

g/l

1.37

333

2019

Infectious mononucleosis

361

2141

1.75

20.76

1.8

1.47

1.25

g/l

1.37

333

2019

Other keratitis

468

2963

1.63

20.76

1.9

1.18

1.35

g/l

2.03

434

2750

Degenerative diseases of the nervous system

643

6769

0.67

20.70

2.0

1.9

1.80

1.37

g/l

1.66

548

6068

Unspecified nephritic syndrome

124

506

2.70

20.68

2.0

1.7

1.23

1.46

g/l

0.49

117

468

Procreative management

1391

8780

1.33

20.68

2.1

1.9

1.24

1.25

g/l

0.07

1303

8196

Disorders of vitreous body and globe

1946

14731

1.27

20.64

2.0

1.29

1.34

g/l

0.37

1764

13519

Other diseases of gallbladder

186

894

2.20

20.64

1.9

1.55

1.52

g/l

0.05

177

814

Use of donepezil

263

4481

0.55

20.53

1.8

1.9

1.63

1.44

g/l

0.28

218

3982

Viral meningitis, including avohilmo

186

900

2.21

20.52

1.9

1.19

1.29

g/l

0.53

172

841

Leisure time condition

714

4951

1.48

20.47

1.9

1.32

1.30

g/l

0.10

643

4579

Meningitis

226

1172

2.04

20.47

2.2

1.8

1.62

1.33

g/l

0.46

209

1085

Personal history of other diseases and conditions

465

2934

1.63

20.44

1.9

1.8

1.22

1.32

g/l

0.84

430

2756

Delirium, not induced by alcohol and other psychoactive substances

452

2838

1.64

20.40

1.9

1.32

g/l

0.00

406

2555

Persistent mood disorders

722

5016

1.47

20.40

1.7

1.9

1.33

1.35

g/l

0.06

650

4626

Infection of intervertebral disc (pyogenic)

288

3.33

20.35

1.5

1.8

1.41

1.80

g/l

0.54

265

Chorioretinal inflammation

148

657

2.44

20.33

2.3

1.7

1.26

1.48

g/l

0.57

134

608

Combinations of oral blood glucose lowering drugs

997

7327

1.39

20.29

1.5

2.1

1.07

1.39

g/l

8.54

905

6736

Other extrapyramidal and movement disorders in other diseases

936

6815

1.40

20.26

1.9

1.33

g/l

0.02

852

6249

Other shoulder lesions

382

2318

1.71

20.10

2.0

1.34

1.39

g/l

0.21

356

2144

Use of pramipexole

800

5686

1.44

20.00

2.0

1.9

1.27

1.33

g/l

0.34

727

5195

Other disorders of eyelid

1592

11787

1.29

19.95

1.9

2.0

1.29

1.37

g/l

0.60

1457

10730

Otitis externa, unspecified

472

3024

1.62

19.94

2.0

1.9

1.33

1.36

g/l

0.10

441

2819

Malignant neoplasm of other connective and soft tissue, including Hilmo

166

774

2.27

19.93

2.4

1.4

0.96

1.19

g/l

1.66

155

715

Other female pelvic inflammatory diseases

604

4080

1.52

19.89

2.0

1.9

1.36

1.38

g/l

0.10

553

3760

Other specified/unspecified soft tissue disorders

194

960

2.12

19.86

2.2

1.9

1.04

1.48

g/l

3.83

186

874

Molar incisor enamel hypoplasia

212

1040

2.09

19.85

2.8

1.9

1.02

1.14

g/l

1.03

205

991

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

356

2133

1.74

19.83

1.8

1.9

1.45

1.35

g/l

0.33

328

1990

Fenamates

523

2298

1.59

19.78

2.0

1.21

1.40

g/l

1.22

480

2114

Suicide or other Intentional self-harm

945

6920

1.40

19.73

1.7

1.9

1.33

1.30

g/l

0.25

864

6456

Disorders of vitreous body

1892

14440

1.26

19.73

2.0

1.30

1.34

g/l

0.34

1712

13256

Mental and behavioural disorders due to sedatives or hypnotics

295

1682

1.84

19.69

1.6

1.9

1.50

1.30

g/l

1.10

276

1566

Other/unspecified synovitis and tenosynovitis

440

2779

1.63

19.65

1.8

2.0

1.34

1.37

g/l

0.08

402

2556

Cervicocranial syndrome

414

2579

1.66

19.59

1.9

1.28

1.42

g/l

0.56

394

2368

Thyrotoxicosis, other and/or unspecified

764

5406

1.45

19.57

1.7

2.0

1.18

1.38

g/l

3.10

712

4999

Other or ill-defined heart diseases

217

1122

2.02

19.56

1.6

1.9

1.38

1.41

g/l

0.06

199

1034

Drug-induced systemic lupus erythematosus

161

4.42

19.53

1.7

1.22

1.40

g/l

0.33

150

Panniculitis, unspecified

224

3.61

19.23

2.3

1.7

1.30

1.49

g/l

0.32

203

Other disorders of glucose regulation and pancreatic internal secretion

340

2029

1.74

19.17

1.7

1.9

1.16

1.32

g/l

1.34

315

1883

Viral meningitis

175

851

2.20

19.09

2.0

1.8

1.21

1.29

g/l

0.34

161

797

Acute alcohol intoxication, ICD10

771

5496

1.44

18.98

1.6

2.0

1.29

1.28

g/l

0.05

711

5122

Disorders of orbit

198

1008

2.08

18.96

2.0

1.8

1.25

1.37

g/l

0.39

186

935

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

669

4511

1.48

18.93

1.9

2.0

1.20

1.27

g/l

0.67

644

4208

Mouth breathing

1505

11814

1.29

18.92

1.8

2.0

1.20

1.29

g/l

0.92

1395

10952

Intrahepatic Cholestasis of Pregnancy (ICP)

299

1733

1.80

18.85

1.7

1.9

1.36

1.38

g/l

0.06

279

1637

Diseases of male genital organs

1868

7488

1.27

18.84

1.9

2.0

1.20

1.21

g/l

0.03

1748

6940

Spontaneous rupture of synovium and tendon

322

1903

1.76

18.80

2.4

2.0

1.29

1.40

g/l

0.44

299

1735

Other abnormal uterine and vaginal bleeding

821

4219

1.43

18.76

1.9

1.40

1.36

g/l

0.18

737

3856

Benign neoplasm: Small intestine

184

919

2.14

18.73

1.9

1.25

1.49

g/l

1.09

170

843

Adult respiratory distress syndrome

253

3.37

18.72

2.0

1.7

0.94

1.58

g/l

1.47

232

Thiazolidinediones

405

2542

1.65

18.67

1.5

2.0

1.12

1.44

g/l

2.84

368

2310

Scleritis and episcleritis

266

1496

1.86

18.66

2.0

1.9

1.29

1.41

g/l

0.28

247

1392

Cluster headache, strict

167

803

2.21

18.65

1.7

2.1

1.22

1.33

g/l

0.47

153

751

Alcohol-induced chronic pancreatitis

267

1507

1.86

18.55

1.5

1.9

1.25

1.35

g/l

0.47

251

1412

Injuries to the neck

903

6634

1.39

18.51

2.0

1.9

1.32

1.30

g/l

0.09

835

6155

Emotionally unstable personality disorder

499

3290

1.56

18.50

1.7

1.9

1.32

1.33

g/l

0.06

461

3091

Necrosis of pulp, including avohilmo

2314

18869

1.23

18.50

2.0

1.9

1.29

1.28

g/l

0.05

2150

17505

Fracture of lower leg, including ankle

2118

17008

1.24

18.45

1.9

2.0

1.31

1.30

g/l

0.05

1973

15666

Nummular dermatitis

326

1945

1.74

18.42

2.2

2.0

1.41

1.33

g/l

0.21

302

1789

Unspecified privation

422

2685

1.63

18.42

2.0

1.29

1.36

g/l

0.27

394

2484

Chondropathies

600

4114

1.50

18.38

1.9

1.18

1.35

g/l

1.38

545

3841

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

703

4818

1.46

18.36

1.9

2.0

1.19

1.28

g/l

0.93

676

4488

Pain associated with micturition

463

3009

1.59

18.34

2.2

2.0

1.39

1.37

g/l

0.04

427

2772

Other hearing loss

963

6917

1.37

18.33

2.3

1.9

1.41

1.37

g/l

0.17

863

6257

Cluster headache, wide

174

856

2.15

18.26

1.7

2.0

1.20

1.39

g/l

0.84

160

798

Vitreous haemorrhage

392

2457

1.65

18.24

1.7

2.0

1.08

1.38

g/l

3.89

348

2256

Congenital malformations of the respiratory system, including avohilmo

116

489

2.62

18.19

1.8

2.0

0.92

1.36

g/l

2.18

109

457

Iridocyclitis in diseases classified elsewhere

106

431

2.70

17.86

2.1

1.7

1.42

1.54

g/l

0.15

399

Paralytic ileus

150

703

2.25

17.80

1.9

1.8

1.32

1.53

g/l

0.58

142

638

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

299

1763

1.77

17.72

1.6

1.9

1.58

1.23

g/l

3.52

283

1650

Vulvovaginal ulceration/inflammation in other diseases

285

1660

1.79

17.63

2.1

1.9

1.31

1.36

g/l

0.35

261

1543

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

286

1669

1.79

17.63

1.8

1.9

1.38

1.33

g/l

0.13

267

1556

Tonsillectomy and adenotomy

2233

12793

1.23

17.48

1.8

1.9

1.23

1.26

g/l

0.32

2095

11989

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

230

1259

1.90

17.47

2.1

1.4

1.00

1.18

g/l

1.63

212

1153

Seronegative juvenile rheumatoid arthritis

106

436

2.67

17.45

2.0

1.30

1.33

g/l

0.07

407

Other and unspecified haemorrhagic conditions

336

2.92

17.43

2.6

1.5

1.31

1.38

g/l

0.10

309

Disorders of refraction and accommodation

1130

8627

1.33

17.35

2.1

1.9

1.34

1.27

g/l

0.42

1040

8050

Malignant neoplasm of other and unspecified parts of biliary tract

252

3.20

17.34

1.7

1.3

1.50

1.11

g/l

0.70

237

Fracture of femur

903

6020

1.37

17.31

1.8

1.9

1.31

1.35

g/l

0.18

807

5420

Barrett oesophagus

199

1046

2.00

17.30

1.6

2.0

1.41

1.39

g/l

0.02

184

961

Tuberculosis, IBD comorbidity

242

1349

1.86

17.28

1.9

1.27

1.45

g/l

0.40

222

1214

Superficial injury of hip and thigh

547

3724

1.50

17.23

1.8

1.9

1.32

1.35

g/l

0.08

498

3416

Extreme obesity with alveolar hypoventilation

181

925

2.08

17.22

2.2

1.9

1.18

1.36

g/l

0.71

166

850

Excessive attrition of teeth

2411

19908

1.21

17.21

1.9

1.32

1.29

g/l

0.19

2251

18461

966

6203

1.36

17.20

1.9

2.0

1.37

1.40

g/l

0.10

864

5559

Other epidermal thickening

195

1023

2.01

17.10

1.9

1.24

1.39

g/l

0.50

186

942

Benign neoplasm: Duodenum

130

590

2.39

17.10

2.0

1.8

1.33

1.49

g/l

0.42

121

543

Other meningitis

387

2.78

17.08

2.2

1.7

1.50

1.38

g/l

0.09

360

Disorders of psychological development

502

3119

1.54

17.07

2.0

1.8

1.12

1.21

g/l

1.22

470

2919

Algoneurodystrophy

153

738

2.21

17.07

1.9

1.7

1.33

1.34

g/l

0.02

146

693

Unspecified/other endometriosis

354

2151

1.66

17.03

1.9

1.25

1.34

g/l

0.92

333

2005

Other nonthrombocytopenic purpura

221

3.49

17.02

2.3

1.4

0.99

1.21

g/l

1.18

201

Benign neoplasm of other and unspecified endocrine glands

508

3427

1.53

16.98

1.7

2.0

1.13

1.33

g/l

2.26

469

3158

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1523

11984

1.27

16.98

1.8

1.9

1.33

1.27

g/l

0.77

1423

11191

Olecranon bursitis

245

1383

1.85

16.94

2.1

2.0

1.36

1.37

g/l

0.02

228

1268

Superficial injury of abdomen, lower back and pelvis

606

4227

1.47

16.92

1.9

1.29

1.30

g/l

0.06

561

3897

Chronic tubulo-interstitial nephritis

153

738

2.19

16.91

1.9

1.7

1.27

1.46

g/l

0.59

136

677

Other and unspecified nerve root and plexus disorders, also in other diseases

779

5675

1.40

16.90

2.0

1.9

1.39

1.32

g/l

0.28

721

5252

Inflammatory disease of uterus

528

3594

1.51

16.79

1.8

1.9

1.37

1.35

g/l

0.09

479

3336

Corneal ulcer

701

5026

1.43

16.76

1.9

1.16

1.29

g/l

1.78

650

4663

Agoraphobia

149

715

2.21

16.76

2.1

1.8

1.19

1.30

g/l

0.75

140

676

Melanocytic naevi

1186

9195

1.31

16.73

2.3

1.9

1.39

1.31

g/l

0.56

1115

8526

Charcot foot

354

2.80

16.73

1.9

2.0

1.65

1.64

g/l

0.01

320

Other noninflammatory disorders of vulva and perineum

373

2358

1.63

16.71

1.9

1.8

1.32

1.33

g/l

0.03

347

2169

Pneumonitis due to solids and liquids

291

1728

1.74

16.67

1.7

2.0

1.24

1.40

g/l

0.69

256

1577

Other disorders of the musculoskeletal system and connective tissue

553

3806

1.49

16.67

2.0

1.30

1.35

g/l

0.15

517

3499

Endocrine disorders, other/unspecified

103

427

2.64

16.66

2.3

1.6

1.12

1.33

g/l

0.83

399

Dermatophytosis, including avohilmo

2530

20834

1.20

16.60

1.9

1.31

1.29

g/l

0.15

2341

19271

Hypoplasia of dental enamel , including avohilmo

195

998

2.00

16.50

2.8

1.9

1.03

1.12

g/l

0.67

189

952

Mixed hyperlipidaemia

163

814

2.11

16.45

1.4

2.0

1.07

1.53

g/l

2.93

149

741

Impetigo

213

1169

1.92

16.31

2.4

1.9

1.45

1.32

g/l

0.27

203

1099

Noninflammatory disorders of female genital tract

1424

5611

1.29

16.19

1.9

1.33

1.35

g/l

0.14

1308

5163

Alcohol withdrawal state with delirium

272

1606

1.77

16.15

1.3

1.9

1.47

1.33

g/l

0.50

248

1495

Osteopathy in diseases classified elsewhere

182

3.76

16.14

5.6

1.7

0.63

1.34

g/l

3.08

165

Infective dermatitis

418

2737

1.57

16.07

2.0

1.32

1.31

g/l

0.04

385

2515

Presence of other devices

783

5654

1.39

16.04

1.7

1.9

1.26

1.43

g/l

0.99

727

5110

Juvenile rheumatoid arthirtis

106

451

2.52

16.04

2.3

1.7

1.20

1.36

g/l

0.78

421

Gingival hyperplasia

178

930

2.04

16.03

2.7

1.9

1.31

1.28

g/l

0.05

163

866

Alcohol abuse, main dg

595

4193

1.46

15.79

1.6

2.0

1.29

g/l

0.04

557

3910

Other disorders of nervous system

268

1587

1.76

15.75

2.7

2.0

1.59

1.41

g/l

0.28

240

1462

Monoarthritis, not elsewhere classified

166

847

2.06

15.74

1.6

2.0

1.47

1.45

g/l

0.04

158

775

Strabismus

1009

7704

1.33

15.70

2.0

1.9

1.27

1.31

g/l

0.32

951

7136

Other blood glucose lowering drugs, excl. Insulins

523

3600

1.49

15.68

1.6

2.0

1.20

1.43

g/l

1.44

486

3264

Erythema multiforme

115

514

2.42

15.66

2.2

1.7

1.05

1.44

g/l

1.71

108

478

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

318

1936

1.68

15.63

2.3

1.9

1.16

1.23

g/l

0.50

300

1839

Other eating disorders

215

1196

1.87

15.61

1.7

1.9

1.23

1.37

g/l

1.32

200

1127

Injuries to the elbow and forearm

2796

20399

1.19

15.56

1.8

1.9

1.30

g/l

0.01

2568

18849

Tuberculosis, wide, including avohilmo

251

1460

1.78

15.55

1.9

1.26

1.45

g/l

0.43

231

1310

Congenital malformations of the respiratory system

104

449

2.56

15.55

1.7

2.0

0.91

1.33

g/l

1.94

421

Benign neoplasm: Liver/bile ducts

130

614

2.27

15.44

2.1

1.8

1.18

1.48

g/l

1.36

124

569

Personal history of allergy to drugs, medicaments and biological substances

267

3.05

15.31

2.0

1.8

1.13

1.31

g/l

0.58

252

Atypical facial pain

214

1201

1.87

15.22

2.5

1.8

1.60

1.36

g/l

0.40

197

1098

Malignant neoplasm, without specification of site

111

490

2.37

15.19

2.3

1.3

1.59

1.22

g/l

0.62

100

445

Pneumothorax

254

1495

1.76

15.17

2.0

1.9

1.13

1.38

g/l

1.94

239

1375

Explicit fungal Sepsis, including avohilmo

158

3.84

15.16

2.0

1.5

0.95

1.64

g/l

0.91

147

Bacterial, viral and other infectious agents, including avohilmo

358

2299

1.61

15.14

2.2

1.9

1.18

1.28

g/l

0.64

324

2159

Diabetic neuropathy

459

3100

1.53

15.11

1.7

1.8

1.26

1.18

g/l

0.30

421

2847

Other erythematous conditions

161

829

2.06

15.07

1.7

1.9

1.29

1.42

g/l

0.44

148

771

Heart failure and hypertrophic cardiomyopathy

399

2.60

15.01

1.9

1.7

1.50

1.43

g/l

0.07

365

Other noninflammatory disorders of vagina

298

1834

1.68

14.99

1.9

1.8

1.43

1.35

g/l

0.33

281

1683

Restless leg syndrome

541

3786

1.47

14.99

2.0

1.37

1.34

g/l

0.09

495

3495

Bacterial, viral and other infectious agents

337

2140

1.63

14.99

2.2

1.9

1.19

1.29

g/l

0.61

306

2008

Morphin

403

2.53

14.89

1.7

1.6

1.21

1.44

g/l

0.50

359

Cluster headache, strict, including avohilmo

216

1225

1.85

14.87

1.7

1.9

1.19

1.33

g/l

0.83

202

1148

Gilbert syndrome

170

3.66

14.84

1.9

1.6

0.99

1.36

g/l

1.17

156

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2223

14461

1.21

14.84

1.9

1.30

1.33

g/l

0.27

2074

13364

Disorders of magnesium metabolism

197

3.49

14.82

1.9

1.7

1.02

1.23

g/l

0.87

182

Tuberculosis, wide

245

1436

1.76

14.79

1.9

1.26

1.46

g/l

0.45

225

1288

Prurigo nodularis

118

546

2.32

14.78

1.9

1.8

1.04

1.32

g/l

1.56

103

497

Fibroblastic disorders

775

5760

1.37

14.77

1.9

2.1

1.31

1.40

g/l

0.36

715

5260

Other predominantly sexually transmitted diseases, not elsewhere classified

652

4724

1.41

14.74

2.0

1.8

1.31

1.29

g/l

0.11

596

4422

Explicit fungal Sepsis

156

3.81

14.72

2.0

1.5

0.95

1.64

g/l

0.90

146

Diabetic retinopathy

1356

6699

1.28

14.68

1.7

1.8

1.12

1.24

g/l

2.07

1232

6134

Brachial plexus disorders

366

2379

1.59

14.66

1.9

1.8

1.33

1.29

g/l

0.14

349

2211

Hallux valgus (acquired)

1077

5961

1.31

14.61

1.9

1.35

1.38

g/l

0.12

977

5440

Scoliosis

319

2010

1.64

14.57

2.0

1.9

1.20

1.40

g/l

1.64

300

1863

Other endocrine disorders

246

1395

1.77

14.56

2.5

1.9

1.09

1.18

g/l

0.64

231

1309

Artificial joint operation, meniscal resection

3405

18863

1.16

14.55

1.9

2.0

1.27

1.31

g/l

0.38

3119

17338

Adhesive capsulitis of shoulder

580

4128

1.44

14.52

1.7

2.0

1.26

1.39

g/l

0.67

540

3795

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

304

1892

1.65

14.51

2.2

1.4

1.55

1.15

g/l

1.19

280

1722

Use of amantadine

375

2.63

14.49

3.6

1.7

0.87

1.46

g/l

2.48

342

Carcinoma in situ of skin of other and unspecified parts of face

292

1804

1.67

14.48

2.8

1.9

1.22

1.44

g/l

0.63

262

1608

Unspecified misadventure during surgical and medical care

232

1354

1.79

14.46

2.1

1.8

1.33

1.40

g/l

0.18

216

1248

Cluster headache, wide,, including avohilmo

223

1287

1.81

14.45

1.8

1.9

1.18

1.36

g/l

1.07

209

1205

Other disorders of conjunctiva

509

3546

1.47

14.44

1.8

1.9

1.15

1.35

g/l

2.07

473

3238

Protein-energy malnutrition of moderate and mild degree

210

3.30

14.40

2.2

2.0

1.43

1.16

g/l

0.63

190

Bell's palsy

430

2902

1.52

14.38

2.3

1.9

1.43

1.34

g/l

0.25

403

2673

Insulin, fast-acting (human)

506

3523

1.47

14.34

1.6

1.9

1.19

1.34

g/l

1.87

466

3271

Cystic fibrosis with pulmonary manifestations

18.57

14.31

3.8

2.5

1.18

1.39

g/l

0.23

Calculus of kidney and ureter

1039

8089

1.31

14.27

1.9

2.0

1.19

1.34

g/l

1.42

967

7444

Traumatic subdural haemorrhage

429

2699

1.52

14.26

1.8

2.0

1.58

1.36

g/l

0.67

383

2455

Car occupant injured in other and unspecified transport accidents

717

5304

1.38

14.24

1.8

1.9

1.27

1.31

g/l

0.27

656

4935

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

684

4105

1.39

14.21

2.0

1.5

1.70

1.19

g/l

2.97

627

3726

Deficiency of other B group vitamins

407

2.50

14.19

2.3

1.7

1.20

1.49

g/l

0.53

372

Primary adrenocortical insufficiency

256

3.03

14.19

2.1

1.7

1.21

1.35

g/l

0.30

239

Eating disorder

344

2219

1.59

14.11

1.7

1.8

1.19

1.37

g/l

2.89

323

2095

Benign neoplasm of mouth and pharynx

402

2691

1.54

14.07

2.3

1.9

1.49

1.35

g/l

0.34

366

2467

Perforation of tympanic membrane

371

2442

1.57

14.05

2.1

1.9

1.24

1.34

g/l

0.62

343

2249

Other and unspecified visual disturbances

403

2700

1.54

14.03

2.2

1.9

1.40

1.38

g/l

0.07

374

2490

Other bacterial agents as the cause of diseases classified to other chapters

235

3.11

14.03

2.8

1.7

1.42

1.69

g/l

0.27

215

Malignant neoplasm of head and neck, including Hilmo

295

1840

1.65

13.94

1.8

1.5

1.20

1.16

g/l

0.16

274

1685

Presbycusis

424

2827

1.51

13.94

2.4

1.8

1.55

1.37

g/l

0.38

368

2499

Urolithiasis

1111

8748

1.29

13.93

2.0

1.19

1.34

g/l

1.59

1029

8047

Erythema nodosum

133

659

2.15

13.92

2.2

1.8

1.01

1.40

g/l

2.54

123

609

Specific development disorders of scholastic skills

209

1173

1.83

13.92

2.5

1.8

1.10

1.14

g/l

0.31

195

1107

Ulcer of oesophagus

231

1358

1.76

13.88

2.0

2.1

1.54

1.44

g/l

0.21

209

1234

Anosmia

252

2.81

13.86

1.6

1.8

0.98

1.37

g/l

2.15

237

Assault

520

3666

1.45

13.85

1.6

1.9

1.51

1.25

g/l

2.12

482

3448

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

778

5852

1.35

13.81

2.0

1.8

1.29

1.28

g/l

0.07

710

5487

Any dementia

788

7211

0.75

13.79

1.9

2.0

1.62

1.38

g/l

0.92

679

6487

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1120

8840

1.29

13.79

1.8

1.9

1.28

g/l

0.02

1038

8245

Localized scleroderma [morphea]

317

2.73

13.79

1.9

1.8

1.31

1.39

g/l

0.14

293

Benign neoplasm: Liver

117

557

2.25

13.69

2.1

1.7

1.20

1.38

g/l

0.96

112

515

Striking against or struck by other objects

1289

10333

1.26

13.69

1.9

1.35

1.26

g/l

0.76

1173

9621

Hypoglycaemia, other or unspecified

266

1632

1.69

13.67

1.6

1.9

1.14

1.36

g/l

1.68

249

1516

Superficial injury of wrist and hand

811

6149

1.34

13.64

1.9

1.27

g/l

0.01

756

5731

Thyrotoxicosis

915

7054

1.32

13.62

1.8

1.9

1.18

1.35

g/l

2.67

855

6491

Pleural plaque

295

1854

1.64

13.62

1.8

2.0

1.18

1.44

g/l

0.76

265

1662

Abscess of lung

368

2.59

13.60

2.6

1.7

1.23

1.56

g/l

0.76

339

Special screening examination for neoplasms

223

1304

1.76

13.59

2.1

2.0

1.52

1.35

g/l

0.34

206

1203

Speech and linguistic disorders

380

2426

1.55

13.58

2.2

1.8

1.08

1.20

g/l

1.46

356

2275

Malignant neoplasm of bladder, including Hilmo

318

2003

1.60

13.56

1.7

1.5

1.28

1.14

g/l

0.47

298

1815

Left ventricular outflow tract obstruction (LVOTO), broad definition

392

2634

1.54

13.55

1.8

2.0

1.14

1.24

g/l

0.77

365

2469

Malignant neoplasm of mesothelium and soft tissue

143

731

2.05

13.54

2.5

1.4

1.05

1.15

g/l

0.46

136

674

Other noninfective disorders of lymphatic vessels and lymph nodes

155

817

2.00

13.54

2.3

1.8

1.27

1.32

g/l

0.13

144

761

Gout due to impairment of renal function

228

3.09

13.53

1.7

1.8

0.89

1.65

g/l

1.73

207

Respiratory conditions due to other external agents

437

2.42

13.49

2.8

1.6

1.25

1.48

g/l

0.34

395

Sequelae of other external causes

225

1328

1.76

13.43

2.3

1.9

1.38

1.39

g/l

0.01

206

1235

Visual impairment including blindness (binocular or monocular)

251

1523

1.70

13.42

2.0

1.8

1.15

1.45

g/l

1.53

218

1385

Malignant neoplasm of urinary organs, including Hilmo

335

2174

1.58

13.39

2.1

1.5

1.53

1.16

g/l

1.20

308

1983

Malignant neoplasm of small intestine, including Hilmo

116

553

2.22

13.35

1.9

1.4

1.29

1.16

g/l

0.23

109

510

Other bullous disorders

127

632

2.15

13.21

1.9

1.8

1.26

1.49

g/l

0.66

120

586

Acute alcohol intoxication

894

6896

1.32

13.21

1.6

2.0

1.25

1.30

g/l

0.49

818

6383

Carcinoma in situ of skin

306

1961

1.61

13.14

2.6

2.0

1.12

1.46

g/l

1.65

280

1771

Abnormal blood-pressure reading, without diagnosis

177

981

1.88

13.10

2.3

1.9

1.21

1.36

g/l

0.51

160

897

Atrophic disorders of skin

568

4109

1.41

13.04

1.8

1.9

1.21

1.32

g/l

1.22

533

3788

Fall on same level involving ice and snow

2190

18583

1.19

13.01

1.9

1.31

g/l

0.02

2019

17115

Amputation of foot

113

541

2.23

12.99

2.0

1.9

0.93

1.53

g/l

3.21

101

497

Nail disorders

328

2141

1.58

12.98

1.8

1.9

1.34

1.31

g/l

0.10

296

1984

Emotional disorders and disorders of social functioning with onset specific to childhood

225

1312

1.75

12.97

2.0

1.9

1.24

1.20

g/l

0.23

209

1232

Malignant neoplasm of small intestine

398

2.43

12.97

2.1

1.4

1.33

1.17

g/l

0.23

374

Congenital malformations of trachea and bronchus

229

3.06

12.95

1.7

1.9

0.91

1.31

g/l

1.93

214

Dilated cardiomyopathy

406

2773

1.51

12.88

1.7

2.0

1.16

1.34

g/l

0.91

381

2535

Other disorders of patella

579

4206

1.40

12.87

1.8

1.9

1.26

1.34

g/l

0.42

526

3890

Aortic aneurysm

725

5342

1.35

12.85

2.1

2.0

1.17

1.39

g/l

1.94

661

4837

Benign neoplasm: Pancreas

128

646

2.12

12.85

2.9

1.8

1.41

1.54

g/l

0.17

123

594

Trigger finger

515

3672

1.43

12.85

1.7

2.0

1.33

1.37

g/l

0.13

471

3392

Chondrocostal junction syndrome [Tietze]

160

868

1.94

12.84

1.8

1.18

1.43

g/l

1.41

142

801

Dementia

936

8195

0.77

12.78

2.0

1.73

1.38

g/l

1.61

806

7402

Open wound of ankle and foot

396

2698

1.51

12.73

1.9

1.21

1.34

g/l

0.73

363

2499

Event of undetermined intent

262

1635

1.66

12.65

2.1

1.9

1.37

1.29

g/l

0.26

249

1528

Extrapyramidal and movement disorders

1349

10984

1.24

12.63

1.9

2.0

1.40

1.34

g/l

0.33

1222

10064

Episcleritis

216

1285

1.75

12.61

2.1

1.8

1.31

1.33

g/l

0.03

200

1197

Gonarthrosis,primary

3266

17180

1.16

12.61

1.9

2.0

1.30

1.33

g/l

0.27

2979

15794

Other and unspecified erythematous conditions

143

754

2.01

12.58

1.7

1.9

1.26

1.44

g/l

0.63

131

701

Lesion of lateral popliteal nerve

192

1106

1.81

12.57

2.3

1.8

1.23

1.28

g/l

0.19

175

1019

Varicose veins

2099

13406

1.19

12.56

1.9

1.29

1.34

g/l

0.30

1929

12260

Erosion of teeth , including avohilmo

1023

8086

1.29

12.54

1.9

1.23

1.30

g/l

0.64

952

7536

Varicella [chickenpox], including avohilmo

225

1355

1.73

12.53

3.1

1.9

1.34

1.27

g/l

0.16

207

1277

Childhood allergy (age < 16)

552

3283

1.41

12.51

1.8

1.23

1.21

g/l

0.22

516

3086

Lichen planus

460

3235

1.46

12.50

1.6

1.9

1.27

1.36

g/l

0.48

423

2961

Other salmonella infections

147

782

1.97

12.50

2.2

1.8

1.35

1.45

g/l

0.13

132

726

Lesion of ulnar nerve

497

3543

1.44

12.47

1.7

2.0

1.16

1.32

g/l

1.32

464

3283

Amiodarone users

341

2265

1.55

12.45

1.5

2.0

1.25

1.38

g/l

0.53

316

2062

Endometriosis of pelvic peritoneum

570

3772

1.40

12.41

1.8

1.9

1.40

1.34

g/l

0.45

513

3490

Use of rivastigmine

206

3405

0.59

12.39

1.7

1.9

1.40

1.42

g/l

0.02

175

3015

Status epilepticus

141

741

1.99

12.39

1.7

1.9

1.49

1.37

g/l

0.25

129

683

Other/unspecified enthesopathies of lower limb, excluding foot

272

1719

1.63

12.38

1.8

1.9

1.27

1.41

g/l

0.80

252

1594

Nonspecific lymphadenitis

232

1413

1.70

12.35

2.2

1.9

1.18

1.32

g/l

0.52

214

1325

Other and unspecified epidermal thickening

121

607

2.12

12.30

1.8

1.7

1.04

1.43

g/l

2.08

115

564

Congenital malformations of the circulatory system

558

3949

1.41

12.30

2.0

1.18

1.28

g/l

1.05

528

3693

Other hammer toe(s) (acquired)

527

3447

1.42

12.27

1.6

1.9

1.19

1.43

g/l

2.28

476

3115

Combined immunodeficiencies

229

2.96

12.27

4.5

1.6

1.23

1.65

g/l

0.63

210

Retinal detachments and breaks

1200

9682

1.26

12.25

2.0

1.41

1.35

g/l

0.29

1108

8854

Thyroiditis

275

1752

1.63

12.19

1.8

1.9

1.37

1.39

g/l

0.05

253

1617

Trigeminal neuralgia

219

1318

1.72

12.18

2.0

1.8

1.33

1.39

g/l

0.11

203

1201

Obsessive-compulsive disorder

258

1617

1.64

12.11

1.7

1.8

1.31

g/l

0.00

235

1528

Mixed and other personality disorders

306

2001

1.58

12.06

2.0

1.9

1.19

1.32

g/l

1.10

277

1883

Idiopathic urticaria

106

511

2.21

12.03

1.4

1.7

1.20

1.28

g/l

0.38

100

474

Sequelae of injuries, of poisoning and of other consequences of external causes

856

6655

1.31

12.03

1.9

2.0

1.27

1.31

g/l

0.30

781

6192

Other specific arthropathies, wide

399

2.37

12.01

2.0

1.8

1.31

1.37

g/l

0.11

369

Acidosis

452

2.30

12.00

1.7

1.9

1.21

1.48

g/l

0.67

416

Collapsed vertebra, not elsewhere classified

149

3.45

11.99

4.0

2.0

0.91

1.82

g/l

1.19

134

Familial hypercholesterolemia, with ischemic heart disease

292

1890

1.59

11.96

1.6

2.0

1.25

1.44

g/l

0.52

268

1681

Chronic conjunctivitis

135

711

2.01

11.95

1.9

1.8

1.05

1.29

g/l

1.90

125

660

Redundant prepuce, phimosis and paraphimosis

722

5399

1.34

11.94

1.9

2.0

1.16

1.22

g/l

0.33

674

5006

Acute nasopharyngitis (common cold)

405

2780

1.48

11.94

2.2

1.8

1.09

1.25

g/l

1.51

375

2604

Acquired absence of limb

182

3.14

11.81

1.9

1.7

0.94

1.50

g/l

0.94

170

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgM [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS